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Abstract 
 
English version 
 
Large-scale proteome analysis of complex biological mixtures requires high resolving 
power separations, high-throughput mass spectrometry and accurate detection, and 
bioinformatics tools. In the present work LC-MALDI TOF/TOF mass spectrometry 
was combined for the first time with a two-dimensional separation based on reversed-
phase chromatography at high and low pH for the analysis of the cytosolic proteome 
of Corynebacterium glutamicum. The proteome coverage achieved by this approach, 
55%, is the highest reported up to day for this bacterium. A total of 1644 proteins 
including single-peptide based identifications were identified.  
The sample was also analysed by other conventional methods in the proteome 
analysis. The classical 2D-PAGE approach presents more limitations and delivered 
166 different proteins including enzymes of the main metabolic pathways. 
Complementary results were found at peptide level for the LC-MALDI and 2D-PAGE 
approaches. Fractions collected during the first dimension at high pH were analysed 
by LC-MALDI MS and compared with the analysis carried out by LC-ESI-IT MS, 
which identified 745 proteins [1]. Further comparison with results found in literature 
confirmed that the two-dimensional reversed phase combination with LC-MALDI 
MS/MS is a promising tool in the proteome analysis. The MALDI based approach 
showed higher sensitivity than other approaches and was able to identify proteins over 
a larger dynamic range, based on the codon adaptation indexes of the proteins. 
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German version 
 
An die Large-Scale Proteomanalyse von komplexen biologischen Mischungen sind 
eine Reihe von Anforderungen gestellt. Unter Anderem sind Trennungen mit hohem 
Auflösungsvermögen, High-Throughput Massenspektrometrie, präzise 
Massenbestimmung und Bioinformatik-Tools erforderlich. Gegenstand der 
vorliegenden Arbeit ist die Evaluierung der Kombination aus LC-MALDI-TOF/TOF 
Massenspektrometrie mit einer zwei-dimensionalen Trennung basierend auf Reverse-
Phase-Chromatographie bei hohen und niedrigen pH-Werten. Des cytosolischen 
Proteoms von Corynebacterium glutamicum wurde mit der Methode analysiert. Dies 
ermöglichte die Indentifizierung von 55% des Proteoms von Corynebacterium 
glutamicum und ist damit der nach momentanem Kenntnisstand effizienteste Ansatz. 
Insgesamt konnten 1644 verschiedene Proteine identifiziert werden.  
Konventionelle Methoden der Proteomanalyse erreichten deutlich schlechtere 
Ergebnisse. So erzielte der klassische 2D-PAGE-Ansatz bei deutlich mehr 
Einschränkungen nur 166 Proteinidentifikationen inklusive wichtiger Enzyme der 
Stoffwechselwege. Komplementäre Ergebnisse konnten auf der Peptid-Ebene für LC-
MALDI und 2D-PAGE Ansätze gefunden werden. Fraktionen der ersten Dimension 
bei hohem pH-Wert mittels LC-MALDI MS wurden analysiert und mit Ergebnissen 
aus LC-ESI-IT MS [1] Untersuchungen verglichen. Es hat sich gezeigt, dass der 
MALDI-basierte Ansatz höhere Sensitivität aufweist und in der Lage war Proteine 
über eine weitaus größere dynamische Reichweite bezogen auf den Codon Adaptation 
Index zu identifizieren. 
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1. Introduction 
 
1.1. Proteomics 
 
In the past years new concepts in biochemistry have emerged as a requisite to define 
new fields of investigation. In the 1980s the term “genomics” was coined to describe 
the study of an organism’s entire genome, which is the hereditary information encoded 
in the DNA of the organism. The term “proteomics” was introduced for the first time 
in 1994 during the Siena meeting for protein separation based on two-dimensional gel 
electrophoresis [2]. This term involves the identification and quantification of all 
proteins present in a sample at a certain time and under certain conditions. Although 
the genome of an organism is steady the product of its expression, the proteome, is 
dynamic.  
In cells there are different levels of organisation according to composition and 
function: DNA, RNA, proteins, metabolites (see Figure 1). The comprehensive 
analysis of each level is called respectively genomics, transcriptomics, proteomics, 
metabolomics. All these levels are interdependent and also influence the proteome 
composition of the cell. The proteins expressed in an organism, cell or tissue depend 
on the life cycle and external factors (temperature, nutrients and other environmental 
factors). Different cellular states lead to different gene expressions, which is revealed 
at RNA and protein level [3]. The global study of all “-omics” including metabolic 
fluxes is called systems biology and it aims the understanding of complex interactions 
across all levels in biological systems and the development of predictive models [4, 5].  
 
 
Figure 1: Different organization levels in a cell. The 
genes are transcribed to RNAs, and these are translated 
to proteins, which catalyze the chemical reactions in the 
cell involving metabolites. 
 
 
 
Protein expression is regulated by transcriptional and translational factors, which are 
proteins subjected also to regulatory mechanisms of synthesis and degradation [6]. 
Protein activity is further influenced by posttranslational modifications (e.g. 
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phosphorylation, glycosylation). The analysis of posttranslational modifications 
regulated by cellular environment, functional characterization of protein complexes 
and the functional characterization of protein pathways and their quantitative changes 
are currently some of the biological applications of  proteomics [7, 8]. 
Since proteins represent the major part of the machinery of the cell, the study of the 
proteome of sequenced organisms yields information about occurrence and abundance 
of proteins and is essential for the understanding of protein activities and metabolic 
regulation. However, the proteome composition of an organism is very heterogeneous 
and its complexity depends on the type of organism. The human genome contains 
20,000-25,000 protein-coding genes [9], whereas the genome of the bacterium E. coli 
encodes for 4,290 proteins [10]. Moreover, protein abundance can cover many orders 
of magnitude e.g. Saccharomyces cerevisiae has been reported to have a protein 
abundance in the cell spanning over six orders of magnitude [11]. As a consequence, it 
happens to be that high abundant proteins are identified multiple times while less 
abundant proteins remain under sampled [12]. In order to face the analysis of such 
complex samples it is essential to combine high-throughput techniques with sensitive 
and accurate mass spectrometers. The large amount of proteomic datasets usually 
generated requires software tools and computational approaches for data processing 
[13]. 
 
1.2. Proteome analysis 
 
The proteome represents all the proteins expressed in the organism, cell or tissue that 
is object of study. Proteins are macromolecules of molecular mass between 104-106 Da 
responsible for a large variety of biological functions in the cell. Enzymes catalyze 
biochemical reactions; transport proteins carry molecules or ions to a specific site; 
regulatory proteins control the reactions of the metabolism. Other proteins form part of 
biological structures, have mechanical, transcriptional or signaling functions. Every 
protein has a unique sequence of amino acids, which is encoded in the corresponding 
gene. All the 20 amino acids contain a tetrahedral carbon linked to an amino group, a 
carboxylic group and a hydrogen atom. They differ in their side-chain, which 
determines the chemical properties of the amino acid. Proteins are linear polymers 
formed by a covalent link between the amino group of one amino acid and the 
carboxylic group of the next amino acid. The sequence of a protein determines the 
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protein folding, its three-dimensional structure and finally, its function. The side chain 
of some amino acid is ionizable and therefore carries a positive or negative charge 
depending on the pH (see pKa in Table 1).  
 
Table 1: Amino acids naturally occurring in proteins. 
 
Name 
Three (one) 
letter code 
Elemental 
composition 
Monoisotopic 
residue mass 
pKa 
Hydrophobic 
Index* 
Alanine Ala (A) C3H5NO 71.037 _ 0.62 
Arginine Arg (R) C6H12N4O 156.101 12.5 -2.53 
Asparagine Asn (N) C4H6N2O2 114.043 _ -0.78 
Aspartic acid Asp (D) C4H5NO3 115.027 4.1 -0.90 
Cysteine Cys (C) C3H5NOS 103.009 8.3 0.29 
Glutamic acid Glu (E) C5H7NO3 129.042 4.1 -0.74 
Glutamine Gln (Q) C5H8N2O2 128.058 _ -0.85 
Glycine Gly (G) C2H3NO 57.021 _ 0.48 
Histidine His (H) C6H7N3O 137.059 6.0 -0.40 
Isoleucine  Ile (I) C6H11NO 113.084 _ 1.38 
Leucine Leu (L) C6H11NO 113.084 _ 1.06 
Lysine Lys (K) C6H12N2O 128.095 10.8 -1.50 
Methionine Met (M) C3H9NOS 131.040 _ 0.64 
Phenylalanine  Phe (F) C9H9NO 147.068 _ 1.19 
Proline Pro (P) C5H7NO 97.053 _ 0.12 
Serine Ser (S) C3H5NO2 87.032 _ -0.18 
Threonine Thr (T) C4H7NO2 101.048 _ -0.05 
Tryptophan (W) Trp (W) C11H10N2O 186.079 _ 0.81 
Tyrosine (Y) Tyr (Y) C9H9NO2 163.063 10.9 0.26 
Valine (V) Val (V) C5H9NO 99.068 _ 1.08 
Terminal amino 
group 
_ _ _ 8.0 _ 
Terminal carboxyl 
group 
_ _ _ 3.1 _ 
* Reference: Eisenberg et al. [14] 
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Amino acids also show a different degree of hydrophobicity, which influences their 
location in a protein. As an example, trans-membrane domains are rich in very 
hydrophobic amino acids while hydrophilic amino acids are situated on the protein 
surface. 
Proteome analysis is usually preceded by protein denaturation to unfold the three-
dimensional structure of the proteins leaving only the linear chain of amino acids or 
primary structure. Protein unfolding is carried out by addition of detergents like 
sodium dodecyl sulfate (SDS), chaotropic agents like urea, organic solvents or heat. 
The covalent disulfide bridges between the side-chains of two cysteines can be 
reduced by addition of dithiotreitol or β-mercaptoethanol. The subsequent alkylation 
of the cysteines avoids refolding of the protein. A protease, an enzyme which cleaves 
the amino acid chain at specific residues, is added to digest the proteins and generate 
peptides with different number of amino acids. As a result, peptides of different 
lengths and with diverse physico-chemical properties are obtained [15, 16]. 
The first development concerning comprehensive analysis of all the proteins present in 
a sample was two-dimensional gel electrophoresis (2D-PAGE) [17, 18], which 
separates proteins according to two physico-chemical properties: isoelectric point and 
molecular mass. Alternatively, peptides resulting from enzymatic digestion of proteins 
with known proteases can be separated by liquid chromatography. Often the 
complexity of a proteome sample requires multidimensional chromatographic steps. 
Nevertheless, the key to high-throughput protein identification was the development of 
the so-called “soft-ionization” techniques in the mass spectrometry field. ESI and 
MALDI are ionization techniques developed in the 1980s which permit ionization of 
peptides and proteins followed by accurate mass measurements. In addition, 
fragmentation of peptides in the mass spectrometer can lead to complete or partial 
sequencing and thus unambiguous identification. In order to accelerate protein 
identification, specific algorithms were developed for systematic comparison of the 
masses in a spectra with the calculated masses obtained from the theoretical digestion 
of sequenced organisms. Currently proteome analysis can be classified in “bottom-up” 
and “top-down” approaches. When the separation takes place at protein level, it is 
called “top-down” whereas if the proteins are digested and separated at the peptide 
level the approach is called “bottom-up”. 
At present most challenging questions in comprehensive proteome analysis are 
sensitivity, dynamic range and instrument capacity to acquire and process data fast and 
  15
effective. While the sensitivity has improved considerably in the past years, it is 
believed that progress in sample fractionation can improve the dynamic range. In 
addition, intelligent acquisition software can aid mass spectrometers to avoid 
redundant measurements on high abundant peptides and improve selectivity [19].  
 
1.3. Separation techniques for the proteome analysis  
 
1.3.1. Two-dimensional gel electrophoresis 
 
Two-dimensional gel electrophoresis is a top-down approach based on protein 
mobility in an electric field. In the first dimension, the isoelectric focusing (IEF), 
proteins are placed on a strip containing an immobilized pH gradient (IPG) and an 
electric field is applied between the extremes of the strip. The proteins are charged due 
to amino-, carboxylic- groups and move towards the electrode of opposite sign until 
they reach the pH region corresponding to their isoelectric point (pI). When they reach 
their pI, proteins carry net charge zero and do not move in the applied electric field. 
Thus proteins are focused on the strip according to their pI.  
After the first dimension proteins focused in the strip are dissolved in a SDS 
containing solution. This anionic detergent binds the protein, denatures it and provides 
a negative charge. SDS binds the protein in a ratio 1.4 g SDS/g protein, proportional to 
its molecular mass. In the second dimension, the strip containing the focused proteins 
saturated with SDS is placed on top of a polyacrylamide gel which has a constant pore 
size and acts as sieve. Proteins are separated in an electric field according to their 
hydrodynamic volume, ultimately according to their molecular mass ( see Figure 2).  
In order to visualise the proteins in the gel, a staining procedure is required. Staining 
can be performed with organic dyes like Coomassie blue, fluorescent dyes [20] or with 
silver nitrate. The interesting protein spots are excised from the gel and digested 
enzymatically. Finally, protein identification is performed by mass spectrometric 
measurement of the peptides released after in-gel digestion [21, 22].  
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Figure 2: Scheme of 2D-PAGE. In the first dimension proteins are separated according to 
their isoelectric point. In the second dimension proteins are denatured in an SDS solution and 
separated according to molecular mass. Finally a protein is digested and identified by MS. 
 
Although 2D-PAGE permits visualisation of up to 1000-2000 protein spots in a gel 
there are still a number of limitations not yet resolved [23, 24]: 
- Sensitivity limits are in the ng region for organic dyes and better for silver 
and fluorescence staining [25]. The fluorescence dyes are, however, more 
expensive. 
- Reproducibility of the gels is not always achieved. Experimental 
performance is laborious and no automation is available. 
- Low dynamic range for quantification due to saturation effects of the dyes.  
- Not all proteins can be resolved in the gels: very acidic, very basic, very 
hydrophobic and membrane proteins are underrepresented, as well as very 
small or very big proteins. 
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1.3.2. Multidimensional liquid chromatography  
 
Multidimensional high-performance liquid chromatography (MD-HPLC) is the 
alternative approach to 2D-PAGE for the proteome analysis. Generally the proteome is 
digested generating a complex mixture of thousands of peptides which is subsequently 
separated by HPLC. Due to the complexity of the sample, separation of the peptides 
cannot be achieved by only one chromatographic step and therefore two-dimensional 
chromatography (2D-HPLC) is employed. The prerequisite to achieve good separation 
efficiency is the orthogonality between both chromatographic dimensions [26]. 
Traditionally, strong-cation exchange chromatography (SCX) is employed in the first 
dimension and reversed-phase chromatography (RP) in the second dimension [27-32].  
SCX separates peptides according to their charge at the working pH. In reversed-phase 
chromatography (RPC) separation is based on the interaction of the peptides with the 
non-polar stationary phase. RP is the method of choice in the second dimension due to 
the compatibility of solvents with mass spectrometry, whereas the presence of salts in 
SCX has a signal suppression effect in the ionization. Frequently RPC of peptides is 
performed by addition of an ion-pairing reagent to the mobile phase generating 
reversed-phase ion-pair chromatography (RP-IPC). In RP-IPC elution of peptides is 
accomplished by a combination of hydrophobic and electrostatic interactions [33]. The 
SCX-RP set-up has been employed successfully for the proteome analysis with either 
on-line [30, 31] or  off-line configurations [28, 34].  
SCX and RP are orthogonal techniques and thus adequate for peptide separation by 
2D-HPLC. However, it has been reported that the efficiency of SCX separations in 
2D-SCX-RP-HPLC setups is lower than expected [35]. Due to the restricted number 
of charge states for the peptides at working conditions, mostly +2, +3 and +4, the 
separation by SCX is clustered. Recently, the orthogonality achieved by combination 
of different chromatographic systems has been studied. It has been reported that two-
dimensional separations based on RP-RP-HPLC [36, 37], RP-IPRP-HPLC [1] and 
zwitteronic hydrophilic interaction liquid chromatography (ZIC-HILIC)-RP [38] 
represent a feasible alternative to the standard SCX-RP-HPLC combination. 
Moreover, compared to the 2D-SCX-RP scheme a 2-fold increase in identified 
proteins/peptides has been reported by switching to 2D-RP-RP [39] and more accurate 
retention prediction models [40]. 
The columns employed for peptide separation by reversed-phase chromatography in 
the second dimension has been traditionally capillary columns packed with 
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microparticulate sorbents. However, it has been revealed that the organic-polymer 
based monolith columns are suitable for proteomic applications due to their excellent 
chromatographic separation efficiency and high peak capacity in a short period of time 
[41-43].  A monolith column is a continuous rigid rod, highly porous resistant to high 
flow rates, which shows high mass transfer and consequently high separation 
efficiency [44, 45]. 
 
1.4. Mass spectrometry 
 
As proteins and peptides are non-volatile and labile molecules under high temperature 
conditions, the development of “soft” ionization techniques was crucial to make 
possible their analysis by mass spectrometry. Currently there are two ionization 
methods introduced in 1988 most suitable for analysis of proteins and peptides: 
MALDI and ESI. Matrix Assisted Laser Desorption Mass Spectrometry (MALDI) was 
introduced by M. Karas and F. Hillenkamp et al. [46], and K. Tanaka et al. [47]. 
Electrospray ionization (ESI) of large biomolecules was introduced by Fenn et al. [48]. 
The volatilization of peptides and proteins permitted the application of mass 
spectrometry for accurate mass determination. Furthermore, it was observed that the 
fragmentation of a peptide delivers sufficient information to sequence it at least 
partially.  Consequently, the protein can be identified by correlation of the acquired 
masses with the predicted masses obtained by a theoretical or “in-silico” digest of the 
protein. The improvements carried out in MS instrumentation during the past 25 years 
have increased the sensitivity in about 5 times every three years [49]. In the following 
lines the mass spectrometric techniques most commonly used in the proteome analysis 
will be described. 
 
1.4.1. MALDI TOF mass spectrometry 
 
In MALDI MS the sample is mixed with a matrix and deposited on a plate for 
analysis. The matrix is a small aromatic organic compound dissolved in an organic 
solvent like ethanol or acetonitrile at acidic pH. On the MALDI-plate the solvent 
evaporates and the sample co-crystallises with matrix crystals. The sample is brought 
into the mass spectrometer under high vacuum and irradiated with a pulsed laser 
(Figure 3). The matrix is characterized by strong absorption at the laser wavelength, 
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usually in the near-ultraviolet. Typically, N2 lasers emitting at λ = 337 nm or Nd:YAG 
lasers emitting at λ = 355 nm, are employed in MALDI mass spectrometry of peptides 
and proteins. 
 
 
Figure 3: Ion source of a MALDI TOF instrument. A laser of typically 355 nm (Nd:YAG) or 
337 nm (N2 laser) irradiates the sample. Peptides are ionized by proton transfer from matrix 
ions. After that they are accelerated (+ 20 kV) by application of a high voltage to the time-of-
flight (TOF) analyzer. 
 
The mechanism of the MALDI ionization is not completely understood but it is 
believed that the matrix absorbs most of the energy and assists desorption and ion 
formation. Basically MALDI ionization of peptides yields singly charged ions [50]. 
Following ionization, the ions are accelerated towards the analyser by a difference of 
potential (Vs) between an electrode and the extraction grid. The ions acquire a defined 
kinetic energy (Ek) given by the electric potential energy (Eel): 
Ek = ½ · (m · v2) = q · Vs = Eel (1) 
Where m is the mass of the analyte and q is the total charge of the ion defined as:  
q = z · e  (2) 
The time of flight (t) of the ion in the mass analyzer depends on its velocity (v) and the 
pathway length of the TOF (L) which is constant:  
v = L / t  (3) 
When the ions enter the field-free region they are separated according to their 
velocities. Because lighter ions travel faster, they reach the detector earlier than 
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heavier ions. In the time-of-flight (TOF) analyzer mass-to-charge ratios (m/z) are 
determined by measuring the time that ions take to reach the detector. Substituting (2) 
and (3) in (1) yields: 
m/z = t2 · (2· Vs ·e / L2)  (4) 
Because the terms in parentheses are constant, m/z can be calculated from a 
measurement of the time of flight. 
In order to improve mass resolution TOF analyzers are equipped with an electrostatic 
reflector also called reflectron (Figure 4). The reflectron is situated opposite to the ion 
source and creates an electric field that slows down the ions and sends them back to 
the TOF. Ions of same m/z but leaving the source with different Ek will be dispersed 
and enter the reflectron at different times. However the ions with higher Ek penetrate 
deeper in the reflector and leave the reflectron focused with ions of the same m/z thus 
reaching the detector at the same time. The reflectron corrects the kinetic energy 
dispersion, thus improving mass resolution [51].  
 
MALDI TOF/TOF 
 
Recently, a new generation of MALDI mass spectrometers have been developed to 
perform high-throughput MS/MS of peptides by collision induced dissociation [52-
54]. Here, the performance of the 4800 MALDI TOF/TOF instrument commercialised 
by Applied Biosystems is described. The spectrum acquired in MS mode supplies a 
measurement of the ions present in a spot and makes possible the selection of the 
precursors for the subsequent MS/MS analysis. In MS/MS mode, the precursor is 
isolated before fragmentation. The desired ion travels through a first short linear TOF 
and is filtered by the Timed Ion Selector (TIS) that consists of two ion gates in series. 
The first gate deflects low mass ions by an applied voltage. When the selected 
precursor arrives, the gate opens (the deflection electrode is set to ground potential) to 
let the ion pass and the second gate closes after it to deflect the high mass ions. The 
precursor entering the collision induced dissociation (CID) cell is decelerated to 1 kV 
and fragmentations are induced by high-energy collisions (1-2 kV) with air molecules 
or a neutral gas like Ar, He or N2. Ions leaving the CID region are accelerated in the 
second source to the second TOF analyser, which is a reflectron TOF, and are finally 
detected [55]. 
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Figure 4: Schematic representation of a MALDI TOF/TOF mass spectrometer. The main 
difference with a standard MALDI TOF mass spectrometer is the presence of the TIS and the 
CID region. 
 
It is also possible to induce peptide fragmentation without employing a gas in the CID 
region. Peptides that have acquired enough internal energy during the ionization 
process can spontaneously experience metastable decay in the field-free region. 
Because this fragmentation, also named post-source decay (PSD), occurs after 
acceleration, the fragment ions have the same velocity as its precursor and are selected 
together by the TIS. These fragments are then accelerated in the second source and due 
to their different masses are separated in the second TOF before arriving at the 
detector [51].  
 
1.4.2. Electrospray mass spectrometry 
 
ESI is, together with MALDI, the method of choice for soft ionization of proteins and 
peptides because it does not cause decomposition of biomolecules. In ESI, the analyte 
is dissolved in a solvent liquid and flows through a capillary tube to a needle where a 
high voltage is applied. Due to the electric field on the needle tip, the eluting liquid 
comes out as a fine mist of electrically charged droplets (electrospray) at atmospheric 
pressure. A potential drop (3-6 kV) between the needle and the inlet of the mass 
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spectrometer separated by 0.2-0.3 cm, guide the droplets towards the entrance of the 
mass spectrometer. The droplets pass through a curtain of heated inert gas or through a 
heated capillary to remove solvent molecules [51]. Solvent evaporation from the 
droplets occurs until the Coulomb repulsion between ions of the same sign becomes of 
the same order as the surface tension. At this point the Rayleigh limit is achieved and 
the droplet explodes generating smaller droplets; this process occurs several times 
until ions are in the gas-phase. To explain the mechanism of gas-ion formation two 
theories have been proposed. The charged residue model (CRM) proposes that 
evaporation of the solvent continues until one solute molecule remains and retains the 
charge to become an ion. The ion evaporation model (IEM) suggests that before the 
one solute molecule is achieved the charge density of the droplet is so high that some 
of the surface ions are ejected into the ambient gas [48, 56]. ESI differs from MALDI 
not only in the mechanism of ionization but also the type of ions generated as it is 
possible to observe multiple charged ions. Ions obtained from large molecules carry as 
many charges as the number of ionisable sites available. Due to the relation mass-to-
charge (m/z), multiple charged ions allow analysis of high molecular mass compounds 
using a conventional mass analyzer. 
In the proteome analysis the ESI ion source is often used with an Ion-Trap (IT) 
analyzer. Ions produced in the source are focused through a skimmer and two RF-only 
octapoles (see Figure 5). The vacuum in the trap is ensured by differential pumping 
between the ion source at atmospheric pressure and the mass analyzer. The IT consists 
of a cylindrical ring electrode and two end-cap electrodes to create a three-dimensional 
electric field. The ions’ trajectories are governed by a radio frequency (RF) voltage 
and a helium bath gas. The ions are stored in the trap and ions of different m/z are 
consecutively ejected by ramping the RF to make ions trajectories sequentially 
become instable. For MS/MS analysis all ions except the precursor ions are ejected. 
The isolated m/z is excited by application of an excitation waveform to the end-cap 
electrodes, increasing the collisions with the He molecules. Finally the fragments are 
ejected according to there m/z and detected. 
 
1.4.3. Liquid chromatography-Mass spectrometry  
 
Interfacing the chromatographic and spectrometric components is fundamental for 
high-throughput proteome analysis and automatic acquisition of data. Because the 
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electrospray is formed directly from a solvent flow, ESI is preferably hyphenated with 
RP-HPLC for analysis of complex samples. The character of the organic solvents used 
in reversed phase chromatography and the absence of salts makes it fully compatible 
with ESI. The electrospray is formed at atmospheric pressure and the ions enter the 
mass spectrometer in the gas phase. This allows direct hyphenation of LC with ESI 
creating a robust on-line system (see Figure 5). One limitation of the on-line coupling 
LC-MS/MS in the analysis of complex samples is that peptide elution is faster than 
most mass spectrometers can collect MS/MS spectra [57].  
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Figure 5: Hyphenation of liquid chromatography and mass spectrometry. On-line coupling of 
liquid chromatography and ESI-IT mass spectrometer (top). In the bottom figure is illustrated 
the off-line process that fixes the chromatographic separation on a MALDI plate followed by 
posterior analysis by MALDI TOF/TOF MS.  
 
Dynamic exclusion is generally applied to avoid missing low-intensity peptides. If the 
number of co-eluting peptides is higher than the number of MS/MS acquirable in one-
data analysis cycle. When low abundant peptides co-elute with high abundance 
peptides their intensity in the spectra exceed the dynamic range of the mass 
spectrometer and the weak ions are not observed [58]. Besides the MS/MS spectra 
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might not be acquired at the maximum of the chromatographic peak, producing a loss 
of sensitivity [59]. 
As mentioned before, recent developments in MALDI TOF mass spectrometry have 
permitted high-throughput MS/MS analysis of peptides. Coupling liquid 
chromatography with MALDI is therefore an attractive possibility for the proteome 
analysis and an alternative to the common LC-ESI combination. Nevertheless, 
MALDI ionization takes place in the mass spectrometer under vacuum and requires an 
off-line coupling (see Figure 5). In a LC-MALDI analysis, the chromatographically 
resolved peptides eluting from the column are mixed on-line with the matrix and 
deposited on the MALDI-plate. Separated peptides are thus immobilized on the 
MALDI-plate and the off-line mass spectrometric analysis is not restricted by the 
chromatographic process. Furthermore, the precursor list can be elaborated after 
complete MS acquisition in order to generate in silico ion chromatograms for each 
detected mass. MS/MS acquisition is thus optimized to perform MS/MS analysis at the 
maximum of the chromatographic peak, increasing the sensitivity. Besides the MALDI 
mass spectrometry shows a high tolerance to the presence of salts and detergents in the 
sample. For these reasons the off-line coupling of the LC separation and MALDI mass 
spectrometry provides fascinating possibilities for the proteome analysis. 
 
1.4.4. Peptide fragmentation and tandem mass spectrometry 
 
MS/MS or tandem mass spectrometry combines the information of the precursor mass 
and the mass of fragments derived from it for protein identification.. The collision 
induced fragmentation of a protonated peptide in the mass spectrometer occurs by 
collision with air or neutral gas molecules (N2, He, Ar). Depending on the collision 
energy of the precursor ion the CID is classified in high-energy CID, range of 1-2 keV 
as in MALDI MS/MS, or low-energy collisions in the range of 100 eV as in an ESI-IT 
or in a triple quadrupole. A peptide sequence is represented from the amino terminus 
(N-terminus) to the carboxyl terminus (C-terminus) as shown in Figure 6 A. 
Fragmentation occurs preferably at the peptide bond between two amino acids. The 
cleavage of one peptide bond generates two fragments containing either the N-
terminus or the C-terminus of the peptide. The nomenclature of peptide fragmentation 
[60, 61] identifies the fragment containing the N-terminus from the original peptide as 
b-ion, whereas the fragment containing the C-terminus is called y-ion (see Figure 6 
A). The b-type ions are all fragments containing the N-terminus derived from all 
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possible fragmentations at the peptide bonds. Similarly are defined the y-type ions, 
which comprise all possible C-terminus peptides. Internal fragments or fragments 
from the series x-, z-, a-, c- are more common in high-energy CID [62].  
In the mass spectrometer, collision induced dissociation yields several fragments from 
all possible peptide bond fragmentation but only fragments retaining a charge can be 
detected. In a MS/MS mass spectrum the mass difference between two consecutive 
ions from the same series correspond exactly to the mass of the amino acid that 
differentiates them (Figure 6 B). 
 
 
Figure 6: (A) Nomenclature for peptide fragmentation. (B) Spectrum generated by 
fragmentation of the peptide SDMQVLAALK by MALDI TOF/TOF with CID. Fragments 
corresponding to b-series and y-series are labelled. The difference between two ions of the 
same series permits calculation of the amino acid between them and thus peptide sequencing.  
 
High-energy CID generally yields immonium ions [H2N=CH-R]+ from some 
individual amino acids in the peptide. These ions can be observed in the low mass 
region of the spectrum and can assist in the sequence assignment by confirming the 
presence of an amino acid. In the MS/MS spectrum in Figure 6 the immonium ion of 
methionine is observed at m/z 104. 
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1.5. Protein identification by database search 
 
The identification of proteins is carried out by matching the acquired spectrum with 
data of a database containing the sequenced genome of the studied organism. There 
are two possible databases searches that can be used for protein identification: peptide 
mass fingerprint (PMF) or MS/MS. Protein identification by PMF uses the masses of 
the peptides generated by digestion of a single protein. Because each protein sequence 
is unique, the digestion yields a distinctive “fingerprint” of peptides, which is 
compared with the theoretical digest of all proteins present in the database. Protein 
identification by tandem mass spectrometry or MS/MS uses the information generated 
by fragmentation of a peptide by collision induced dissociation (CID) or post source 
decay (PSD). The database search is performed by an algorithm that compares the 
experimental data with data calculated from a protein or nucleotide database until it 
matches the spectrum to an amino acid sequence. Moreover, the algorithm applies the 
cleavage rules of the enzyme used in the proteolysis of the proteins. The most widely 
used programs for correlation of spectra with theoretical data are Mascot [63] and 
Sequest [64]. In the present work Mascot, a search engine which incorporates a 
probability-based scoring, has been used. To perform a search the user has to define 
some parameters like the enzyme employed for digestion, the error window on the 
measured mass values, modifications expected or number of missed cleavages. The 
search engine returns a list of best matches to a spectrum and a score that permits 
determining if a result is significant or not. In proteomics large datasets of MS/MS 
data are submitted for database search and the rate of false-positives associated with 
the search can be calculated. Estimation of the false positive rate (FPR) of the 
identifications can be performed by searching in a composite “target-decoy” database 
[65]. While the “target database” is the one used for the routine identifications, the 
decoy database can be either the reversed or randomised of the “target” [28, 66]. The 
false positive rate can be estimated by doubling the number of decoy hits and dividing 
this by the total number of hits (decoy and target hits). 
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1.6. Corynebacterium glutamicum 
 
Corynebacterium glutamicum is a gram-positive bacterium (Figure 7) of economic 
interest in biotechnology, it grows fast without forming clumps and it is a GRAS 
(generally recognized as safe) organism [67]. It belongs to the suborder 
Corynebacterineae, which includes also the pathogenic bacteria Corynebacterium 
diphteriae, and the family related Mycobacterium leprae and Mycobacterium 
tuberculosis. Together with other well-known organisms like Escherichia coli or 
Saccharomyces cerevisiae, C. glutamicum is of industrial relevance and is therefore 
intensively studied.  
 
Figure 7: Corynebacterium glutamicum wildtype cells. The cells are 
typically rod form cells (Source: J. Krömer).  
 
 
 
The feature which has made C. glutamicum especially interesting in the last 50 years is 
its ability to produce amino acids. In 1957, Kinoshita found that C. glutamicum was 
able to secrete L-glutamic acid, which is used in its sodium glutamate form as a 
powerful food taste enhancer. The possibility of biotechnological production of L-
glutamate was exploited by the industry and the interest in this bacterium increased. 
As a consequence, new strains were developed by random mutagenesis (chemical 
mutagenesis or UV irradiation), making possible large scale production of L-glutamate 
and L-lysine [68]. L-lysine is an essential amino acid usually present in the diet. 
However, manufactured cattle foodstuff lacks of this amino acid and therefore the 
addition of L-lysine is necessary to promote animal growth. Other amino acids 
produced industrially by C. glutamicum but to a less extent include L-threonine and L-
glutamine [69]. One advantage of the biotechnological amino acid production is that it 
is a highly selective process and that yields exclusively the physiologically active L-
isomer, whereas the production based on chemical methods yields a racemic mixture. 
Additionally, biotechnological processes promise easy waste disposals and 
consumption of renewable resources.  
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The complete genome of C. glutamicum was published in 2003 [70, 71] by two 
different institutions: Kitasato University (Japan) and the company Kyowa H.K., and 
the University of Bielefeld (Germany) in collaboration with the company Degussa. 
The genome size of C. glutamicum has 3.3 Mbp and the predicted open reading frames 
(ORFs) reported by Kitasato and Bielefeld Universities were 2993 and 3057 
respectively. The information about the metabolic network and genome of C. 
glutamicum has permitted rational design of new strains by metabolic engineering 
(Ohnishi et al., 2002).  
The proteome of C. glutamicum has been studied extensively by 2D-PAGE followed 
by identification by mass spectrometry [72-74]. The number of spots observable on a 
Coomassie Blue stained 2-gel of the cytosolic proteome was reported to be between 
800 and 900. Based on this methodology Schaffer et al. reported the identification of 
147 different soluble proteins and 13 membrane-associated proteins [74]. Moreover, 
one study on the closely related Corynebacterium efficiens based on 2D-PAGE and 
mass spectrometry identified up to 177 different proteins [75]. Recently, 2D-PAGE 
and identification by MS has been the method of choice to confirm results from 
transcriptome analysis of C. glutamicum cells grown on citrate [76]. While cytosolic 
proteins with pI 3-7 appear well resolved in 2D-gels, basic proteins with pI > 7 are 
underrepresented [74]. Membrane proteins are difficult to analyse by 2D-PAGE 
because they show low solubility and aggregate during IEF focusing. Therefore 
diverse strategies have been developed in order to identify the membrane proteome of 
C. glutamicum. The combination of anion-exchange chromatography followed by 
SDS-PAGE permitted the identification of 50 membrane-integral proteins [77]. 
Alternatively, a new protocol based on a predigest of isolated bacterial membranes of 
a lysine producing strain with trypsin, followed by digestion with trypsin 
/chymotrypsin in 60% methanol delivered the identification of  326 integral membrane 
proteins [78] in addition to 1181 cytosolic proteins. An approach using SDS-PAGE 
separation of C. glutamicum proteome followed by enzymatic digestion of individual 
gel bands prior to LC-MALDI analysis, reported the identification of 350 non-
redundant proteins [79]. Recently, the combination of two-dimensional reversed phase 
chromatography and detection with an ESI-IT delivered the identification of 745 non-
redundant cytosolic proteins [1]. Nevertheless, these numbers of identified proteins are 
still far from the roughly 3000 gene products predicted and improvements in the 
proteome analysis are necessary in order to achieve higher proteome coverage.  
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2. Goal of the thesis 
 
Proteomics or proteome analysis is still a young research area of the bio-sciences. The 
study of the whole proteome of an organism is a huge task which requires the 
combination of different analytical techniques. Classically the separation of proteins 
has been achieved by 2D-PAGE. Alternatively the proteome can be digested yielding a 
complex mixture of peptides, which requires the combination of several 
chromatography stages for peptide separation. The standard set-up is a two-
dimensional combination of SCX and RPC. The identification of the proteins is 
achieved by accurate mass spectrometric analysis of the peptides and/or peptide 
fragments.  
The aim of this work was to develop an analytical method for the proteome analysis 
and more concrete to improve the methodology for the study of C. glutamicum. 
Because it is used for large-scale production of amino acids, C. glutamicum is a 
relevant organism in the industry. The importance of the achievements of the present 
work relies not only on the application of the method for general proteome analysis 
but also, from the biotechnological point of view, on the knowledge gained about this 
amino acid producing organism. The novel combination of two-dimensional RPC at 
acidic and basic pH with high-throughput analysis by LC-MALDI TOF/TOF is a very 
promising tool for the proteome analysis. In the first part of the thesis the 
establishment and optimization of the LC-MALDI technique for the proteome analysis 
is described. Further on, the results from the investigation of the proteome of C. 
glutamicum by means of 2D-RP-HPLC combined with MALDI MS/MS are presented. 
In the next part of the thesis the method is evaluated by comparison with two classical 
approaches for the proteome analysis as illustrated in Figure 8. In the first case the 
separation takes place at the protein level by 2D-PAGE. The LC-MALDI approach is 
compared with the standard 2D-PAGE followed by mass spectrometric analysis with 
the MALDI TOF/TOF instrument. In the second case the same separation is followed 
by a different mass spectrometric detection. Finally, the results are compared with 
results of previous proteome studies on C.glutamicum in the literature. The success 
obtained on our model organism Corynebacterium glutamicum suggests that the 
established method is also suitable for other organisms. 
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Figure 8: Strategy employed in this work for the proteome analysis of C. glutamicum. The 
digestion of the proteins extracted from the organism followed by the novel combination of 
2D-RP-HPLC pH based and MALDI TOF/TOF MS is shown on the left side. This approach is 
compared with the 2D-PAGE approach shown on the right side and with the result obtained by 
using a ESI-IT mass spectrometer. 
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3. Materials and methods 
 
3.1. Materials 
 
Ethylenediamine-tetraacetic acid disodium salt (EDTA, Approx. 99%), zwitterionic 
detergent 3-[(3-cholamidopropyl)dimetylammonio]-1-propanesulfonate (CHAPS, for 
electrophoresis, min 98%), ammonium persulfate (min 98%), bromophenol blue 
sodium salt, sodium thiosulfate pentahydrate, the MALDI matrix α-cyano-4-
hydroxycinnamic acid (CHCA, powder, ≥98%), the peptide for internal calibration 
[Glu1]-fibrinopeptide B human (≥ 90%) and all chemicals employed for 
chromatography (of HPLC grade) were obtained from Sigma-Aldrich (Steinheim, 
Germany). Thiourea (analysis grade), N,N,N´,N´ tetramethylethylendiamine (TEMED, 
min 99%), Coomassie brilliant blue for electrophoresis, ammonium 
hydrogencarbonate (estra pure) and ammonium sulfate were purchased from Merck 
(Darmstadt, Germany). Urea (≥ 99.5%), Tris-(hydroxymethyl)-aminomethane (≥ 
99.9%), sodium dodecyl sulfate (SDS, ≥ 99.9%for electrophoresis), acrylamide 
solution Rotiphorese® Gel 30 were purchased from Carl Roth GmbH (Karlsruhe, 
Germany). The protease inhibitor cocktail Complete Mini employed for protein 
extraction was purchased from Roche (Mannheim, Germany). Sodium carbonate 
(99.5%) was provided by Grüssing (Filsum, Germany). Chemicals employed for the 
2D-PAGE like glycerin (99%, water free), iodoacetamide (for synthesis, > 98%), 
ethanol (99%), acetic acid (99.5 - 99.8%), methanol (for synthesis), phosphoric acid 
(85%), silver nitrate (for analysis), formaldehyde for synthesis were obtained from 
Chemical Storage Facility of the University of Saarland. Dithiotreitol (DTT, molecular 
biology grade, ≥ 99%) was purchased from MBI Fermentas (St. Leon-Rot, Germany). 
The precast inmobilized pH gradient Ready Strips™ IPG and the carrier ampholytes 
Bio-Lyte 3-10 for the electrophoresis were purchased from Bio-Rad Laboratories 
(Hercules, CA, USA). Trifluoroacetic acid (TFA, ≥ 99.5%) was purchased from Fluka 
(Steinheim, Germany). Sequencing grade modified trypsin was obtained from 
Promega (Madison, WI, USA). All solvents were HPLC grade and water milliQ was 
prepared with a Millipore water purification system (Bedford, MA, USA). 
 
 
  32
3.2. Cultivation of Corynebacterium glutamicum 
 
C. glutamicum wild-type strain ATCC 13032 (American Type and Culture Collection) 
cells were taken from -80 °C frozen stock culture and grown in agar plates at 30 °C. A 
single colony was taken for the first preculture and cells were grown for 8 h at 30°C in 
50 mL complex medium (5 g L-1 glucose, 5 g L-1 yeast extract, 10 g L-1 g tryptone, 5 g 
L-1 NaCl) in 500 mL shake flask. Cells were harvested by centrifugation (8800 × g, 2 
min, 30 °C) washed twice with sterile 0.9% NaCl and resuspended in 25 mL minimal 
medium for the second preculture in 250 mL shake flasks. Main cultivation was 
performed in minimal medium at 30°C and 230 rpm in an incubator shaker 
(Multitrom, Infors AG, Bottmingen, Switzerland) and cells were harvested at optical 
density (OD660)  14 measured as described previously [80] when the growth rate 
reached µ= 0.37 h-1 corresponding to 4.9 g L-1 biomass dry weight. Minimal medium 
containing 15 g L-1 glucose was prepared by combination of the following solutions 
after autoclaving: (A) 1 g NaCl, 55 mg CaCl2 and MgSO4 · H2O in 559 mL deionized 
water; (B) 5 g (NH4)2SO4 in 200 mL deionized water; 16 g K2HPO4 and 2 g KH2PO4 
in 100 mL deionized water; (C) 20 mg FeSO4· 7 H2O, pH 1 with HCl; (D) 15 g 
glucose in 100 mL deionized water; (E) 20 mL of vitamin solution (2.5 mg biotin, 5 
mg thiamin HCl, 5 mg Ca-panthotenate in 100 mL deionized water); (F) 10 ml of 
100X trace elements solution (200 mg L-1 Fe3Cl 6H2O, 200 mg L-1 MnSO4 H2O, 50 
mg L-1 ZnSO4 H2O, 20 mg L-1 CuCl2 2H2O, 20 mg L-1 Na2B4O7 10H2O, and 10 mg L-1 
(NH4)6Mo7O24 4H2O; and (G) 1 mL of a 10 mL DHB solution (30 mg 3,4-
dihydroxybenzoic acid and 0.5 mL NaOH 6 M). Cells were harvested by 
centrifugation at 4°C for 5 min (8500 rpm, HFA 8.50 Highconic™ Rotor, Biofuge 
Stratos Sorvall), washed twice with 1 mL sterile 0.9% NaCl and stored at -75 °C.  
 
3.3. Protein extraction from Corynebacterium glutamicum cells 
 
Cell wall disruption was performed mechanically with a mixer mill (MM 301, Retsch 
GmbH, Haan, Germany). Approximately 200 mg (wet cell weight) of C. glutamicum 
cells were resuspended in lysis buffer 1:3 (20 mM TRIS, 5 mM EDTA, pH 7.5 and 
protease inhibitor cocktail). The vial and lysis buffer were kept in ice at 4 °C. About 
0.8 g of glass beads of 0.25 - 0.5 mm external diameter was added. The vial was 
inverted 3 - 4 times to ensure homogeneity and placed in the mixer mill for cell 
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disruption. The mixer mill was set to maximal vibration intensity of 30 Hz (1800min-1) 
for 15 min. After that, the vial was centrifuged (13000 × g, 5 min, 4°C) and the 
supernatant was collected in a fresh vial. Again fresh lysis buffer was added and the 
extraction procedure repeated for five times. The resulting supernatant containing the 
cytoplasmic proteins was centrifuged for 30 min at 50000 x g and 4°C to remove 
insoluble rests from cell debris. Protein concentration was determined by Bradford test 
(Bio-Rad Protein Assay, Bio-Rad Laboratories GmbH, Munich, Germany) [81] and 
the sample was stored in aliquots at -20 °C. 
 
3.4. Two-dimensional liquid chromatography 
 
3.4.1. Digestion of cytosolic proteins 
 
About 300 µg of total protein were denatured in presence of 3M urea and 187 mM 
ammonium hydrogencarbonate for 1 hour at 37 °C. The disulfide bridges were 
reduced in 11 mM DTT for 2 h at 37°C and 600 rpm shaking in a Thermomixer 
comfort (Eppendorf). The solution was degassed and cysteines were alkylated in 
presence of 50 mM iodacetic acid for 30 min in a dark place. Excess of iodacetic acid 
was quenched by addition of ß-mercaptoethanol to a 45 mM final concentration and 
the sample was incubated for 20 min at room temperature. The sample was dialyzed 
overnight in a dialysis cassette (Slide-A-Lyzer® 3500 MWCO, Pierce) against one 
liter distilled water. Proteins were digested with trypsin (Promega, Madison, WI, 
USA) in a ratio 1/50 (w/w) for 24 hours at 37 °C. Trypsin was dissolved in 50 mmol/L 
acetic acid and incubated for 30 min at 30 ºC before digestion. Digestion was stopped 
by addition of TFA to 1% (v/v) end concentration. 
 
3.4.2. First dimension: reversed-phase HPLC at pH 10 
 
Peptide separation at high pH was performed on a Gemini C18 column, 150 mm x 2 
mm, 3 µm, 110 Å (Phenomenex, Aschaffenburg, Germany). About 280 µg of digested 
peptides were manually injected with a 400 µL loop onto the column at 200 µL/min 
with eluent A (72 mM aqueous triethylamine, pH 10 adjusted with acetic acid). 
Peptide elution was accomplished with a gradient of 0 - 55 % B in 55 min using a low-
pressure gradient pump (Rheos 2000, Flux Instruments, Basel, Switzerland) equipped 
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with a degasser (Knauer GmbH, Berlin, Germany) and an injection system (Model 
7725, Rheodyne, Rohnert Park, CA, USA). Eluent B consisted of 72 mM 
triethylamine, 52 mM acetic acid in acetonitrile. Detection of peptide elution was 
performed at 280 nm. Fractions were collected every minute (approx. 200 µL) and 
subsequently acetonitrile was removed by evaporation to 1/10 of the original volume 
in a vacuum concentrator (Model 5301, Eppendorf AG, Hamburg, Germany).  
 
3.4.3. Fraction screening by MALDI TOF MS 
 
In order to determine the fractions to be analysed by LC-MALDI, a rapid screening of 
all collected fractions was performed by MALDI TOF MS. A few microliters of each 
fraction were used to prepare sample dilutions. Dilutions 1:10 and 1:100 were 
prepared employing 0.1 % TFA. Each sample was spotted three times as follows: 0.5 
µL of the sample was deposited on a MALDI plate, followed by addition of 0.5 µL of 
MALDI matrix (2.6 mg/mL CCA in 50% ACN, 0.1% TFA). Calibration was 
performed for the mass range 800 - 4000 Da and sample spectra were acquired under 
the following parameters: 50 shots per sub-spectrum and accumulation of 30 sub-
spectra. 
 
3.4.4. Second dimension: reversed-phase HPLC at pH 2.1 
 
The selected fractions were reconstituted with 105 µL of 0.10 % heptafluorobutyric 
acid previous to analysis and analysed in triplicate. A 10 µL aliquot of each selected 
fraction was injected with a Famos/Ultimate HPLC instrument (LC Packings, 
Amsterdam, Netherlands) onto a PS-DVB trap column (10 mm x 0.2 mm i.d.) for 
peptide preconcentration and peptides were washed for 2.5 min with 10 % aqueous 
heptafluorobutyric acid at 10 µL/min. Peptides were eluted onto the PS-DVB monolith 
column (60 mm x 0.1 mm i.d.) at flow rate 0.7 µl/min. Mobile phase composition was 
(A) 0.05% TFA in H2O, (B) 0.05% TFA in ACN. The gradient employed was a 60 
min linear gradient from 0 to 20 % B followed by a 3 min isocratic elution at 100% B. 
The oven temperature was set to 25 °C and UV detection was performed at 214 nm. 
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3.4.5. LC-MALDI spotting  
 
The effluent from the column was 0.7 µL/min and the eluting peptides were mixed 
post-column with MALDI matrix in a ratio 1: 4 (v:v). The resulting flow rate for the 
spotting procedure was 3.5 µL/min. The matrix concentration used was 3 mg/ml in 70 
% acetonitrile and 0.1% TFA aqueous solution. The spotting of the MALDI-plates was 
accomplished by a Probot microfraction collector (LC Packings, Dionex, 
Netherlands). Spots were deposited every 5 seconds on the MALDI-plate (Opti-TOF™ 
LC MALDI Insert, Applied Biosystems, USA) for 62 minutes. Spotting was started 12 
minutes after injection corresponding to the delay time between the column and the 
spotter. The spots were distributed on the MALDI-plate in 32 rows and 49 columns 
which conferred a total capacity of 1568 spots per plate. 
 
3.4.6. LC-MALDI TOF/TOF analysis 
 
A MALDI TOF/TOF 4800 (Applied Biosystems, Darmstadt, Germany) mass 
spectrometer was used for acquisition and processing of the data. MS data from the 
spots was acquired in positive reflector ion mode in the mass range of 800-4000 m/z 
by accumulation of 1000 laser shots. In addition to the default calibration, MS spectra 
were internally calibrated with [Glu1]-fibrinopeptide B (Sigma) added to the matrix to 
a concentration of 21 fmol/µL. The list of precursors for MS/MS analysis was 
automatically generated by the instrument software according to the following 
selection criteria: minimum signal to noise ratio 35; precursor mass tolerance between 
spots ± 200 ppm; minimum chromatogram peak of two spots and a maximal of six 
precursors per spot. An exclusion filter was used to eliminate the internal mass 
standard. MS/MS spectra were generated by one kilovolt collisions with air using a 
source voltage of 8 kV, a collision cell voltage of 7 kV and an accelerating voltage in 
the second source of 15 kV. Maximal 3000 laser shots were accumulated for a MS/MS 
spectrum. Stop conditions for MS/MS were defined as a minimal number of 10 peaks 
above 35 S/N with at least 12 accumulated sub-spectra. 
 
3.4.7. Database search and protein identification  
 
Raw files containing a peak list of the precursors and fragment ions were filtered with 
the Peak to Mascot tool (4000 Series Explorer Software, ABI) for generation of 
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MASCOT generic files. The settings for peak export were the following: maximal 
peak density of 20 peaks per 200 Da; mass range from 60 Da to the precursor mass 
minus 35 Da; minimal peak area 200; minimum signal/noise 10 and maximum 65 
peaks per precursor. The filtered files were submitted for database search using 
MASCOT search engine [63] version 2.1 (Matrix Science, London, UK). The search 
was performed in Corynebacterium glutamicum ATCC 13032 Kitasato database (2993 
protein coding genes), downloaded from the Comprehensive Microbial Research 
(CMR) public database of the Institute for Genomic Research (TIGR, www.tigr.org). 
The following search parameters were used: enzyme, trypsin; allowed missed 
cleavages, 1; fixed modifications, carboxymethylation of cysteine; variable 
modification, oxidation of methionine; mass tolerance for precursors was set to ± 50 
ppm and for MS/MS fragment ions to ± 0.2 Da. The confidence interval for protein 
identification was set to ≥ 95% (p < 0.05) and only peptides with an individual ion 
score above the identity threshold were considered correctly identified. Estimation of 
the false positive rate was calculated by MASCOT search in a composite database 
created by appending a random database to the normal database thus generating a 
database twice the size of the original [65, 66]. The number of hits in the random 
database was doubled and divided by the total number of hits (random and target) as 
described in [66].  
 
3.5. Two-dimensional gel electrophoresis 
 
3.5.1. First dimension: isoelectric focusing 
 
The protein solution was diluted with rehydration buffer (8 M urea, 2 M thiourea, 4% 
CHAPS, 40 mM DTT and 1% Bio-lyte 3-10) up to 350 µL. The amount of protein 
loaded in the strip depended on the staining method: 200 µg of protein for Comassie 
blue staining and 75 µg of protein for silver staining. The IPG strips used for 
isoelectric focusing (pH 4-7, 17cm) were unfrozen at room temperature and rehydrated 
overnight with 350 µL of the rehydration solution in the rehydration tray covered with 
a lid. The rehydrated strips were transferred to a focusing tray and covered with 
mineral oil to prevent solvent evaporation. Paper wicks wet in distillated water were 
placed between the end of the strips and the electrodes. Isoelectric focusing was 
performed in the Protean IEF cell (Bio-Rad) at 20 °C and a maximum current of 
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50µA/strip was allowed. The focusing conditions were as follows: 500V gradient for 
1500 Vh, 500 V constant for 2500 Vh, 3500 V gradient for 10 kV h and 3500 V 
constant until 70 kVh were completed. The strips which were not directly used after 
focusing were stored at –20 °C. 
 
3.5.2. Second dimension: SDS-PAGE 
 
The gels employed for the second dimension consisted of two parts: staking gel (T 
5%, 0.125 Tris, pH 6.8, 0.1% SDS) and separating gel (T 12.5%, 0.375 Tris, pH 8.8, 
0.1% SDS). Gels were 0.1 cm thick, 18.3 cm wide and 19.3 cm long, and were freshly 
polymerized prior to use. The 30% acrylamide/bis-acrylamide (37.5:1) solution was 
purchased from Roth. The polymerization was started by addition of 10% aqueous 
ammonium persulfate solution prepared fresh (1/200, v/v) followed by addition of 
TEMED (1/2000, v/v) under stirring. The separating gel was prepared firstly and was 
allowed to polymerize for 30 min. The stacking gel was allowed to polymerize for a 
minimum of two hours. The focused strips were equilibrated for 15 min in two 
different SDS containing buffers by gentle shaking previous to the second dimension. 
The first equilibration solution contained DTT for reduction of the sulfhydryl groups 
(6 M urea, 0.375 M Tris HCl, pH 8.8, 2% SDS, 20% glycerol, 2% (w/v) DTT and 
Bromophenol blue). After removal of the reducing buffer, the strips were equilibrated 
in an iodoacetamide containing buffer for alkylation of the reduced sulfhydryl groups 
(6 M urea, 0.375 M Tris HCl, pH 8.8, 2% SDS, 20% glycerol, 2.5% (w/v) 
iodoacetamide and Bromophenol blue). After removal of the alkylating buffer the 
strips were shortly equilibrated in running buffer (25 mM Tris, 192 mM glycine, 0.1% 
SDS, pH 8.3). Second dimension was run in a Protean II xi Cell (Bio-Rad) with the 
following settings: 20 mA constant for 2 h and 22 mA constant for 10 h. 
 
3.5.3. Gel staining 
 
In order to remove rests of running buffer which may interfere with the staining 
(especially SDS) and fix the proteins, gels were fixed in an aqueous solution of 30% 
ethanol and 10% acetic acid for at least two hours. Before staining, the gels were 
washed in distillate water for one hour. Coomassie Blue staining is based on ionic and 
hydrophobic interactions between the dye molecules and the proteins at acidic pH. The 
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staining protocol used is called “Blue silver” [25] and is based on the Neuhoff´s 
procedure [82]. Gels were incubated in equilibrating solution (10% methanol, 2% 
phosphoric acid) for one hour under gentle shaking. After that the equilibrating 
solution was replaced by the staining solution (aqueous solution of 10% phosphoric 
acid, 10% ammonium sulphate, 20% methanol and 0.12% of Coomassie Blue G-250 
(w/v)). The equilibration solution was prepared as described by Candiano et al. (2004) 
and the gels were incubated under gentle shaking for 24 hours. Before scanning, the 
gels were incubated in distillate H2O to remove the staining from the background of 
polyacrylamide gel. Gels were stored in a 20% ethanol, 2% glycerol aqueous solution. 
 
3.5.4. Gel image analysis 
 
Gels were digitalized by scanning the gel and image analysis was performed with the 
ImagemasterTM 2D Platinum Software version 5.0 (Amersharm Biosciences, Uppsala, 
Sweden). Spots selected for analysis were excised from the gel and the 1 mm thick gel 
plugs were either digested or stored in Eppendorf tubes at -20 °C.  
 
3.5.5. In-gel digestion  
 
The vials containing the spots were placed in a Thermomixer comfort (Eppendorf). 
The gel plugs were washed with 100 µL milliQ water for 5 min at 37 °C and 600 rpm. 
Next, they were washed with 100 µL of a solution water/acetonitrile (50/50) for 5 min 
at 37 °C and 600 rpm. In the next step the gel plugs were incubated for 1 hour in 50 
µL (when necessary more volume was used for complete coverage of the spot) of a 10 
mM DTT solution at 56 °C and 600 rpm. After reducing of the proteins, the gel plugs 
were washed with 100 µL milliQ H2O for 5 min at 37 °C and 600 rpm. Alkylation was 
performed at room temperature by addition of 50 µL of a 55 mM iodacetamide 
solution in 40 mM ammonium hydrogencarbonate. Gel plugs were incubated for 30 
min in the dark. In order to remove rests of dye the gel plugs were washed for 5 min 
alternatively with water and water/acetonitrile (50:50) at 37 °C and 600 rpm. When the 
dye was completely removed, the gel plugs were incubated for 1 min in 100 µL of 
100% acetonitrile. After removal of the acetonitrile the gel plugs were allowed to dry 
for 15 min with the cap of the vial open. Digestion was started by addition of 5 µL (or 
10 µL for big gel plugs) of a trypsin solution (Promega Sequencing Grade Modified 
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Trypsin, Promega Corporation, Madison, USA). The trypsin solution was prepared by 
dilution 1:30 with 40 mM ammonium hydrogen carbonate. If necessary to keep the gel 
plug in solution, a few microliters of 40 mM ammonium hydrogen carbonate solution 
were added. Digestion was carries out overnight by incubation at 37 °C and 600 rpm 
shaking. 
 
3.5.6. Zip Tip™ 
 
If peptide concentration was very low for detection, purifying and concentration of 
peptides was achieved with 10 µL ZipTipC18 pipette tips. The C18 chromatography 
media bed was prepared by aspiration and dispense of 10 µL of 100% acetonitrile 
solution twice. Then the media was equilibrated with 10 µL of 0.1% TFA solution 
three times. For peptide binding the sample was aspirated and dispensed up to 10 
cycles. Tip washing was performed with a 0.1% TFA solution and elution was 
accomplished with 1-4 µL of 50% acetonitrile 0.1% TFA solution. The sample was 
directly deposited on the MALDI-plate and mixed with MALDI matrix for analysis. 
 
3.5.7. MALDI TOF/TOF analysis 
 
The identification of proteins from in-gel digests was performed with a MALDI-
TOF/TOF 4800 mass spectrometer (Applied Biosystems). 0.5 µl of digest was 
deposited on the plate followed by addition of 0.5 µl of matrix. The matrix consisted 
of 5 mg/ml of CCA in 50% ACN and 0.1% TFA. The default calibration was updated 
with standard peptides before starting the measurements. Spectra were acquired 
automatically in positive mode and a total of 1500 shots were accumulated per 
spectrum. Mass range was selected between 800 and 4000 m/z. The three strongest 
precursors showing S/N better than 50 in the MS spectrum were selected for further 
MS/MS analysis. MS/MS was performed with the 1kV positive operating mode and 
CID was off. A maximum of 2000 laser shots were accumulated per MS/MS 
spectrum. The acquisition of MS/MS spectra stopped automatically when the 
following conditions were fulfilled: at least 10 of the peaks in the spectra were above 
35 S/N after accumulation of a minimum of 12 a sub-spectra. 
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3.5.8. Database search 
 
The spectra acquired by MALDI-TOF/TOF were searched in MASCOT® v 2.1 with 
the GPS Explorer™ software (Applied Biosystems). A combined search with MS and 
MS/MS data was performed in the database of C. glutamicum (downloaded from 
TIGR website) and NCBI, the enzyme was trypsin and maximal missed cleavage was 
set to 1. Two variable modifications were considered: methionine oxidation and 
cysteine carboxymethylation. The mass tolerance for the precursor was set to ±50 ppm 
and for MS/MS fragments was set to ±0.2 Da.  
 
3.6. One-dimensional gel electrophoresis 
 
The gels, 7.4 cm wide x 6.8 cm length, were cast in the Mini-Protean System of Bio-
Rad. 10 ml of solution (T 12.5%) were required to cast two separating gels for SDS-
PAGE separation. The solution was prepared by adding 3.2 ml distillate water, 2.5 ml 
of 1.5 M Tris pH 8.8 solution, 100 µl of 10% SDS solution, 4.1 ml of 30% 
acrylamide/bisacrylamide (37.5:1) solution, 5 µl of TEMED and 50 µl of 10% 
ammonium persulphate solution. The gel was allowed to polymerize for 30 min. 
Following that, the collecting gels were prepared. The solution consisted of 3.05 ml 
distillate water, 1.25 ml of 0.5 M Tris pH 6.8 solution, 50 µl of 10% SDS solution, 
0.65 ml of 30% acrylamide/bisacrylamide (37.5:1) solution, 5 µl of TEMED and 50 µl 
of 10% ammonium persulphate solution. The comb for the wells was placed on top of 
each gel and polymerization was allowed for 10 min. The samples for analysis were 
incubated with SDS reducing buffer for 4 min at 95 ºC. The SDS reducing buffer had 
the following composition: 62.5 mM Tris-HCl, pH 6.8, 20% glycerol, 2% SDS, 5% β-
mercaptoethanol. 10 µl of sample in reducing buffer were placed on each well of the 
gel for separation of the proteins by SDS-PAGE. The running buffer composition was 
25 mM Tris, 192 mM glycine, pH 8.3 and 0.1% SDS. Running conditions were set at 
150 volts for one hour. Gel staining was achieved in the following steps: 10-20 min in 
fixing solution (30% ethanol (EtOH) 10% HAc), 20 min in staining solution (0.2% 
Coomassie R-250, 0.005% Coomassie G-250 in 10% EtOH, 40% MetOH, 2% 
glycerin). To destain the background, gels were placed in 40% MetOH, 10% HAc, 2% 
glycerin solution. 
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4. Results 
 
4.1. Optimization of the protein extraction procedure 
 
The cell wall of C. glutamicum has an unusual composition because although C. 
glutamicum is a gram-positive bacterium, its cell envelope has an additional outer 
membrane like in gram-negative bacteria [83]. This outer membrane, rich in mycolic 
acids, plays a crucial role in the resistance of the related organism Mycobacterium to 
various antibiotics [84].  
Cell disruption efficiency is of major importance for proteomic studies. Optimization 
of the method for protein extraction is a requisite, especially for quantification studies 
where total protein extraction, including low abundant proteins, is required. Cell 
disruption methods are usually classified in mechanical processes (e.g. Mixer Mill, 
Sonicator, French Press) and non-mechanical processes (chemical, biological or 
physical disruption). Mechanical processes are the methods of choice in the laboratory 
because they disrupt completely the cell wall and liberate the cytosolic proteins. 
Chemical disruption by addition of detergents or antibiotics was discarded in order to 
avoid contamination of the sample. Enzymatic lysis of the cell wall with egg white 
lysozyme was not considered because C. glutamicum is resistant to it [85]. One of the 
limitations in the proteome analysis is that the volume of sample available is usually 
small and therefore cell disruption with ultrasonic disruption or French Press are not  
suitable methods. For proteome studies, especially for quantitative purposes, a fast and 
efficient method yielding high concentrations in the desired buffer is required. 
Therefore an improved protocol was developed for isolation of the cytosolic proteome 
when working with small samples from C. glutamicum by mechanical grinding. 
Cell harvest of C. glutamicum was carried out at OD 12. Around 10 mL of cell culture 
were harvested by centrifugation, followed by two washing steps with saline solution 
and transferred to a 2 mL vial. Subsequently cell pellets were mixed with 1.5 times 
lysis buffer (w:w), and 2.5 times glass beads (w:w). The cell wall was disrupted in a 
mixer mill by the shear forces generated during vibration and enforced motion of glass 
beads [86]. All the cell pellets employed for the study had a similar wet cell weight 
(WCW) which was approximately 300 mg. After a defined shaking time in the mixer 
mill, the vial was centrifuged to separate the supernatant from cell debris, glass beads 
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and unbroken cells. The collected supernatant was stored for analysis and fresh lysis 
buffer was added to the cell debris. Then the vial was inverted a few times to 
homogenize the mixture before the subsequent extraction step in the mixer mill. In 
total, the extraction protocol was performed consecutively up to ten times. Different 
shaking times – 1, 8, 15, 30 min - were investigated in order to determine the optimal 
conditions for extraction of C. glutamicum proteins. The extraction yield was 
controlled after each grinding step by running a SDS gel and measuring the protein 
concentration of the recovered supernatant [81]. The same bands were observed in all 
the SDS gels from collected supernatants of different grinding times (see Figure 9). 
The bands differ only in the intensity which is due to a different protein concentration 
in the collected supernatants. Thus no effect was observed due to selective release of 
proteins with respect to protein molecular mass, in dependence with the extraction 
time. 
 
 
Figure 9: SDS-PAGE analysis of the supernatants collected after every disruption step for 
different grinding times: (A) 1 min, (B) 8 min, (C) 15 min, (D) 30 min. Cells were 
resuspended in lysis buffer (20 mM TRIS, 4mM EDTA, pH 7.5, proteases inhibitor) and 
mixed with glass beads. After a defined disruption time, the vial was centrifuged and the 
supernatant collected for SDS-PAGE analysis.  On top of the gels the number of extraction in 
which the supernatant was collected is shown. 
 
In Figure 10 the protein concentration of the supernatant collected after each 
consecutive extraction is plotted for the four different grinding times (1, 8, 15 and 30 
min). It was found that short grinding times like 1 or 8 min, yield protein 
concentrations lower than 4.5 mg/ml per extraction step during the first 2-3 extractions 
steps. This is probably due to incomplete cell wall disruption. Increasing the grinding 
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time to 15 min improved the yield of the extraction up to 5-6 mg/ml per extraction step 
in the first four steps. Longer grinding times were also tested - 30 min - and the 
concentration of extracted protein in the first four extractions was slightly higher. It 
was observed that longer grinding times (15 min, 30 min) yielded higher 
concentrations with less extraction steps. Grinding times lower than 8 min were not 
sufficient for optimal cell wall disruption of C. glutamicum.  
 
 
Figure 10: Protein concentration in the supernatant after the different extractions. Ten 
consecutive extractions were performed on C. glutamicum cell pellets for different grinding 
times in the mixer mill. 
 
Extraction time periods of 15 min are basically better than 30 min because the 
improvement gained by a 30 min grinding over 15 min is very little, while the time 
needed for the extraction doubles. Besides that, longer grinding times generate 
additional sample heating. To avoid excessive heating of the sample during the 
grinding time, the plastic holders where the vials were placed, were stored at -20 ºC 
before and between grinding steps. Sample temperature was checked after every 
grinding step. For grinding times of 15 min the sample temperature registered was in 
average 17 °C, while for 30 min grinding the average sample temperature raised to 25 
°C. No significant improvement could be recognized when the experiment based on 15 
min grinding was repeated in presence of more lysis buffer (1:3, cell pellet to buffer, 
w/w) data not shown.  
Because complete filling of the vial negatively influences protein extraction [86], all 
experiments were carried out by filling the vial less than 3/4 of its capacity. Assuming 
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that all pellets had the same weight (300 ± 5 mg WCW) and that complete extraction 
was achieved after grinding ten times for 30 min, the percentage of extracted proteome 
accumulated after each consecutive extraction was calculated in dependence with the 
time and the results are shown in Figure 11. 
 
 
Figure 11: Percentage of total released proteome after each consecutive extraction in 
dependence with the total time employed for the extraction. Ten extractions were 
consecutively carried out for each of the four different grinding times.  
 
It was assumed that the whole proteome was released after 10 consecutive extractions 
employing 30 min grinding times because the protein concentration determined for the 
last two extractions was close to zero. However, a 10 times 30 min extraction 
procedure represented a total extraction time of 300 min. Moreover, the 30 min 
extraction involves overheating of the sample. In contrast to that, the 1 min shaking 
time in the mixer mill provided less than 75% of the proteome after ten times. For an 
extraction time of fifteen minutes, it was possible to achieve a total extracted proteome 
of 81% after five consecutive extractions, in total 75 minutes shaking time. In order to 
achieve the same degree of extracted proteome with 8 min periods of shaking times, 
seven consecutive extractions and 56 min total time were necessary. The optimal 
conditions for extraction of the C. glutamicum cytosolic proteome were determined 
either 5 x 15 min or 7 x 8 min to gain 80% of the proteome. Higher extractions of the 
proteome were achieved for 10 x 8 min (89% and 80 min total time) or 7 x 15 min 
(93% and 105 min total time). More extractions or longer grinding times increase the 
total time unnecessarily and generate little improvement. 
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4.2. Evaluation and optimization of the LC-MALDI system 
 
In a LC-MALDI experiment the chromatography is coupled off-line via deposition of 
the effluent of the column on a MALDI plate, the so called sample spotting. The 
subsequent mass spectrometric measurement is carried out by a MALDI TOF/TOF 
instrument. Consequently and in contrast to an LC-ESI-IT measurement, the time for 
MS acquisition in a LC-MALDI experiment is independent of the chromatographic 
process. However, a number of parameters are involved in a LC-MALDI experiment 
and their optimization is described in the next section. 
 
4.2.1. LC-MALDI spotting set-up 
 
The LC-MALDI spotting set-up employed in this work consisted of a HPLC system 
connected to an automatic fraction collector. The HPLC system was integrated by a 
Famos (LC Packings) autosampler equipped with a 10 µL loop for sample injection. 
The trap-column for sample pre-concentration and the analytic column were monolith 
based. The outlet of the UV detector was connected to a microfraction collector 
(Probot, LC Packings) for deposition of the sample on the MALDI-plate (see Figure 
12).  
 
Figure 12: Set-up employed for LC-MALDI spotting. The sample was injected by the 
autosampler and trapped in the trap-column. Peptides were desorbed by an acetonitrile 
gradient and separated in the analytical column. The effluent was sent to the spotter and mixed 
on-line with the MALDI matrix.  
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The sample was injected by the autosampler on a PS-DVB trap-column (10 x 0.2 mm 
i.d.) which was mounted on a ten-port valve. The trap-column permitted pre-
concentration of the peptides. The peptides retained in the trap-column were washed 
with a 0.1% heptafluorobutyric acid (HFBA) solution at 10 µL/min. HFBA was 
employed because it has been shown to enhance peptide retention during the washing 
step on the trap-column for peptide pre-concentration [34]. After 2.5 min the ten-port 
valve was switched (see Figure 13 A) and the gradient from the HPLC system flows in 
backflush mode into the trap-column at flow 0.7 µL/min. Desorbed peptides are, as a 
result, transferred to the PS-DVB monolith column (60 x 0.1 mm i.d.) where 
separation is accomplished by an acetonitrile gradient in 0.05% TFA at 25 ºC.  
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Figure 13: (A) Scheme of the ten-port valve employed for loading the sample on the trap-
column after injection (left) and desorption of peptides trapped by the HPLC gradient followed 
by separation in the analytic column (right). (B) Automatic spot deposition on a MALDI-plate. 
Effluent from the column is mixed on-line with the matrix and deposited at regular intervals. 
 
Peptides eluting from the monolith column pass the UV detector and reach a μ-Tee 
connection piece in which the column effluent is mixed on-line with MALDI matrix. 
The matrix employed in this work was α cyano-4-hydroxicinnamic acid (CHCA). The 
mixture effluent-matrix enters a needle in which a fused silica capillary is mounted 
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and directly deposited on the MALDI-plate at regular intervals (see Figure 13 B). The 
spot collection or plate spotting performed with a Probot microfraction collector is 
achieved by displacement of the table where the MALDI plate is placed. 
 
4.2.2. Optimization of LC-MALDI  
 
Optimization of the spot deposition 
The optimal concentration of CHCA employed for manual spotting is about 5 mg/mL, 
mixed 1:1 (v/v) with the sample. As a result the matrix concentration on the plate is of 
2.5 mg/mL and thus provides an optimal ionization. For the LC-MALDI application it 
was considered necessary to achieve the same matrix concentration on the plate. 
Despite a broad range of optimal matrix concentrations reported for LC-MALDI 
applications [87-89] in the range 3 - 7.5 mg/mL (70% acetonitrile, 0.1% TFA) it was 
decided to work with a low matrix concentration in order to avoid tube plugging due 
to possible matrix crystallization. For that reason the matrix concentration employed 
for automatic spotting was 3 mg/mL and was mixed on-line with the column flow rate 
effluent which was 0.7 µL/min. In Table 2 a list of possible ratios column flow rate to 
matrix flow rate is shown together with the final combined flow. In addition, the 
matrix concentration on the plate is shown for each ratio and the resulting spot 
volumes with two spotting times, 5 and 10 seconds, are considered. 
 
Table 2: Flow rate after mixing the effluent from the column (0.7 µL/min) with matrix in 
different ratios. The matrix concentration on the plate and calculated volume per deposited 
spot (5 and 10 seconds spotting) are also shown. 
 
Ratio Flow (µL/min) column+matrix 
Matrix conc. 
(mg/mL) 
Spot 5s 
V (µL) 
Spot 10s 
V (µL) 
1:1 1.4 1.5 0.12 0.23 
1:2 2.1 2 0.17 0.35 
1:3 2.8 2.25 0.23 0.47 
1:4 3.5 2.4 0.29 0.58 
1:5 4.2 2.5 0.35 0.70 
1:6 4.8 2.6 0.41 0.82 
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It was decided to use a ratio 1:4 (effluent/matrix) because it provides an appropriate 
matrix concentration on the plate and the spot volume is 0.3-0.6 µL. Bigger spot 
volumes are less homogeneous and generate large spot areas which need to 
accumulate more laser shots and thus longer measurement times. Small spot volumes 
below 0.2 µL are more homogeneous but generate small spot areas which are difficult 
to visualise. In addition, the low amount of sample hampers the performance of 
several MS/MS experiments on a single spot and results in loss of sensitivity [59]. 
A spot deposition of five seconds was chosen for the analysis of complex peptide 
mixtures by LC-MALDI. A five seconds spot generated a volume of about 300 nL 
that, after acetonitrile evaporation, showed a spot diameter of about 1200 µm. For 
optimal distribution of the space available on the plate the spots were arranged in 32 
rows and 49 columns, which provided a capacity of 1568 spots. 
 
Optimization of the mass accuracy  
Mass accuracy is a key parameter for protein identification by database search because 
a high mass accuracy delivers more confident identifications and reduces the 
probability of false peptide matching. The mass accuracy indicates the deviation of the 
instrument response from a known calculated monoisotopic mass. The mass accuracy 
for a peptide is usually expressed in ppm and defined by the formula (5). To express 
the mass accuracy of a peptide in this work, the absolute error was employed. 
 
Mass accuracy (ppm) = [(observed mass – theoretical mass) / theoretical mass] * 106               (5) 
 
A good mass accuracy is achieved with a MALDI MS instrument by either internal or 
external calibration. The internal calibration calibrates the spectrum based on the 
observed time of flight of known standards within the sample. The external calibration 
calibrates the spectrum based on the observed time of flight of known standards that 
have been acquired before in a different spot and calibrated internally in that spot. For 
routine measurement it is common to use the default calibration. The default 
calibration is based on the external calibration provided by eight calibration spots on 
the MALDI-plate. It uses a multi-parameter calibration equation with values based on 
the configuration of the system to provide calibration for the entire plate. 
In order to test and improve the mass accuracy for the proteome analysis by LC-
MALDI, a complex mixture of peptides of known composition was analyzed. The 
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peptide mixture was kindly provided by the group of Prof. Huber (Instrumental 
Analysis and Bioanalysis, University of Saarland, Germany). It was obtained by 
digestion of 10 standard proteins of different molecular masses and combining them to 
give the concentrations shown in Table 3. The mixture was diluted 1/10 and one 
microliter was employed for LC-MALDI analysis. Consequently the lowest amount of 
protein subjected to analysis was 0.250 pmol for transferrine and the highest amount 
was 1.61 pmol, which corresponded to cytochrome C. 
 
Table 3: Digested protein mix used for mass accuracy improvement. 
 
Protein MW (Da) Concentration (pmol/µl) 
Cytochrom C 12360 16.18 
BSA 66534 7.51 
β-lactoglobulin A 18362 10.89 
Carbonic Anhydrase 29022 6.89 
Catalase 57585 3.47 
Lysozyme 14306 13.98 
Myoglobine 16951 11.79 
Ribonuclease A 13682 14.61 
Transferrine 79593 2.51 
α-Lactalbumin 14180 14.11 
 
 
In order to investigate if the mass accuracy was affected between LC-MALDI runs the 
ten protein digest mixture was spotted consecutively three times on a MALDI plate 
employing the same gradient and analysed by MALDI TOF/TOF MS. The default 
calibration was updated for MS and MS/MS mode, once before the consecutive 
measurement of the three spotted chromatograms (LC1, LC2, LC3) by MALDI 
TOF/TOF. The mass accuracy observed for each of the ten proteins in each analysed 
chromatographic run is shown Figure 14. After identification of the protein by 
database search, the calculated mass accuracy is the average of all the mass accuracy 
values assigned to the peptides correctly matched to the protein.  
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Figure 14: Mass accuracy observed for each protein on three consecutive LC-MALDI runs. 
Only LC1 was preceded by an update of the default calibration. Default calibration was not 
updated previous to LC2 and LC3 measurements.  
 
In average, the mass accuracy observed for the identified proteins was 30 ppm during 
the first LC-MALDI run (LC1). However the mass accuracy was not constant between 
runs and got worse for the next two runs, LC2 and LC3. On the other hand the mass 
accuracy of the MS/MS mode was not affected between runs. To avoid a decrease in 
mass accuracy between LC-MALDI runs, the default calibration in MS mode was 
updated before each single run. Thus the mass accuracy was improved and the average 
mass accuracy of three consecutive analysis for the proteins was 34 ppm (see Figure 
15A). 
A further improvement in mass accuracy can be achieved by internal calibration, using 
a reference peptide present in the spot together with the sample. Internal calibration 
was performed on every single spot of the MALDI plate by addition of the peptide 
[Glu1]-fibrinopeptide B (MW 1570.57 Da) to the matrix solution at a concentration of 
21 fmol/µL. Because the matrix was mixed in the ratio 4:1 with the column effluent,  
the final concentration of the internal standard was 15.7 fmol/µL. The spot deposition 
was set to 5 seconds and consequently the spot volume was about 300 nL. The final 
amount of Fibrinopeptide on the plate per spot was of 4.7 fmol.  
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Figure 15: Mass accuracy in ppm calculated for the identified proteins by database search. In 
(A) only default calibration of the instrument was employed. In (B) the peptide Glu-
Fibrinopeptide B was added to the matrix to perform internal calibration in addition to the 
default calibration. 
 
The internal calibration improved the average mass accuracy of the proteins from 34 to 
14 ppm (see Figure 15). Despite a quantitative improvement in the average mass 
accuracy by employing the internal calibration, the standard deviations observed were 
in some cases larger than the ones observed with external calibration (see Figure 15B). 
This is due to the fact that the amount of the Fibrinopeptide B on a spot is low and the 
presence of peptides at higher concentrations and different composition on the same 
spot can induce peak suppression of the Fibrinopeptide B [90]. For this reason in some 
spots the Fibrinopeptide B peak may not be present or not labelled because of a low 
S/N. In these cases internal calibration is not performed and only the default 
calibration is applied leading to higher deviations. In any case, the best mass accuracy 
was obtained when internal calibration was employed and a default calibration update 
was run before every single LC-MALDI analysis. Therefore this procedure was 
employed for the proteome analysis of C. glutamicum. 
 
Collision induced dissociation (CID) versus post-source decay (PSD) 
The MALDI TOF/TOF 4800 can be operated in the MS/MS mode with or without 
CID. Peptide fragmentation in the CID region is achieved by collisions between the 
precursor isolated prior to the CID region and gas molecules. When the CID is not 
employed, fragmentation happens by metastable decomposition occurring in the field-
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free region after the ion source. This is the so called post source decay (PSD). In this 
case the precursor is isolated with its fragments according to their time of flight and 
re-accelerated in the second source. The spectra obtained by PSD deliver abundant y- 
and b- ions. Nevertheless CID spectra from peptide fragmentation of high-energy 
tandem mass spectrometry present some special features. Peptide fragmentation 
employing CID delivers immonium ions in the low-mass region (m/z 60-160). These 
signals are especially intensive for peptides containing histidine, isoleucine, leucine, 
phenylalanine, proline, tryptophan and tyrosine and are useful to confirm assignments 
about peptide composition. The partial loss of side-change fragments during high-
energy collisions leads to the formation of d- and w-ions which permit distinguishing 
the isomeric amino acids leucine and isoleucine. In addition, CID is known to deliver 
more internal fragments and a-ions aside from y- and b-series [52, 53].  
In order to investigate the most advantageous conditions for the proteome analysis a 
digest of ten different proteins (Table 3) was analysed by LC-MALDI with CID and 
without CID. The sample was spotted three times and analysed by LC-MALDI 
MS/MS with the same acquisition parameters. The results were analysed by database 
search. Figure 16 shows that the total number of peptides counted per protein with 
CID and without it, is very similar except for the proteins presenting higher molecular 
weight. When employing peptide fragmentation without CID the three biggest 
proteins, BSA (66534 Da), transferrine (79593 Da) and catalase (57585), presented a 
higher number of peptides successfully sequenced.  
Considering the sequence coverage achieved for the different proteins, the situation is 
different. Although the number of sequenced peptides was similar for six of the 
proteins (myoglobine, lysozyme, carbonic anhydrase, ribonuclease A, β-lactoglubuline 
and cytochrome) the sequence coverage achieved with CID was higher.  Higher 
sequence coverage can be explained in terms of a higher number of different peptides 
successfully sequenced. The ion scores reported for both methods, with CID and 
without CID, were very similar. 
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Figure 16: Comparison of peptide fragmentation in the MALDI TOF/TOF with CID and 
without CID. The peptide count (top figure) and sequence coverage (bottom figure) was 
evaluated for a digest of ten proteins. 
 
CID was more successful in sequencing different peptides for some of the proteins. 
The capacity to deliver successful sequencing of different peptides of a single protein 
is of great importance in the proteome analysis. Proteins identified by one unique 
peptide, even if sequenced repetitively many times, are the so called one-hit wonders 
and usually not accepted as valid identifications. Besides, the calculated standard 
deviation was better with CID for the number of peptides count as well as for the 
sequence coverage. The absence of error bars in the plot indicates that the same results 
were achieved in the three subsequent measurements. Despite similar performance 
with and without CID, the results with CID on were slightly more reproducible and 
therefore more convenient for the proteome analysis of C. glutamicum.  
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Performance of the Timed Ion Selector (TIS) 
 
The TIS is an ion gate situated before the CID region and deflects ions lighter than the 
selected precursors and therefore flying faster, as well as ions heavier than the 
precursor which are slower. The time during which the ion gate is open, is the so 
called “mass window for precursor selection”. The precursor mass window of the 
MALDI TOF/TOF ABI 4800, expressed in Da, can be set by the user as an absolute 
fixed value or relative to the resolution. The maximal TIS resolution given from the 
manufacturer is 400. The definition of resolution based on the full width half 
maximum (FWHM) is shown in Figure 17 A. High resolution values provide small 
windows for ion selection. As a consequence selectivity improves but too narrow 
precursor windows can compromise the sensitivity as the intensities of the fragments 
decrease [91]. 
 
 
 Figure 17: (A) Definition of resolution for the MALDI TOF/TOF mass spectrometer. (B) 
Relative precursor mass window applied by the TIS for three different masses when the 
resolution is set to 280. 
 
The use of low resolution and therefore a broad mass window, compromises the 
selectivity of the precursor selection. In the present work the resolution for precursor 
selection was set to 280, relative to the mass of the precursor. The mass windows 
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calculated for three precursor masses (1000, 2000 and 3000 Da) with TIS resolution of 
280 are shown in Figure 17 B. The resolution chosen for precursor selection offered a 
different mass window relative to the mass of the precursor. For instance, for a 
precursor mass of 1000 Da the full width at half maximum mass window is 3.6 Da, 
which allows selection of the monoisotopic peak and part of the isotopic cluster. For 
an ion of 2000 Da the mass window is 7.1 Da and for an ion of 3000, 10.7 Da. A 10.7 
Da precursor mass window guaranties the selection of the monoisotopic peak together 
with the isotopes. However, in a complex sample like a proteome digest the presence 
of neighbour peaks within the mass window of the precursors can interfere in the 
identification. If more than one precursor is selected by the TIS, the MS/MS spectrum 
gets more complicated due to unassigned fragments. The presence of unassigned 
fragments in the spectrum complicates the assignment of a sequence by database 
search and yields a lower ion score for the identified peptide. This problem is more 
pronounced for peptides of high molecular mass above 3000 - 3500 Da.  
 
4.3. Proteome analysis of Corynebacterium glutamicum by 
two-dimensional liquid chromatography & MALDI TOF/TOF MS 
 
The cytosolic proteins of C. glutamicum wild-type extracted as described in section 
3.3, were digested enzymatically with trypsin generating a mixture of peptides. The 
high complexity of the sample required fractionation before performing mass 
spectrometric analysis. Peptides were resolved by a novel bottom-up approach in 
which reversed phase (RP-HPLC) was employed in the first dimension and ion-pair 
reversed-phase (IP-RP-HPLC) in the second dimension [1, 36]. In the text we will 
refer to the two-dimensional separation as 2D-RP-HPLC. Because elution was 
accomplished in both dimensions by an increasing gradient of acetonitrile, the 
orthogonality of the separation was based on the use of a different pH in the mobile 
phase. The charge state shown by the different ionisable amino acids in a peptide 
sequence at pH 10 and pH 2.1 is shown in Table 4. A peptide carries different charges 
at different pH values depending on its amino acid composition. Also the polarity of 
the peptide is affected and thus the interaction with the stationary phase. As a result, 
the retention times of the peptides carrying ionisable amino acids are different in each 
dimension.  
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Table 4: Charge state of the ionizable amino acids at the working conditions for the first 
dimension (pH10) and the second dimension (pH 2.1). Values are based on the pKa values of 
the side chain of ionizable amino acids (see Table 1). The contribution of the amino-terminus 
and carboxyl-terminus is also shown. 
 
Amino Acid pH 2.1  pH 10 
Asp 0 -1 
Glu 0 -1 
His 1 0 
Cys 0 -1 
Tyr 0 -0.5 
Lys 1 0.5 
Arg 1 1 
N-terminus 1 0 
C-terminus 0 -1 
 
4.3.1. First dimension: reversed-phase chromatography at high pH 
 
Peptides generated by digestion of the proteome of C. glutamicum were separated in 
the first dimension by reversed-phase chromatography carried out at pH 10.  This 
dimension should show high orthogonality with the second dimension, with a working 
pH of 2.1.  
The high pH was achieved in the mobile phase by addition of triethylamine (TEA) 
titrated to pH 10 with acetic acid. The amount of sample injected was 280 µg of 
peptides from the digest of C. glutamicum cytosolic proteins and the gradient 
employed was linear from 0 to 55% acetonitrile in 55 min. The the chromatogram 
acquired at wavelength 280 nm is shown in Figure 18. In the chromatogram peptide 
signals are observed between minutes 17 and 45. However, not resolved peaks are 
observed due to the high complexity of the sample. The effluent from the column was 
collected in one minute intervals. Accordingly, a total of 55 fractions of 200 µL 
volume were collected for further analysis. 
Since the first dimension was performed by reversed-phase chromatography instead of 
the common SCX, there were no salts present in the collected fractions but 
acetonitrile. As the second dimension was RP-HPLC and separation is based also on 
an acetonitrile gradient, it was necessary to remove the acetonitrile from the fractions. 
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The fractions were subjected to evaporation of acetonitrile in a vacuum concentrator 
thus increasing sample concentration 10 times.  
 
 
Figure 18: Separation of 280 µg of C. glutamicum digested proteome at high pH (pH 10). The 
column was a C18 Gemini from Phenomenex and mobile phase composition was: (A) 72 
mmol/L TEA in H2O, pH 10 with acetic acid; (B) 72 mmol/L TEA, 52 mmol/L acetic acid in 
acetonitrile. Elution at pH 10 was achieved by a 55 min linear gradient from 0 to 55% B 
followed by 2 min at 100% B. The chromatogram was acquired at wavelength 280 nm. 
 
4.3.2. Fraction screening by MALDI TOF MS 
 
The total number of fractions collected during the first dimension at pH 10 was 55 
(one per minute). In the chromatogram peptide peaks are observed between fractions 
17 and 45 but is not possible to discriminate clearly the peptide containing fractions. 
In order to elucidate the fractions to be analysed a fast screening method was 
developed employing the MALDI-TOF MS technology. All fractions were analyzed 
by preparation of two dilutions and each dilution was measured three times. Dilutions 
were prepared after evaporation of the acetonitrile from the elution gradient in a 
vacuum concentrator. The first dilution consisted of a 1:10 dilution of one microliter 
of the sample with a 0.1% TFA solution. The second dilution was prepared by dilution 
1:100 of one microliter of the sample with a 0.1% TFA solution. Each dilution of a 
fraction was spotted three times on a MALDI-plate by deposition of 0.5 µL of the 
sample followed by 0.5 µL of matrix solution and it was allowed to co-crystallize for a 
few minutes. Following the MALDI-plate was measured by MALDI-TOF MS. After 
calibration, one spectrum was acquired from each spot in MS mode and the number of 
peaks labelled by the software was counted. A total of 1500 shots were accumulated 
per spectrum. Figure 19 depicts the average and standard deviation of the number of 
peaks counted in the MS spectra from the collected fractions. 
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Figure 19: Number of peaks detected in each collected fraction by MALDI-TOF MS analysis.  
Two dilutions were prepared from each fraction, 1:10 (A) and 1:100 (B). The samples were 
spotted three times on the plate for measurement. 
 
Almost no peaks are observed in the first and last ten fractions, where the few signals 
observed are derived from the matrix signals, CHCA clusters with sodium and 
potassium. The fractions where more peaks were counted correlate with the peptide 
peak signals in the chromatogram acquired during the first dimension (Figure 18). The 
dilution rate 1:10 (Figure 19 A) generated better results than dilution 1:100 and a 
higher number of peaks was observed per fraction as well as a smaller standard 
deviation. It can be speculated that the concentration of many peptides in the more 
diluted sample was below the limit of detection of the mass spectrometer for the 
acquisition parameters employed. The measurement of the fractions 1:100 could be 
improved by increasing the number of laser shots accumulated for each collected 
spectrum. However, because the purpose of the method is to screen the fractions, the 
preparation of two dilutions was sufficient to select the fractions for analysis. 
Fractions collected between minutes 15 and 45 were selected for further analysis by 
LC-MALDI. Because the number of peptides in a single fraction is very high and ion 
suppression during ionization [90] has a strong effect on the ionization efficiency of 
the peptides, the method employed does not provide quantitative information. 
However, the obtained information is sufficient to provide a criterion that permits 
rapid evaluation and selection of the fractions to analyze. The rapid screening method 
presented here minimizes the analysis time by rapid selection of the fractions to be 
analyzed; it facilitates the analysis planning and consumes only little sample volume.  
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4.3.3. Second dimension: reversed-phase chromatography at low 
pH  
 
From a total of 55 collected fractions, thirty-one fractions corresponding to minutes 15 
to 45 of the gradient were selected for further analysis by LC-MALDI. After 
acetonitrile removal the volume was reduced to 1/10. Each of the fractions was 
reconstituted with buffer, injected and spotted on a MALDI-plate three times 
generating a total of 93 chromatographic separations. The UV chromatograms of the 
three consecutive chromatographic separations of fraction 30 are illustrated in Figure 
20. It can be observed the excellent reproducibility of the second dimension 
separation. 
 
 
 
Figure 20: Three replicate injections of fraction 30 analysed by the LC-MALDI set-up 
described in section 4.2.1. 
 
Spots were collected on the plate every 5 seconds for 62 minutes and one single 
chromatography run generated 747 spots on a MALDI-plate. Because it was possible 
to spot up to 1568 spots on each MALDI-plate, two chromatographic runs were 
spotted on each plate. The triplicate analysis of the 31 fractions generated a total of 47 
MALDI-plates for analysis by MALDI TOF/TOF mass spectrometry. The total time 
required for the chromatographic separation and spotting was 116.25 hours. 
Figure 21 shows the chromatograms of the 31 fractions later analysed by LC-MALDI 
TOF/TOF. Only one of the three replicate injections is shown per fraction. In the three 
first and last fractions there is almost no peptide signals observed, whereas fractions 
20 to 37 show the presence of high amount of peptides and no resolved peaks can be 
observed. 
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Figure 21: Analysis by LC-MALDI of 31 fractions collected during the first dimension. UV-
chromatograms (214 nm) were acquired by the detector situated between the outlet of the 
monolithic column and the spotter. Mobile phase composition was: (A) 0.05% TFA in H2O 
(B) 0.05% TFA in 100% ACN. Gradient: 60 min linear gradient from 0 to 20% B, followed by 
3 min isocratic elution at 100% B. Flow rate 0.7 µL/min. Column temperature was 25 ˚C. 
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4.3.4. MALDI TOF/TOF analysis 
 
The 31 fractions selected for LC-MALDI analysis and spotted on MALDI-plate where 
subjected to high-throughput MALDI MS/MS analysis. The analysis of a MALDI-
plate in which a chromatographic run is spotted, is carried out as follows: a MS 
acquisition on every spot of the plate for generation of a precursor list is followed by 
MS/MS of the precursors/peptides for protein identification. During the MS analysis 
one mass spectrum is acquired on each spot of the chromatographic run deposited on 
the plate. The mass range selected for the MS acquisition in this work was 800-4000 
m/z. The instrument software evaluates all ions of the MS data acquired on each spot 
using the fraction-to fraction tolerance and the minimum chromatogram width in order 
to derive LC-MALDI peaks. The fraction-to-fraction precursor mass tolerance is 
expressed in ppm and prevents the redundant acquisition of a precursor in adjacent 
spots if the corresponding m/z values belong to the same elution profile. The first m/z 
in the list is assigned to the first LC-MALDI peak. The fraction-to-fraction mass 
tolerance (in the present work 200 ppm) is applied to the first m/z in the next spot. If 
the centroid mass is within the tolerance of the first LC-MALDI peak, the software 
merges the masses into the same LC-MALDI peak and derives a weighted average 
mass. If the centroid MS mass is outside the tolerance, the mass is selected as a new 
theoretical LC-MALDI peak. Every time a mass is merged into an existing LC-
MALDI peak, the average mass is modified and the software examines all other 
masses to check if they are now within the tolerance. The minimum chromatogram 
peak width specifies the minimum number of spots to consider a precursor as LC-
MALDI peak. This parameter facilitates to avoid selection of nonreproducible 
chemical noise. A gap of one spot is permitted in order to allow detection of low 
abundant peptides within a range of spots. The criteria specified for generation of the 
precursors list in the present work were as follows: 
 
- A signal-to-noise (S/N) ratio equal to or above 35. 
 
- A minimum chromatogram peak width of 2. This specifies that the peak must be at 
least in two spots.  
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- Fraction-to-fraction precursor mass tolerance of 200 ppm. m/z values in two adjacent 
spots within 200 ppm and consequently belonging to the same elution profile will be 
merged into a single LC-MALDI peak. 
 
- Exclusion list: 850 ± 50 m/z in order to avoid selection of matrix peaks; peak 
1571.57 m/z from Glu1-Fibrinopeptide B used for internal calibration; masses above 
3000 m/z. 
 
- A maximum of 6 precursors per spot were selected for analysis, starting with the 
strongest precursor. 
 
During the second stage of the analysis, MS/MS data was collected on the masses 
included in the precursor list according to the spot where the highest intensity of the 
LC-MALDI peak was registered. After ionization, the selection of the precursor was 
carried out by the timed ion selector (TIS). The typical resolution observed in the 
spectra acquired in MS mode for the selected mass range m/z 800-4000 was between 
11000 and 20000. In MS/MS mode the resolution observed was up to 6500. 
An example of protein identification by LC-MALDI MS/MS is illustrated in Figure 
22. The measurement corresponds to the LC-MALDI analysis of the fraction 32 
collected during the first dimension. In Figure 22 A is shown the extracted ion 
chromatogram (EIC) of m/z 2569.3 ± 0.5 Da. The EIC is obtained by plotting the sum 
of the signal intensities of all the MS peaks in a specific mass range as function of the 
spot number. In the plot the signal intensity was calculated as peak height for the ion 
m/z 2569.9 on each spot of the LC-MALDI analysis of fraction 32. The maximum of 
the LC-MALDI peak was found in the spot 419 and corresponds to an elution time of 
46.9 min. The FWHM recorded for this peak was 15 seconds. The MS/MS 
fragmentation was performed on the precursor m/z 2569 selected on the spot number 
419 and the subsequently mass spectrum acquired is shown in Figure 22 B. After 
database search, the MS/MS spectrum (see Figure 23) was matched to the peptide 
IATGFIADHPHLLQAPPADDEQGR, which belongs to the pyruvate carboxilase of 
C. glutamicum (locus ID NCgl0659). This protein was identified after analysis of all 
the fractions by 102 matches that corresponded to 38 different peptides across 
different fractions. 
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Figure 22: Peptide identification by LC MALDI MS/MS. The data shown here were obtained 
by analysis of fraction collected during minute 32 in the first dimension. (A) Extracted ion 
chromatogram of m/z 2569 from analysis by LC-MALDI of fraction 32. The maximum of the 
LC-MALDI peak was situated in the spot 419. The LC-MALDI peak width recorded at half 
maximum was 15 seconds. (B) MS spectrum obtained in the spot 419. 
 
 
Figure 23: MS/MS spectrum of the precursor ion m/z 2569 performed on spot number 419 of 
the LC-MALDI analysis of fraction 18. The sequence assigned by database search with 
Mascot on C. glutamicum database was IATGFIADHPHLLQAPPADDEQGR.  
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The number of precursors selected for MS/MS analysis in each of the analysed 
fractions strongly depends on the complexity of the sample. The analysis of the 31 
fractions from the first dimension generated 93 LC-MALDI runs. Figure 24 shows the 
number of masses included in the precursor list for subsequent MS/MS, resulting from 
the analysis of fractions from the first dimension. The average standard deviation of 
the three replicate measurements was 84 but in fraction 27 the standard deviation was 
higher than in the others. This was probably due to an experimental error in one of the 
analysis leading to a lower number of masses in the precursor list. However, the total 
number of peptides identified in this fraction was not affected as shown in Figure 25, 
where the number of different peptides successfully identified per fraction is shown. 
 
 
 
 
Figure 24: Number of masses selected for MS/MS in the list of precursors of each LC-
MALDI analysis. The measurements correspond to the 31 fractions analyzed in triplicates.  
 
In order to obtain the number of different identified peptides per fraction, the three 
replicate measurements of each fraction were merged to perform a single database 
search and the results are plotted in Figure 25. The highest number of different 
peptides sequenced per fraction was registered for fractions 30, 31 and 32. In these 
fractions a total of 612, 664 and 597 were, respectively, successfully sequenced. The 
lowest peptide content was found in the first and last analysed fractions. In these 
fractions36 and 48 different peptides were identified. 
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Figure 25: Number of different peptides identified by database search in each fraction. 
Results were obtained after pooling the three replicates of a fraction analyzed by LC-MALDI 
TOF/TOF MS. 
 
The number of precursors registered per fraction (Figure 24) correlate well with the 
number of non-redundant peptides identified per fraction (Figure 25), as well as with 
the results obtained by MALDI-TOF fraction screening in section 4.3.2. The number 
of non-redundant peptides identified by database search per fraction was, on an 
average, 62% of the m/z values in the corresponding precursor list of the fraction.  
 
4.3.5. Database search and identified proteins 
 
All files generated by MALDI TOF/TOF analysis of the fractions were merged to 
perform one single search in the C. glutamicum database. This resulted in 75262 
search queries. The Mascot search engine assigned an ion score to each experimental 
peptide correctly matched to a theoretical peptide sequence. The statistical significance 
threshold for proteins was ≥ 95% and only peptides with score above the identity 
threshold were accepted. The number of identified proteins returned by Mascot was 
1644 (see Appendix II) and the false discovery rate determined for this data set was 
2.4%. The number of false positives (FP) was estimated by repeating the search in a 
composite database created by attaching a randomised C. glutamicum database to the 
original database thus generating a database twice the size of the original. The  FPR 
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was calculated by doubling the number of hits in the randomised  database and 
dividing the result by the total number of identified peptides from both databases [66].  
The bar chart in Figure 26 shows the number of non-redundant proteins identified in 
each subsequent fraction with respect to the accumulated protein hits. The number of 
identified proteins increased till fraction eighteen and after that the number of newly 
identified proteins decreases in every fraction. The contribution to the overall number 
of identification in the last six fractions was very small. 
 
 
Figure 26: New protein hits identified in each fraction by database search with respect to the 
previously identified and starting with fraction 15. Proteins identified in a fraction by database 
search were not previously identified. 
 
The identified proteins of C. glutamicum were classified based on the genome 
information of the Comprehensive Microbial Resources (CMR) of the TIGR database 
and is shown in Table 5. The percentage of proteins from each category identified in 
the present study is also shown. Almost all proteins involved in biosynthesis functions 
in the cell were identified in the present work: biosynthesis of amino acids (88%), 
biosynthesis of proteins (83%), nucleosides and nucleotides (75%), biosynthesis of 
cofactors, prosthetic groups and carriers (71%). Besides it is remarkable that over 50% 
of the predicted proteins involved in cellular processes (61%), energy metabolism 
(58%), DNA metabolism (55%), transcription (57%) and central intermediary 
metabolism (51%) were identified. In contrast, transport and binding proteins as well 
as proteins from the cell envelope are the underrepresented (34% and 32% identified 
respectively) as expected in a fraction of the proteome containing mainly cytosolic 
proteins. Especially interesting is the fact that almost 50% of the proteins involved in 
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regulatory functions in C. glutamicum were identified. The proteins involved in 
regulation of gene expression are usually present in the cell only at low concentration 
and thus difficult to identify in a complex mixture of proteins. 
 
Table 5: Classification of identified proteins according to their biological function. Gene role 
categories were obtained from the Comprehensive Microbial Resources, Institute for Genomic 
Research (www.tigr.org). Note than some genes are assigned to more than one category.  
 
Gene role category 
# of 
genes 
Identified by 
LC-MALDI TOF/TOF 
% 
Amino acid biosynthesis 100 88 88 
Biosynthesis of cofactors,  
prosthetic groups and carriers 
100 71 71 
Cell envelope 297 94 32 
Cellular processes 95 58 61 
Central intermediary metabolism 99 51 51 
DNA metabolism 99 55 55 
Energy metabolism 234 137 58 
Fatty acid and phospholipids metabolism 33 10 30 
Hypothetical proteins 139 19 14 
Hypothetical proteins-Conserved 541 246 45 
Mobile and extrachromosomal element 
functions 
43 4 9 
Protein fate 104 50 48 
Protein synthesis 121 100 83 
Purines, pyrimidines, nucleosides and 
nucleotides 
71 53 75 
Regulatory functions 174 86 49 
Transcription 35 20 57 
Transport and binding proteins 292 100 34 
Unclassified 580 372 64 
Unknown function 60 30 50 
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Most of the regulatory proteins in C. glutamicum are DNA-binding transcriptional 
regulators [92] containing a helix-turn-helix structural motif responsible of the protein-
DNA interaction [93]. Recently, a list of 56 transcriptional regulators that have known 
function was published based on experimental characterization and prediction by 
bioinformatics tools [92]. Thirty-three of the fifty-six DNA-binding transcriptional 
regulators of known function were identified in the present study and are listed in the 
Appendix III.  
About 22% of the encoded proteins in C. glutamicum are classified as membrane 
proteins [70]. Because the extraction procedure was focused on cytosolic proteins a 
low coverage of membrane proteins was expected. The results of the present work 
were compared with the membrane proteins reported by Fischer et al.[78]. As a result, 
121 integral membrane proteins which include soluble components or subunits, were 
identified in this work and are listed in the Appendix IV. Within the identified proteins 
48% of them were hypothetical proteins, 11 were predicted proteins and 12 proteins 
were permease components of ABC-type transporter. In the appendix, proteins are 
classified according to the number of transmembrane helices (TMH). In addition, the 
number of different peptides identified together with the number of hits that were 
matched to a protein is shown. 63 of these proteins were identified by one non-
redundant peptide. 
In the genome of C. glutamicum, 13 two-component signal transduction systems have 
been annotated [94]. The signal transduction systems are integrated by two domains: a 
kinase and the corresponding response regulator. As sensor kinases are integral 
membrane proteins with at least one trans-membrane helix, they were not extracted 
with the cytosolic proteins analyzed in this work and therefore not identified. 
However, it was possible to identify seven of the response regulators which form part 
of a two-component system (see Appendix V). 
The identification of enzymes, which catalyse biochemical reactions of the central 
metabolism is essential in a proteomic study and relevant for further investigations on 
the organism. In the present study, all enzymes involved in the glycolysis and 
gluconeogenesis were identified. Further, all enzymes of the citrate cycle were 
identified except a hypothetical membrane protein (locus identification NCgl0359) 
and the succinyl-CoA synthetase β subunit (NCgl2477). Because only the cytosolic 
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fraction of the proteome was analyzed, the identification of membrane proteins was 
not probable. All enzymes of the pentose phosphate cycle were identified. All 
enzymes involved in the methionine biosynthesis and lysine biosynthesis pathway 
except the lysine exporter (NCgl1214) were identified (see Appendix X and XI). 
During the first dimension peptide separation was performed at pH 10. It is known that 
peptides are likely to suffer deamidation under alkaline conditions, especially the 
sequence -Asn-Gly- [95]. To study how far peptides were affected by this 
modification in the present work, a new database search was performed and 
deamidation was chosen as variable modification in addition to oxidation of 
methionine. Deamidation of an Asn to Aps/IsoAsp does not modify peptide net charge 
but the mass is increased in 0.984 Da. The deamidation rate observed was 13% of the 
total identified peptides, whereas oxidation rate was 4%. One third of the deamidated 
peptides contained the sequence -Asn-Gly-. However, it is not possible to discern if 
the origin of these modifications was the basic pH employed in the first dimension or 
naturally occurring post-translational modifications.  
 
4.4. Proteome analysis of Corynebacterium glutamicum by 
two-dimensional gel electrophoresis and MALDI TOF/TOF MS 
 
Two-dimensional gel electrophoresis has been the most popular approach for 
proteome analysis during the past thirty years. The main advantage of this technique is 
the visualization of a high number of proteins after separation into two orthogonal 
dimensions. Visualization permits direct comparison of the spots from different 
samples and rapid detection of differences by overlapping of the gels with the 
appropriate software after gel scanning. Furthermore, the spot of interest can be 
excised from the gel for in-gel digestion and thus all resulting peptides that belong to 
the protein are analysed together in one single experiment. In contrast, digestion in a 
bottom-up approach leads to a mixture of peptides from all proteins present in the 
sample. Peptides are analysed after separation and peptides distributed all over the LC 
fractions but belonging to the same protein will be merged by the database search 
machine. 
The 2D-PAGE top-down approach was applied to the analysis of the cytosolic proteins 
of C. glutamicum and employed as reference method to evaluate the results obtained 
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by the new shotgun approach exposed in section 4.3. Protein extraction was carried 
out as described before and 200 µg of proteins were dissolved in rehydration buffer. 
This solution was used to rehydrated the strip with the immobilized gradient used for 
isoeletric focusing. The pH range employed was 4 to 7 because most of the proteins of 
C. glutamicum show a pI in that range. According to the virtual 2D gel of the proteins 
of C. glutamicum (see Figure 27) there are also a number of basic proteins but 
preliminary studies testing different pH ranges (data not shown) did not allow the  
visualization of these proteins. This fact has been previously reported by Schaffer et al. 
[74]. 
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Figure 27: Theoretical 2D-gel of C. glutamicum based on the calculated isoelectric point and 
molecular weight of the 2993 proteins coded by the genome. The dashed line shows the area 
covered by the proteins identified by 2D-PAGE and MALDI TOF/TOF MS in this work. The 
borders of this area are represented by: 3.9 < pI < 6.6 and 8.7 < Mr (Da) < 315. 
 
Three technical replicate gels were performed and stained with Coomassie brilliant 
blue according to the protocol of Candiano et al. [25]. After gel digitalization and 
evaluation of the gels with the Imagemaster 2D Platinum software over 600 protein 
spots were reported per gel. One digitalized 2D-gel is shown in Figure 28. The spots 
selected for analysis were cut out of the gel and the resulting gel plugs were either 
subjected to digestion or stored in Eppendorf tubes at - 20 ˚C. In-gel digestion was 
carried out after de-staining of the spots by washing steps with water and 
water/acetonitrile (50:50) solutions. Disulfide bridges were reduced and cysteines 
alkylated with iodoacetamide to avoid side reactions with rests of unpolymerized 
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acrylamide. The gel plugs were incubated in acetonitrile for 1 min and allowed to dry 
for 15 min after removal of the acetonitrile. Then, trypsin solution was added and 
absorbed by the gel plug to ensure digestion of the protein. After 15 min of digestion, 
if necessary, the gel plugs were covered with buffer solution to facilitate peptide 
migration to the solution. Digestion was carried out overnight at 37 ˚C and was either 
stopped with 0.1% TFA for subsequent analysis or frozen at - 20 ˚C. Analysis of the 
spots digests was carried out by MALDI TOF/TOF MS. 0.5 µL of the digest was 
deposited on the plate followed by addition of 0.5 µL of MALDI matrix (5 mg/mL 
CHCA in a solution 50% ACN and 0.1% TFA).  
 
 
 
Figure 28: 2D-PAGE of C. glutamicum cytosolic proteins. The horizontal axis represents the 
pH range between 4 and 7. On the vertical axis proteins are separated according to their 
molecular mass; observe the scale is not lineal. The gel was stained with Coomassie Brilliant 
Blue and digitalized with the Imagemaster software. 
 
The analysis of a spot started with the acquisition of a PMF. Subsequently 3 of the 
most intensive peaks were selected for further MS/MS analysis. In the cases with very 
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low peptide concentration, the sample was concentrated by using ZipTip™ pipette tips 
with C18 chromatography beds. The MS and MS/MS information acquired on every 
spot was sent for database search performed by the Mascot search machine. In total 
174 spots were successfully analyzed after enzymatic in-gel digestion with trypsin. 
The total number of different proteins identified by MALDI MS/MS was 166 (see 
Appendix I). In some cases, like in spot number 748 or 802, a mix of proteins was 
identified on a single spot. This problem is common due to overlapping of the proteins 
with similar molecular mass and pI [96]. The number of identified proteins of C. 
glutamicum in this work is similar to previous proteome studies by 2D-PAGE. 
Schaffer et al. [74] identified 152 different proteins of C. glutamicum in the cytosolic 
fraction, out of 970 protein spots detected by colloidal Coomassie staining. Similarly, 
164 proteins of the 635 protein spots from the 2D-PAGE analysis of Corynebacterium 
efficiens were identified [75]. 
The pI of the identified proteins ranged from 3.9 to 6.63. The periplasmic component 
of an ABC-type transporter was identified in the spot number 105 with the lowest pI, 
whereas the ribosomal protein L5 with the pI 6.63 was identified in the spot number 
73. Only one protein fell out of this range, the ribosomal protein L1 which has pI 8.84 
(spot 74). The lowest molecular mass of the identified proteins was 8.7 kDa for the 
FGAM synthase (spot 834) and the highest was 315 kDa that corresponds to the fatty-
acid synthase. According to these border proteins the window of proteins of C. 
glutamicum observable by 2D-PAGE method employed here is marked by a frame in 
Figure 27 with a dashed line. Whereas the 2D-PAGE approach is efficient to cover 
almost the whole range of masses (vertical axis) of the proteins in C. glutamicum, it is 
not capable of resolving the very acidic proteins and the proteins with pI above 6.63.  
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5. Discussion 
 
5.1. Evaluation of 2D-RP-HPLC combined with MALDI TOF/TOF 
for proteome analysis 
 
The novel combination of pH based two-dimensional reversed phase liquid 
chromatography with MALDI TOF/TOF mass spectrometry for the proteome analysis 
of C. glutamicum yielded the identification of 1644 proteins. This number of proteins 
is, to our knowledge, the highest number from C. glutamicum reported in a single 
study till now. Fischer et al. [78] reported the identification of 326 integral membrane 
proteins and 1181 cytosolic proteins of C. glutamicum. In the present work, the total 
number of peptides successfully sequenced by Mascot was 20553, which 
corresponded to 1644 proteins. 436 of these proteins were single-peptide based 
identifications. 
 
5.1.1. Evaluation of the first dimension 
 
In the first dimension, peptide separation was carried out by reversed phase liquid 
chromatography at pH 10 instead of the common SCX. Peptide net charge was 
predominantly negative because most ionizable amino acids carry negative charge (see 
Table 4) at high basic pH. Peptides carrying negative charges are rich in ionized 
carboxylic groups due to the presence of aspartic acid (D), glutamic acid (E), in 
addition to cysteines (C) and the C-terminus. In order to analyze peptide separation in 
the first dimension in terms of net charge the specific net charge of all identified 
peptides was calculated according to Table 4. Peptides were grouped according to their 
net charges and plotted against the elution time in the first dimension in Figure 29. The 
maximum of each elution profile is marked with an arrow in Figure 29. Peptides 
carrying the most negative net charges are more acidic (see Appendix VII and VIII) 
and eluted in the early fractions. These peptides are, consequently the most 
hydrophilic. As an example, the peptide DTSDDDDEISEEQQALIDR contains six D 
and three E, one R (charge +1) and the C-terminal (charge -1). This peptide has pI 4.9, 
carries net charge -9 at pH 10 and was identified in fraction 18 of the first dimension. 
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It is important to remark that the total number of identified peptides showing net 
charge -12, -11 and -10 was 19 including redundant peptides.  
 
19 24 29 34 39 44
0
5
Fraction
0
10
0
30
0
100
0
100
0
200
0
300
0
300
0
400
0
100
N
um
be
ro
fp
e
p
ti
de
s
Net charge -12, -11, -10
Net charge -9, -8
Net charge -7
Net charge -6
Net charge -5
Net charge -4
Net charge -3
Net charge -2
Net charge -1
Net charge 0 and positive
 
Figure 29: Separation of peptides during the first dimension at pH 10 in dependence with 
their net charge. Peptides carrying similar net charge were plotted against their elution time. 
The elution maximum for each category is pointed by the arrow. Acidic peptides carrying high 
negative net charge elute in the early fractions and the maximum displaces to later fractions 
according to increasing peptide basicity. 
 
At high pH, basic peptides are more retained [37]. Peptides carrying net charge -1, 
zero and +1 have in general basic pI (see Appendix VII) show more hydrophobic 
character (see Appendix VIII) and tend to elute in the later fractions. The peptides 
presenting net charge +1 at pH 2.1 are generated by the presence of missed cleavage 
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sites in which at least two basic residues are present. Because only one missed 
cleavage was considered for database search, peptides with net charge higher than +1 
were not found.  
Figure 30 compares the net charge distribution for the identified peptides at basic and 
acidic pH. The number of different net charge states observed at pH 10 (B) is greater 
than at pH 2 (A). At acidic pH most peptides present net charge +2 (57%) or +3 
(33%). At pH 10 the net charge range is broader and more equally distributed: net 
charge 0 and positive (12%), -1 (22%), -2 (24%), -3 (18%), -4 (12%), < -4 (10%).  
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Figure 30: Distribution of peptide net charges at pH 2 (A) and pH 10 (B) for the peptides 
identified in this work. 
 
The use of reversed-phase chromatography at pH 10 in the first dimension represents 
an advantage over the common SCX. A SCX separation is commonly carried out at 
acidic pH and peptides elute in narrow clusters according to their charge, mostly +2 
and +3 [1, 37]. In consequence, the selectivity of the first dimension is restricted to 
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these two charge states. In contrast, the elution of peptides in RPC is based on peptide 
hydrophobicity. The employment of pH 10 increases the net charge states distribution 
of the peptides. As shown in the Appendix VIII peptide hydrophobicity calculated 
according to Eisenberg et al. [14] increases with peptide basicity. As a consequence 
peptide separation at pH 10 is dominated by a reversed-phase mechanism in which 
peptide net charge enhances the selectivity of the separation. 
 
5.1.2. Evaluation of the second dimension 
 
In order to achieve a high number of protein identifications, peptide selectivity must 
be dissimilar in both dimensions. Because the gradient in the two dimensions 
employed in this work was based on increasing the amount of acetonitrile, peptide 
elution was exclusively influenced by the mobile phase pH and the presence of ion-
pairing reagents. The employment of different stationary phases to alter peptide 
selectivity is not as decisive as the mobile phase pH [37]. As shown in Table 4 the 
charge of the ionisable amino acids varies at pH 10 and 2.1.  
In the following lines the influence of the peptide net charge on peptide identification 
in both dimensions will be studied. In order to see how peptide net charge was affected 
by the working pH values, the peptide net charge of the identified peptides was 
calculated at pH 10 and 2.1. In addition, the net charge of the peptides from the in-
silico digest of C. glutamicum was calculated at the working pH and compared with 
the peptides identified in this study (see Figure 31). For the theoretical digest only 
peptides in the working mass range (800-4000 m/z) were considered for the 
calculations. As a result the number of peptides of the theoretical digest susceptible for 
detection was restricted to 95477 different peptides, including the possibility of one 
missed cleavage. In the theoretical digest most of the peptides are negatively charged 
at pH 10 (see Figure 31 A) and only 20% of the peptides carry positive or zero net 
charge. Although the distribution of net charges was similar for the identified and 
theoretical peptides at pH 10, the identification of peptides with zero or positive net 
charge was underrepresented compared to peptides with net charges -2, -3 and -4. 
Peptides carrying net charge -2, -3 and -4 at pH 10 are peptides containing aspartic 
acid and glutamic acid in their sequence, in addition to the negative charge provided 
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by the C-terminus. In section 5.2.2 it will be demonstrated that the relative occurrence 
of aspartic acid and glutamic acid is higher than predicted (see Appendix IX). 
 
 
 
Figure 31: Percentage of peptides carrying the same net charge. Net charges were calculated 
for the identified peptides (●) and the peptides from the theoretical digest (■). Two situations 
were considered: the first dimension at pH 10 (A) and the second dimension at pH 2.1 (B).  
 
Positive charges at pH 10 are due to the accumulation of arginine and lysine in the 
peptide; the presence of a missed cleavage yields a peptide with two basic residues and 
net charge +1. Because only one missed cleavage was considered during the database 
search, the finding of higher net charge states was excluded. All the underrepresented 
peptides showing zero or positive net charge at pH 10 are basic peptides (pI > 7). The 
distribution of charges for identified and theoretical peptides at pH 2.1 is shown in 
Figure 30 B. All identified peptides with net charge +1 were peptides derived from 
protein C-terminus without the presence of histidine (see Appendix VI), e.g. the C-
terminus peptide WVTAQAMFG (m/z 1010.4) from 6-phosphofructokinase. Due to 
the absence of K or R, the positive charge was exclusively supplied by the N-terminus. 
Net charge +2 was supplied by the N-terminus and one K or R at the C-terminus, 
resulting from enzymatic cleavage with trypsin. Net charges +3, +4 and > +4 were due 
to the presence of one missed cleavage (one additional R or K) and the presence of 
histidine. At pH 2.1 there was a negative discrimination in the detection of peptides 
carrying net charge higher than +2. This is due to the fact that in the theoretical digest 
all peptides with one missed cleavage were considered for the calculations, whereas in 
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the real situation not all missed cleavages always occur. Only 22% of the identified 
peptides comprised the presence of one missed cleavage site. Peptides of net charge +2 
at pH 2.1 were identified predominantly (57%). These peptides had mostly acidic or 
neutral isoelectric point: 0.02% had pI 4; 9% had pI 5; 53% had pI 6; 26% had pI 7 
and only 12% had pI 8. 
 
5.1.3. Orthogonality of the separation 
 
The successful separation of peptides in a complex mixture by 2D-LC is achievable 
only if the selectivity in both dimensions is dissimilar, ideally orthogonal. In order to 
evaluate the orthogonality of the two dimensions the peptides were plotted on a two-
dimensional spatial distribution according to the elution time in each dimension. The 
orthogonality of the 2D-LC employed in this work is shown in Figure 32.  
 
 
Figure 32: Orthogonality of the separation. Peptides are plotted according to their retention 
time in the first dimension (collected fraction) and in the second dimension (elution time 
assigned to the spot where a peptide was identified).  
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The elution time in the first dimension was given by the fraction in which a peptide 
was identified whereas the elution time in the second dimension was given by the spot 
number of the MALDI-plate where the peptide was successfully sequenced. A 
MATLAB-based program was employed to correlate the identified peptide with the 
spot where it was sequenced and assigned the corresponding retention time.Although 
peptides are distributed almost over the whole separation area there is an empty region 
in the bottom right corner and therefore the separation can be described as “nearly-
orthogonal”. Because an acetonitrile gradient was employed in both dimensions for 
peptide separation, very hydrophobic peptides eluting in the latest fractions of the first 
dimension (35 - 45% of acetonitrile content) elute in the second dimension also at 
higher acetonitrile content. These peptides are displaced to the top right corner of the 
separation area leaving an unpopulated area in the bottom right corner. Also the area in 
the left top corner is partially unoccupied because in the first fractions of the first 
dimension elute very hydrophilic peptides.  
In order to visualize peptide elution quantitatively peptide density was plotted in a 2D 
partitioned space (see Figure 33). The separation area was divided in 90 uniform-sized 
bins (30x30) and the number of identified peptides per bin was computed according to 
their retention times with MS Excel. For the calculations all identified peptides by 
MALDI TOF/TOF were considered including redundant peptides. Figure 33 illustrates 
that most of the peptides are concentrated along the diagonal of the separation space. 
Most of the peptides elute in the first dimension for an acetonitrile percentage of 23 to 
38%. In the second dimension peptides are mostly well distributed except for the very 
hydrophobic ones present in the last fractions of the first dimension. These peptides 
start eluting on the minute 29 of the first dimension and in the second dimension elute 
during the 3 minutes washing step with 100% eluent B.  
The orthogonality of the system could be improved by adapting the acetonitrile 
gradient to the peptide content. As shown above, the latest fractions from the first 
dimension are rich in hydrophobic peptides. In the second dimension, many peptides 
from fractions collected between 29 and 43 min in the first dimension elute during the 
washing step of the gradient. The original gradient for the second dimension was 0 to 
20% of acetonitrile in 60 min. An improved gradient for fractions from the first 
dimension between minutes 29 and 45, could be faster from 0 to 10% of acetonitrile 
and extended from 10 to 25% acetonitrile. 
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Figure 33: Peptide density in the two-dimensional separation space. The space was divided in 
30x30 bins. In the legend (right side) the number of peptides identified per bin is shown in a 
gray scale. 
 
Another improvement in order to reduce the analysis time could be to merge together 
the first and the latest 5-6 fractions of the first dimension. These fractions have the 
lowest peptide content. This would reduce the analysis from 31 to 20 fractions of the 
first dimension and save 33 LC-MALDI runs. 
 
5.1.4. Evaluation based on peptide identification 
 
The number of identified proteins strongly depends on the performance of the mass 
spectrometer and its capability to sequence peptides successfully. The 31 fractions 
analysed generated 93 LC-MALDI runs and 75262 precursors, but only the 27% of the 
masses selected for fragmentation yielded a successful identification by database 
search. Some of the reasons why a precursor was not correctly identified or did not 
match to a peptide are low concentration of the peptide, suppression effects and 
heterogeneous crystal morphology of the deposited samples. Peptides at low 
concentration are very much affected by sample depletion after several acquisitions on 
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the same spot. It has been reported that roughly 30% of the MS/MS spectra of a low 
intensity peptides was identified from the first five MS/MS acquisitions on the same 
spot [97]. Peak suppression can be reduced by employing longer gradients or smaller 
spots. However, the size of the spots on the plate is a compromise between the sample 
complexity and the analysis time. In the case of complex samples, smaller spot sizes 
(e.g. half the time) generate more spots and longer analysis time. A negative 
consequence is that the sample concentration per spot reduces and peptides present at 
low concentration may be under the limit of detection of the mass spectrometer. The 
number of times a peptide was successfully repeatedly sequenced by LC-MALDI 
MS/MS in this work is shown in Figure 34. 
 
 
 
Figure 34: Number of times a unique peptide was successfully sequenced by MALDI 
TOF/TOF MS. 
 
Each m/z recorded in the precursors list for MS/MS corresponds, in theory, to one 
peptide mass and it should be selected only once within a chromatographic run. The 
majority of the peptides was identified once, twice or three times due to the fact that 
three replicates were performed on each fraction. Peptides identified only once (35%) 
or twice (25%) are probably present in the sample at low concentration or have a low 
S/N. These peptides are available in not many spots and are more susceptible to be 
affected by peak suppression effects during the ionization process. Peptides identified 
three times were sequenced during each of the triplicate LC-MALDI measurements. 
These are abundant peptides are not much affected by peak suppression effects. The 
percentage of peptides measured more than four times was 17. Peptides sequenced 
more than three times are usually high abundant peptides, which were found in more 
than one fraction of the first dimension. Also variations in the mass accuracy during 
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the acquisition process can lead to the assignment of more than one precursor to one 
peptide during a LC-MALDI experiment. 
A carry-over effect is frequently observed in SCX separations [27, 98] due to 
unspecific interactions with the stationary phase. Because in this work a RP separation 
was employed in the first dimension, a low carry-over of peptides was expected. 
Therefore the elution of peptides in the collected fractions was analyzed in the first 
dimension. These results are ilustrated in Figure 35. 80% of the peptides identified by 
MALDI TOF/TOF MS eluted in one single fraction, 13% of the peptides were 
identified in two adjacent fractions and only 1% of the peptides were sequenced within 
three fractions. 
 
Peptides sequenced across
more than 3 fractions (5%)
Peptides sequenced in 3
consecutive fractions (1%)
Peptides sequenced in 2
consecutive fractions (13%)
Peptides sequenced
within 1 fraction (80%)
 
 
Figure 35: Peptide cross-over along different fractions. Most of the peptides (80%) eluted in 
one fraction whereas only 20% were identified in more than one fraction. 
 
The residual 5% of the identified peptides were found in more than three fractions; the 
majority of them was identified more than four times and stem from highly abundant 
proteins. In conclusion, the observed cross-over effect of peptides during the first 
dimension was very small. 
 
5.1.5. Evaluation based on protein identification 
 
The total number of identified proteins returned by the Mascot search engine was 1644 
proteins. 18% of these proteins were identified by matching two different peptides to 
their sequence, 12% by three different peptides and 44% by matching to them three or 
more peptides by database search. However, 26% of these proteins were single-peptide 
identifications (see Figure 36).  
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Figure 36: Protein distribution according to the number of peptides correctly assigned. 
 
Assuming that proteins identified by at least two different peptides are confident 
identifications [99], 1208 proteins were definitely identified in this work. As a result, 
1783 proteins of C. glutamicum were not identified. 52% of the not identified proteins 
were hypothetical proteins and 14% were membrane proteins.  
It is generally assumed that high abundance proteins are more likely to be detected 
than proteins expressed at lower levels. An attempt to predict protein expression levels 
is the codon adaptation index (CAI), which is based on the degree of codon usage bias 
in genes. The degree of the codon usage bias has been proved to correlate with the 
level of gene expression in yeast [100] as well as in bacteria [101, 102]. The CAI 
values [103] are indicators of protein expression level and were employed in this work 
for estimation of protein expression. The CAI values for all predicted proteins in the 
C. glutamicum database as well as for the proteins identified by the 2D-LC-MALDI 
approach with more than one different peptide, were automatically generated 
(www.jcat.de) according to a procedure previously defined [104]. CAI close to unity 
indicates high expression, whereas CAI values close to zero point to low expression 
levels. Figure 37 illustrates the distribution of proteins of C.glutamicum according to 
their CAI value; additionally, the percentage of identified proteins from each CAI 
interval is shown. The graph shows that the percentage of identified proteins increases 
in agreement with their predicted expression level. 90% of the proteins encoded by 
genes that have a high CAI (CAI > 0.8) were successfully identified, as can be 
expected for highly expressed genes. In the range of CAI values between 0.8 and 0.4 
the percentage of identified proteins is between 83 and 64%. Between 0.3 - 0.4 it was 
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50%, 30% between 0.2 - 0.3 and below 0.2 CAI it was only 19%. It is important to 
remark that the number of proteins identified within an interval of CAI values was not 
influenced by the number of total proteins in the interval. 
 
 
Figure 37: Distribution of CAI indexes for all predicted gene products of C. glutamicum (□) 
and the proteins identified by LC-MALDI (■). The line graph shows the percentage of 
identified proteins within the corresponding interval. 
 
The CAI has been used as expression level indicators to evaluate the ability of the 2D-
RP-HPLC MALDI TOF/TOF approach to identify proteins based on their abundance. 
A rough estimation shows that the approach presented here enables the identification 
of more than 80% of highly expressed proteins (CAI > 0.5), more than 50% of middle 
expressed proteins and more than 20% of low abundant proteins. 
The proteome coverage achieved by the present method was 55% but reduces to 40% 
when considering only the proteins identified by more than one peptide. Taking in 
account that 22% of the proteins are classified as membrane proteins and the 
extraction protocol employed was specific for cytosolic proteins, 78% of the protein 
coding genes remain to be detected. In addition not all proteins are expressed under 
normal cultivation conditions [102]. The identification of half of them is a high-quality 
result as it is the highest number of proteins of C. glutamicum reported in a single 
study up to now. 
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5.2. Comparison of the novel 2D-RP-HPLC MALDI TOF/TOF 
approach with two alternative approaches for proteome 
analysis 
 
In the following lines the novel 2D-RP-HPLC MALDI TOF/TOF approach for the 
proteome analysis of C. glutamicum is compared with two alternative platforms for 
proteome analysis. In order to estimate the efficiency of the method, the results 
obtained by the combination of 2D-RP-HPLC with MALDI TOF/TOF are weighed 
against the classical 2D-PAGE top-down approach described in section 4.4. and the 
approach described by Delmotte et. al. [1]. The later method employed the on-line LC-
ESI-IT analysis of fractions collected by the first dimension at high pH. While the 
capabilities of the mass spectrometer employed the earlier study, an ion trap Esquire 
HCT (Bruker Daltonics Inc.), have been overcome by new instruments, the 4800 
MALDI TOF/TOF represents the latest improvements in MALDI-TOF technology. As 
a consequence, the use of a more up to date mass spectrometer than the ESI-IT HCT 
for the analysis of fractions in the second dimension can lead to other improved 
results. Also the 2D-PAGE technique is a classical method for protein separation. 
However it has been little improved since it was established over twenty years ago 
[23] and its drawbacks limit it use for the proteome analysis [24].  
 
5.2.1. Comparison with a top-down approach: 2D-PAGE 
 
The cytosolic proteome of C. glutamicum was analysed by a classical top-down 
approach for proteome analysis as described in section 4.4. Separation was performed 
at the protein level by 2D-PAGE and identification was carried out by MALDI 
TOF/TOF analysis after digestion of each gel plug overnight. The results of this 
approach were compared with the novel 2D-RP-HPLC MALDI TOF/TOF system 
employed for bottom-up analysis of C. glutamicum. 
Although the 2D-PAGE was capable of resolving around 600 protein spots, in practice 
around 200 gel plugs containing stained proteins were manually excised from the gel 
and 166 different proteins were successfully identified. As expected, the number of 
proteins identified by the bottom-up approach was superior to the 2D-PAGE approach. 
It has been reported that low abundant proteins, usually from genes with codon bias of 
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< 0.1, are usually not found by 2D-PAGE [96]. Thus, the potential of the 2D-PAGE 
technique is limited for the proteome analysis, in which a large range of expression 
levels are present in a sample. Therefore the comparison of the methods was 
performed at the peptide level. The MALDI TOF/TOF analysis of the digested spots 
was performed in two stages. In the first stage a mass spectrum was acquired from the 
spot on the plate, this is the so called peptide mass fingerprint (PMF). Subsequently, 
the three most intensive peaks of the mass spectrum were selected automatically for 
MS/MS analysis. Protein identification was carried out by combination of the 
information acquired by MS and MS/MS for the database search. In some cases 
fragmentation of the selected precursors was not successful and protein identification 
was subsequently based on PMF information. The comparison between the 2D-PAGE 
and LC-MALDI approach was based on the evaluation of the identified peptides of 46 
proteins identified by both approaches. 560 peptides from the 2D-PAGE approach and 
498 peptides from the LC-MALDI approach were studied. The degree of overlapping 
of the identified peptides is shown in Figure 38.  
 
 
 
Figure 38: Venn diagram of the overlapping degree of the two sets of peptides from proteins 
identified by 2D-PAGE and LC-MALDI. Forty-six proteins identified by both approaches 
were employed for the data evaluation. The total number of non-redundant peptides was 703. 
 
The total number of non-redundant peptides was 703 and 51% of them were 
successfully identified with both approaches. Each approach also supplied unique 
peptides, 29% of the peptides were only identified by the 2D-PAGE approach and 
20% of the peptides were only identified by the LC-MALDI approach. Despite the use 
of the same mass spectrometer for peptide detection, the data in Figure 38 indicate that 
the bottom-up and the top-down approaches generated complementary information at 
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the peptide level.Identified peptides by each individual approach were analysed more 
closely in order to find out any discrimination that explains the complementarity of the 
methods. Figure 39 illustrates the distribution of peptides identified by each approach 
based on the peptide length or number of amino acids. Also peptides with one missed-
cleavage were considered for analysis. The peptides solely identified by the 2D-PAGE 
approach were mostly small peptides of 5, 6 or 7 amino acids. The LC-MALDI 
approach was especially not successful to identify very small peptides composed of 5 
or 6 amino acids. These peptides fall in the low mass range of MALDI MS mode 
which is below 900 Da. Because of the presence of matrix clusters in that m/z region 
these peptides were not chosen for fragmentation during LC-MALDI analysis. 
However, the LC-MALDI approach was capable of identifying more peptides of 
length 15 to 29 amino acids. This can be due to the fact that longer peptides originated 
by enzymatic digestion in the gel plugs can not diffuse as easy as smaller peptides 
from the polyacrylamide gel into the solution. 
 
 
 
Figure 39: Distribution of peptides identified either by the 2D-PAGE approach or by the 2D-
LC-MALDI approach. Peptides are represented based on the number of amino acids and 
belong to 46 proteins identified by both approaches. 
 
Most of the peptides released after enzymatic digestion, which are susceptible of 
detection by MALDI MS are in the mass range between 800-2500 Da. Because all 
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peptides obtained by in-gel digest are ionized together for PMF analysis, peptide 
competition for the available protons can cause signal suppression [90]. Therefore 
peak suppression may play a role in detection of peptides originated from digestion of 
gel spots. These peak suppression effects are reduced if peptides are separated by 
liquid chromatography previous to mass spectrometric analysis. The combination of 
the bottom-up and top-down approaches delivered higher sequence coverage for most 
of the studied proteins. Figure 40 shows the sequence of a representative protein, 
Thioredoxin reductase of locus identification number NCgl2984 that is 317 amino 
acids long. 
 
 
Figure 40: Sequence coverage of the protein Thioredoxin reductase achieved by the 2D-
PAGE approach and by the 2D-LC-MALDI approach. Both approaches were able to identified 
unique peptides increasing the total sequence coverage to 83%. 
 
The sequence coverage achieved by the 2D-PAGE approach was 58% whereas the 
LC-MALDI approach achieved 62%. Because each approach delivered unique 
peptides, the combination of both approaches raised the total sequence coverage to 
83%. Consequently both methods supply complementary information, which improves 
the sequence coverage of the proteins by increasing the number of non-redundant 
peptides identified. 
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5.2.2. Comparison MALDI TOF/TOF vs. ESI-IT 
 
The two mass spectrometric approaches employed for the analysis of the fractions 
collected during the first dimension present several differences. The different 
ionization methods, ESI and MALDI, are supported by different mass analyzer, ion-
trap and TOF, respectively, which are based on different mass separation principles 
(see introduction). Furthermore the coupling of liquid chromatography and mass 
spectrometry requires an on-line set-up for the ESI-IT analysis and an off-line set-up 
for the MALDI approach. Despite the use of the same chromatography set-up and due 
to the intrinsic differences of the mass spectrometers mentioned above, some 
differences in the results could be expected. In Table 6 some of the features 
concerning the results delivered by MALDI MS and ESI MS are compared. 
 
Table 6: Comparison of MALDI and ESI results based on the analysis of the digested 
proteome of C. glutamicum by 2D-RP-HPLC. 
 
Parameters MALDI TOF/TOF ESI-IT 
Spectra acquired  75262 25209 
Total identified peptides 20553 10882 
Unique identified peptides 7416 2709 
Total identified proteins (% of 
the proteome) 1644 (55%) 745 (25%) 
Identified proteins with two or 
more different peptides (% of 
the proteome) 
1208 (40%) 468 (16%) 
False positive rate 2.4% 2.3% 
MS average mass accuracy 20 ppm 218 ppm 
 
The MALDI approach delivered undoubtedly a higher number of identifications and 
consequently higher proteome coverage for all identified proteins as well as for 
proteins identified with more than one peptide. However the ESI approach yielded a 
better efficiency of MS/MS spectra successfully assigned (43%) compared to the 
MALDI approach (27%). The MS/MS efficiency was calculated by dividing the 
number of assigned MS/MS spectra by the total number of spectra acquired. One of 
the advantages of the MALDI approach relies on the off-line coupling because the 
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analysis time is not restricted to the chromatographic elution. Under these conditions 
only the amount of sample on the plate is the limiting factor for analysis of a spot. 
However, the time required for the complete experiment was longer than in the ESI 
approach: about 375 hours were required to analyse the thirty-one fractions in 
triplicates by MALDI TOF/TOF MS, whereas 124 hours were required for the 
analysis by ESI-IT. The improvement of the MS/MS efficiency by using a precursor 
ion exclusion list could yield more positive identifications [97] and thus reduce the 
analysis time. Such an exclusion list contains all the identified peptides in the 
preceding runs and avoids subsequent redundant acquisitions. As a consequence, 
sample depletion is reduced and identification of low abundant peptides is improved. 
As expected the mass accuracy in MS mode delivered by the TOF mass analyzer was 
ten times better than the mass accuracy provided by the ion trap. The calculated false 
positive rate was similar in both approaches. 
The MALDI approach yielded 2.7 times more unique peptides than the ESI approach. 
As a consequence, a better sequence coverage of the identified proteins was achieved 
by the MALDI approach (see Figure 41). The sequence coverage of a protein is 
calculated relative to the number of amino acids of the protein and expressed in 
percentage. Both approaches delivered a similar number of proteins with sequence 
coverage between 15 and 25% but MALDI yielded more proteins than ESI with 
sequence coverage above 25%. 
 
 
Figure 41: Comparison of the sequence coverage reported for the identified proteins by the 
ESI and MALDI approaches.  
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In the next lines, the differences between identified peptides by the ESI- and MALDI-
approaches were investigated based on peptide mass, pI and hydrophobicity. The 
masses of the 95477 peptides from the theoretical digest were computed and compared 
with the masses of the peptides identified by both approaches (see Figure 42). Figure 
42 illustrates the distribution of the peptides masses obtained by in-silico digest in the 
mass range of 800 to 4000 Da. For the MALDI approach the mass range of the 
fragmented precursors was m/z 800-3000, whereas in the ESI the range was 600-3900. 
Both approaches were especially not efficient in the detection of peptides with masses 
below 1000 Da in comparison with the theoretical data. Although 51 peptides with 
molecular masses below 800 Da were sequenced by the ESI approach, MALDI 
provided a superior rate of identified peptides for masses below 1000 Da.  
 
 
Figure 42: Distribution of peptides according to their masses expressed in percentage. The 
number of peptides obtained by theoretical digestion was 95477. The peptides used for the 
evaluation of data correspond to proteins identified by more than one peptide. The percentage 
was calculated with respect to all the peptides within a class. 
 
In the mass range 1000 to 1400 Da MALDI showed better detection efficiency. The 
tendency inverts for higher masses and the ESI approach delivered a higher rate of 
successful identifications in the mass range 1400 - 2400 Da. Both approaches are 
equally comparable for mass ranges 2000 - 2200 and 2600 to 3000. With respect to 
peptide masses above 3000 Da the relative number of peptide identifications was 
lower than the predicted. This can be due to the fact that the theoretical approach 
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considers all possible one missed cleavage situations derived from the in-silico digest. 
The presence of one missed cleavage results always in a longer peptide. However in 
the experimental digest missed cleavages occur randomly. The ESI approach has an 
intrinsic advantage over MALDI for analysis of high mass peptides because during the 
ionization multiple charged ions (+2 and +3) are formed.  
To compare the chemical properties of the identified peptides by MALDI and ESI, the 
pIs and hydrophobicities of the peptides were computed and are shown in Figure 43 
and Figure 44. Figure 43 shows the distribution of identified peptides according to 
their calculated pI. The ESI approach identified more acidic peptides (pI < 6), whereas 
the MALDI approach tends to favor identification of peptides with pI above 6. 
Consequently it can be concluded that the MALDI approach yields preferentially more 
basic peptides. These observations are in accordance with data previously reported 
[105]. 
 
 
Figure 43: Calculated pI of the identified peptides by the ESI and MALDI approaches. 
Percentages are referred to the total number of peptides of the corresponding approach. 
 
Hydrophobicities were computed according to the normalized scale of Eisenberg [14], 
where higher values indicate hydrophobic amino acids and negative numerical values 
indicate hydrophilic amino acids. In the present study it was found that the MALDI 
approach identified slightly more hydrophobic peptides (Figure 44). This fact could 
represent an advantage for the identification of peptides from proteins with 
transmembrane domains. However, there is no agreement about the preferential 
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ionization of hydrophobic or hydrophilic peptides by MALDI or ESI in previous 
studies. It has been reported that MALDI ionizes preferentially hydrophilic peptides 
[106], but it has also been reported that more hydrophobic peptides are preferentially 
ionized in CHCA matrix [90].  
 
 
Figure 44: Hydrophobicity of the identified peptides by the MALDI and ESI approaches 
calculated according to the Eisenberg scale. 
 
Previous studies have found that the MALDI technique is more prone to identified 
tryptic peptides ending with arginine, whereas ESI identifies rather peptides with a 
lysine at the C-terminus [105, 107]. The ratio of lysine to arginine (K/R) calculated for 
the theoretical digest was 0.68. The ratio for MALDI and ESI approaches was found to 
be 0.49 and 0.76, respectively. These results are in accordance to previous results that 
showed a  tendency of MALDI to identified peptides with arginine, which is the most 
basic of all amino acids and has the highest proton affinity [108]. The frequencies of 
the different amino acids within the identified peptides were examined in Figure 45 for 
both MALDI and ESI techniques, and for the predicted peptides of the in-silico digest. 
Amino acids were grouped according to the properties of the side-chains for plotting. 
The acidic amino acids are not shown because the frequencies of both aspartic acid 
and glutamic acid were almost equal for the MALDI and ESI approaches (see 
Appendix IX). Besides that, the identification of these amino acids was higher than the 
predicted by the in-silico digest. The amino acids occurrences varied between 0.6% for 
cysteine identified by ESI and 7.8% for alanine identified by MALDI. The most 
pronounced differences are observed for the basic amino acids. As mentioned before, 
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ESI ionizes preferentially lysine containing peptides and MALDI arginine containing 
peptides. Besides, the identification of histidine is preferred by the two ionizations 
techniques compared to other amino acids. As a consequence, the frequency of 
occurrence of this amino acid for MALDI and ESI is higher than in the theoretical 
digest. The ESI approach showed a slight preference for aliphatic amino acids when 
compared with MALDI. MALDI showed a bias towards identification of aromatic 
amino acids, specially phenylalanine and tryptophan. In the case of amino acids with a 
hydroxyl group, they were preferentially identified by ESI, especially threonine. The 
identification of cysteine and methionine containing peptides was lower for both 
MALDI and ESI approaches than in the theoretical digest; however MALDI reported 
slightly more peptides than ESI.  
 
 
Figure 45: Relative occurrences of amino acids expressed as percentages for MALDI and ESI 
approaches. The percentage is referred to the number of amino acids from all identified 
peptides. The amino acids are grouped according to their side-chain properties. 
 
In conclusion, the MALDI approach favors ionization of peptides containing arginine 
and aromatic amino acids. The ESI approach shows a preference to ionize peptides 
containing lysine, histidine and hydroxy amino acids. If the data are compared with 
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the predicted peptides, it can be concluded that both methods tend to preferentially 
ionize peptides containing histidine, aliphatic side-chain amino acids, aromatic amino 
acids and acidic amino acids. 
The complementarity of the ESI and MALDI approaches at peptide level was 
investigated based on the unique peptides identified by each spectrometric approach 
(Figure 46).  
 
Figure 46: Venn diagram of the overlapping degree for the identified peptides by the MALDI 
approach and ESI approach. Only peptides of proteins identified by more than one unique 
peptide were considered. 
 
The studied peptides belong to proteins identified by more than one peptide. The 
number of peptides considered was 2431 and 7413 for ESI and MALDI respectively. 
26% of the peptides were common to both mass spectrometric approaches. However 
the MALDI approach delivered a higher number of unique peptides, 69%, compared 
to the 5% delivered by the ESI approach. Because the chromatographic separation 
employed was the same, the differences in peptide identification are due to the 
hyphenation to the mass spectrometer and differences in the ionization processes. 
Unique peptides identified exclusively by one of the methods were analyzed more in 
detail according to their peptide length. Peptide relative distribution according to the 
number of amino acids, expressed in percentage, is shown in Figure 47. The 
distribution of unique peptides in percentage is slightly different for both approaches. 
However the ESI approach shows a better detection for very short and very long 
peptides. Although the MALDI approach delivered higher number of unique peptides, 
a deficiency for the detection of short peptides (5-7 amino acids) and long ones (>26 
amino acids) was observed. This is a direct consequence of the mass range selected for 
MS/MS analysis by LC-MALDI. Precursor’s masses below 900 were not selected for 
fragmentation in order to avoid selection of matrix clusters.  
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Figure 47: Distribution of peptides identified exclusively by one of the approaches, according 
to the number of amino acids in the peptide. 
 
5.2.3. Comparison of methods based on protein identification 
 
The evaluation of the proteins identified by the three proteomic approaches was based 
on proteins identified by more than one peptide. Therefore the number of proteins 
considered for comparison was: 166 proteins identified by 2D-PAGE, 468 proteins 
identified by 2D-RP-HPLC-ESI-IT and 1208 proteins identified by 2D-RP-HPLC 
MALDI TOF/TOF. 
In previous studies, a complementary identification has been claimed between LC-
MALDI MS/MS and LC-ESI MS/MS approaches [87, 89]. Although a small 
complementarity was observed at the peptide level between both approaches, at the 
protein level the LC-MALDI approach was clearly superior to the other approaches. 
Figure 48 illustrates the protein identifications shared by the different approaches. The 
LC-MALDI approach showed a higher total number of identifications including 726 
unique identified proteins not identified by the other two approaches. 144 of the 
proteins overlapped for the three employed methods. These shared proteins are 
essentially enzymes present in the main metabolic pathways. These highly expressed 
proteins are more likely to be detected by all of the approaches. 
Twenty-one proteins were identified by the MALDI and 2D-PAGE approach but not 
by the ESI approach. However, fifteen of them were found in the list of proteins 
identified by one unique peptide in the ESI approach. The other six proteins which 
could not be successfully identified by ESI have protein masses between 22 and 35 
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kDa. However, there is no apparent reason why they should not be identified by the 
ESI approach. The corresponding protein stained spots showed low intensity in the 
Coomassie stained polyacrylamide gel. The CAI values are between 0.3 and 0.6 and 
thus they are neither highly expressed nor low expressed proteins. 
 
 
 
 
Figure 48: Comparison of methods based on identified proteins by the three approaches 
employed for the proteome analysis of C. glutamicum. The Venn diagram shows the degree of 
overlapping in the identifications. 
 
These proteins identified by MALDI but not by the ESI approach were investigated 
more closely. Based on the retention time of the peptides from these proteins identified 
by the LC-MALDI approach, it was demonstrated that the identified peptides eluted 
from the column at times that show strong co-elution with other peptides. The 
retention times of these peptides are found in high peptide density areas from the 
Figure 33. Strong peptide co-elution appears to be the most probable cause of the 
failure to detect them by the ESI approach. The number of co-eluting peptides 
probably exceeds the number of MS/MS spectra that the mass spectrometer can 
acquire in one data-dependant analysis cycle. In the case of strong peptide co-elution 
the approach based on off-line coupling shows enhanced detection ability. 
One single protein with locus ID NCgl0385 was exclusively identified by the 2D-
PAGE and ESI approaches. Nevertheless one of the peptides was sequenced by the 
LC-MALDI approach and therefore belongs to the one-hit wonder proteins identified 
by MALDI. The six proteins identified exclusively by the ESI approach were 
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identified by the MALDI approach as one-hit proteins (see Table 7). Except NCgl1841 
(MW 70kDa), the other proteins are low molecular mass proteins (below 16 kDa). 
Smaller proteins generate less possibly tryptic peptides within the m/z range of the 
mass spectrometer [30]. 
Table 7 shows that the six proteins identified exclusively by the ESI approach were 
identified by the MALDI approach, however by one peptide hit only. In all cases the 
peptide was sequenced more than once. Two of the proteins shown in Table 7, 
NCgl0459 and NCgl2493, were identified by ESI based on two peptide hits. One of 
the peptides was also identified by MALDI and the sequence is given in Table 7. The 
second peptide had molecular mass over 3000 Da and charge +3. As already shown in 
Figure 42, the ESI approach was more successful than the MALDI approach for the 
identification of high molecular mass peptides due to the advantage of multiple 
charged peptides generated by the ESI ionization process. 
 
Table 7: List of proteins identified by the ESI approach with more than one non-redundant 
peptide and by the MALDI approach with only one sequenced peptide. 
 
Protein  
Single-peptide 
sequenced by 
MALDI TOF/TOF 
Times the 
peptide 
was sequenced 
NCgl0459 Ribosomal protein L11 GNVVPVEITVYEDR 3 
NCgl0519 Ribosomal protein L30/L7E HTVIRPDTPEVR 6 
NCgl0930 hypothetical protein ATEFLDSDSGEQK 2 
NCgl1448 pyrophosphohydrolase 
[3.6.1.31] 
TFDSLYEELLNR 3 
NCgl1861 phosphotransferase system 
[2.7.1.69] FAGKPVIESGVK 
3 
NCgl2493 hypothetical protein YSSPDMDLDSLQR 3 
 
In the case of the protein NCgl1861 a complementarity of the methods was observed: 
the two peptides sequenced by the ESI approach were different from the peptide 
identified by the MALDI approach.  
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The comparison of the methods based on pI and molecular weight of the identified 
proteins is shown in Table 8. In addition, in the table are listed the proteins showing 
extreme pI and MW values from the predicted proteome of C. glutamicum. The 
MALDI approach identified the most acidic, most basic and smallest protein of all the 
approaches. The identified proteins with highest and lowest pI were hypothetical 
proteins which have pI 11.72 and 3.3 respectively. The protein with highest molecular 
weight was 3-oxoacyl-(acyl-carrier-protein) synthase, which has 316 kDa and the 
smallest protein identified with at least two different peptides was the ribosomal 
protein L33 (6.4 kDa). 
 
Table 8: Comparison of the three methods for the proteome analysis based on pI and MW of 
the proteins identified from C. glutamicum. 
 
Approach Lowest pI Highest pI 
Lowest 
MW (kDa) 
Highest  
MW (kDa) 
2D-RP-HPLC  
MALDI TOF/TOF 
3.3 
(NCgl1090) 
11.7  
(NCgl0838) 
6.4 
(NCgl0833) 
316 
(NCgl2409) 
2D-RP-HPLC ESI-IT 
3.8 
(NCgl1057) 
11.6  
(NCgl0834) 
6.8 
(NCgl0519) 
316 
(NCgl2409) 
2D-PAGE &  
MALDI TOF/TOF 
3.9 
(NCgl1915) 
6.63 (8.8) 
NCgl0501(0460) 
8.7 
(NCgl2501) 
315 
(NCgl0802) 
Predicted proteins  3.08 13.62 3.7 316 
 
The results generated by the ESI approach were very close to the MALDI approach. 
The 2D-PAGE was comparable to the other approaches for identification of high MW 
proteins and acidic proteins. As mentioned earlier it was not possible to separate and 
detect basic proteins by 2D-PAGE. In accordance with previous studies, 2D-PAGE is 
not suitable for identification of proteins of C. glutamicum which have basic pI. The 
present work also failed to identify small proteins (below 8 Da). 
In order to investigate the ability of the different approaches to identify the enzymes 
involved in the central metabolic pathways, the enzymes of the TCA cycle, the 
glycolysis and the pentose phosphate pathway are represented in Figure 50, Figure 49 
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and Figure 51, respectively. Enzymes identified by the three methods, MALDI and 
ESI or just MALDI are marked with an ellipse, square or dashed square respectively. 
The information shown here is a compendium of the information provided by three 
different sources: KEGG (Kioto Encyclopedia of Genes and Genomes; 
www.genome.jp/kegg/), ExPASyProteomics Server (www.expasy.org) and 
CoryneRegNet Release 4.0 of the Bielefeld University [109]. 
 
CENTRAL METABOLIC PATHWAYS 
TCA cycle 
 
None of the methods was able to identify the cytochrome subunit of the succinate 
dehydrogenase and the β-subunit of the succinyl-CoA synthetase. The cytochrome 
subunit has been described as a membrane protein and therefore is not achievable by 
the extracting protocol used here, which was optimized for cytosolic proteins.  
 
 
Figure 49: Enzymes of the TCA cycle which were identified by the three approaches, only by 
MALDI and ESI approaches or only by the MALDI experiment. 
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The β-subunit of the succinyl-CoA synthetase was, however, listed in the one-hit 
protein list of the MALDI approach and of the ESI approach. Interestingly the peptide 
reported by ESI was different (VIPVLIK) from the peptide sequenced by MALDI 
(MDLFEYQAR), which represents a case of complementary information provided by 
both techniques. The 2D-PAGE based approach failed in the identification of 
oxoglutarate dehydrogenase and malate dehydrogenase. MALDI exclusively identified 
the other two subunits of the succinate dehydrogenase as well as the α-subunit of the 
succinyl-CoA synthetase. The subunits of the succinyl-CoA synthetase have low CAI 
values and therefore it can be estimated that they are low expressed proteins. The 
biosynthesis of L-glutamate from oxoglutarate is also shown in Figure 49. The enzyme 
that catalyzes this reaction, the glutamate dehydrogenase, was identified by all three 
approaches. 
 
Glycolysis 
 
All the enzymes of the glycolysis pathway taking part in the transformation of the 
glucose to pyruvate were identified by the MALDI approach. Only one enzyme, locus 
ID NCgl1860, was not identified by the ESI approach. The 2D-PAGE approach was 
capable of identifying the enzymes which catalyze fructose-6-P to pyruvate. However 
the 2D-PAGE approach failed to identify the enzymes involved in phosphorylation 
and isomerization of glucose, as well as the subunits of the pyruvate dehydrogenase 
complex. 
 
Pentose phosphate pathway 
 
The pentose phosphate pathway is shown in Figure 51. All enzymes which catalyze 
the reactions of this metabolic pathway were identified by the LC-MALDI approach. 
Fewer enzymes were identified by the 2D-PAGE approach and one enzyme, NCgl 
1536, was not identified by ESI. However it was found that the ESI approach reported 
one non-redundant peptide for this protein. Other representative pathways of amino 
acid biosynthesis in C. glutamicum, like lysine biosynthesis, and methionine 
biosynthesis are given in the Appendix X and XI. 
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Figure 50: Enzymes of C. glutamicum participating in the glycolysis and identified by the 
different approaches. 
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Figure 51: Biochemical reactions involved in the pentose phosphate pathway and enzymes 
that catalyze the reactions. 
 
5.2.4. Comparison of methods based on the codon adaptation 
index  
 
Protein expression levels have been shown to correlate well with codon adaptation 
index and mRNA expression for Mycobacterium smegmatis [102]. C. glutamicum is a 
family related organism and therefore a similar behaviour is expected. It was decided 
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to evaluate the three proteomic approaches employed on the proteome analysis of C. 
glutamicum according to protein expression levels predicted by CAI. For this purpose, 
the CAI values were computed for all proteins of C. glutamicum and for the proteins 
identified in each approach. Figure 52 shows the percentage of proteins identified by 
each analytical approach within different CAI intervals and referred to the total 
number of proteins in the considered interval. Considering that the CAI is an indicator 
of protein expression some conclusions can be drawn for the different sensitivities of 
the compared approaches.  
 
 
Figure 52: Sensitivity of the three approaches (2D-PAGE, 2D-RP-HPLC-ESI-IT, 2D-RP-
HPLC MALDI TOF/TOF) based on the CAI. The relative abundance of identified proteins 
within a CAI interval is plotted for each analytical method employed in the analysis of C. 
glutamicum proteome. Percentages are calculated with respect to all the predicted proteins of 
C. glutamicum grouped into CAI intervals. 
 
The most sensitive approach was the LC-MALDI TOF/TOF, followed by LC-ESI-IT 
and 2D-PAGE. In all the approaches protein identifications were in agreement with the 
protein expression levels indicate by the CAI. The MALDI-approach and ESI-
approach delivered comparable results for high expressed proteins with CAI-values 
between 0.6 - 0.9. The percentage of identified proteins was 75 and 90% for ESI and 
MALDI, respectively. The electrophoresis based approach yielded significantly less 
identified proteins for this CAI values. At lower expression levels, the MALDI-based 
approach showed significantly better results. For example, in the CAI range between 
0.2 - 0.3, MALDI yielded 30.2% (396 proteins) of the predicted proteins, but ESI only 
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3.9% (47 proteins). The lowest protein expression levels are indicated by CAI values 
between 0.1 and 0.2 and the MALDI approach yielded 107 proteins (19.3%) compared 
to 6 proteins (1.1%) by the ESI approach. No proteins having CAI below 0.3 were 
identified by the 2D-PAGE approach. Low abundant proteins with low CAI values are 
usually not identified by 2D-PAGE [96]. According to Figure 52 the limit of detection 
given by the CAI is situated in 0.3 for the 2D-PAGE and 0.2 for the ESI approach, 
whereas the MALDI approach was capable of identifying proteins of all CAI values. 
The data presented here show that the three approaches are biased towards detection of 
highly expressed proteins. However, the MALDI approach, which was the most 
sensitive method, permitted the identification of 19% of the lower abundant proteins. 
Furthermore, the low abundant proteins were identified from a complex mixture of 
peptides obtained by digestion of the cytosolic proteins of C. glutamicum. These 
results suggest that the LC-MALDI approach is able to expand the dynamic range of 
protein identification further than the other two methods employed for the proteome 
analysis of C. glutamicum.  
 
5.3. Comparison with results from literature 
 
5.3.1. Comparison with the MudPIT approach  
 
The highest number of identified proteins of C.glutamicum reported up to now in the 
literature was published by Fischer et. al. from a lysine producing strain [78]. Two 
optimized prefractionation protocols for extraction of membrane proteins were used 
for enrichment in membrane proteins. Both resulting samples were enzymatically 
digested by a trypsin/chymotrypsin mixture in an organic solvent. Subsequently, the 
peptides were separated using the multidimensional protein identification technology 
(MudPIT) [30, 31] coupled to a Finnigan LTQ ion trap mass spectrometer (Thermo 
Electron Cop., San Jose, CA) for detection. The combination of the results from both 
extraction protocols yielded the identification 326 integral membrane proteins and 
1181 soluble proteins of C.glutamicum. The comparison of the proteins identified by 
the 2D-RP-HPLC MALDI TOF/TOF platform used in this work with the proteins 
identified by Fischer et al. [78] is illustrated in Figure 53. The identified proteins 
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include single-peptide based identifications in both approaches. Because nine of the 
1181 soluble proteins identified by the MudPIT approach were not referred to a gene 
number, the comparison was carried out with the rest 1172 proteins. 
 
 
 
 
 
Figure 53: Overlapping degree of the identified proteins. A total of 1812 different proteins 
were identified by both proteomic platforms. 55% of them were common to both approaches.  
 
In total, 1644 proteins identified by the LC-MALDI approach were compared with 
1172 proteins identified by application of MudPIT technology. The total number of 
different proteins was 1812, which represents 60.5% proteome coverage of 
C.glutamicum. Although the extraction protocols employed in both studies were very 
different and focused on proteins with different properties, 55.4% of the proteins were 
common to both approaches. As expected, the approach employing an extraction 
protocol exclusive for cytosolic proteins identified more of these proteins: the LC-
MALDI yielded 3.8 times more soluble proteins. 
 
5.3.2. Comparison with a 2D-PAGE approach  
 
The investigation of the cytoplasmic proteins of C.glutamicum by 2D-PAGE carried 
out by Schaffer et. al. [74] reported the detection of 970 Coomassie stained protein 
spots. The amount of protein loaded in the gel was 300 µg and the pI range used in the 
first dimension was 4 - 6. The successful identification of 169 spots by PMF MALDI 
TOF MS yielded 152 different proteins, including 35 proteins of no known function. 
The proteins identified by this approach will be compared with the proteins identified 
in the present work by 2D-PAGE analysis and described in 4.4. Because the proteins 
identified by Schaffer and colleagues did not have a gene number code, both 
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approaches were compared based on the protein name and the results are shown in 
Table 9.  
 
Table 9: Cytosolic proteins of C.glutamicum identified by 2D-PAGE and MALDI MS by 
Schaffer et al. [74] (a) or in the present work (b) (see 4.4). 
 
Identified proteins Matched peptides (a) 
Matched 
peptides (b) 
Spot no. 
(Appendix I) 
Glycolisis    
Phosphoglycerate kinase 16 20 8 
Enolase 13 14 749 
Phosphofructokinase 5 19 781 
Triosephosphate isomerase 10 12 81 
Phosphoglycerate mutase 14 12 793 
Fructose-bisphosphate aldolase 12 x x 
Glyceraldehyde-3-phosphate 
dehydrogenase 10 15 768 &769 
Fructose-1,6-bisphosphatase x 12 745 
Pyruvate kinase x 16 724 
Pentose phosphate pathway    
Glucose-6-phosphate-dehydrogenase 6 7 120 
6-phospho-gluconolactonase x 9 121 
6-phosphogluconate dehydrogenase x 22 753 
Ribulose-5-phosphate isomerase 7 6 837 
Ribulose-5-phosphate-3-epimerase 3 5 816 
Transketolase 16 x x 
Transaldolase x 16 761 
TCA cycle    
Citrate syntase x 18 742 
Aconitase 11 33 50 
Isocitrate dehydrogenase 16 32 715 
Fumarase 19 25 735 
Malate quinone oxidoreductase 17 15 722 
 
Almost the same enzymes of the main metabolic pathways were identified by both 
approaches. The enzymes which were omitted in Table 9 were not identified by any of 
the methods. In 2D-PAGE approaches, protein detection is usually restricted to the 
abundant proteins of the sample [96]. 
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6. Summary and conclusions 
 
The common methods for the proteome analysis involve top-down and shotgun 
bottom-up approaches. In this work an alternative bottom-up approach based on 2D-
RP-HPLC and MALDI TOF/TOF has been established as a method for the proteome 
analysis and tested with C. glutamicum. Besides that, an improved procedure for 
extraction of the cytosolic proteome of C. glutamicum was developed. The extraction 
method supplies a high recovery of proteins without contaminants and permits direct 
analysis of the sample without additional pre-concentration treatment. 
The pH based 2D-RP-HPLC system represents some advantages over the classical 2D-
SCX-RP application for the separation of peptides from a digested proteome sample. 
The absence of salts in the first dimension facilitates sample concentration by simple 
evaporation of the acetonitrile. A high selectivity of peptides in the first dimension 
was observed due to a broader net charge spectrum. Furthermore the use of RP-HPLC 
in the first dimension provides a low carry-over effect, in contrast to SCX. A method 
for rapid screening of the fractions from the first dimension was developed based on 
MALDI TOF MS. This method permits selection of the peptide containing fractions 
for further analysis. 
The high-throughput LC-MALDI MS/MS technique based on an off-line coupling of 
liquid chromatography and mass spectrometry was compared with the common on-
line set-up LC-ESI MS/MS. The MALDI approach yielded higher proteome coverage 
than the ESI approach: 1644 proteins (1208 with more than one peptide) vs.745 (468). 
The number of proteins identified by MALDI represents more than twice the 
identification of the ESI approach but also the measurement time increased three times 
due to the off-line set-up of the LC-MALDI approach. With respect to the peptidome 
coverage, both methods shared 26% of all the identified peptides and a small 
complementarity was observed between the methods. The ESI approach yielded 5% 
unique peptides but the MALDI approach was capable of delivering 69% of unique 
peptides. Furthermore, the MALDI TOF/TOF mass spectrometry shows higher 
flexibility than other mass spectrometric approaches. Because the liquid 
chromatography is decoupled from the mass spectrometry, column flow rates can be 
varied and adjusted with the matrix flow rate for optimal spot composition. Besides 
that, the spotting frequency can be adapted to the sample complexity. MALDI 
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tolerates better the presence of salts and contaminants than ESI and is more compatible 
with the presence of ion-pairing reagents like TFA, which do not compromise the 
ionization process [110]. 
The novel 2D-RP-HPLC MALDI TOF/TOF approach was compared with a classical 
approach for separation of proteins: 2D-PAGE followed by in-gel digest analysis by 
MALDI TOF/TOF. The 2D-PAGE approach is not the most appropriate for a whole 
proteome study of C. glutamicum because it fails to detect low abundant proteins and 
it can not compete with the high number of identifications delivered by the LC-MS 
approaches. However, 2D-PAGE is a suitable choice when the object of the study 
involves visualization of expression changes in enzymes which show moderate to 
highly concentration and are consequently easily stained and detected [111, 112]. 
Although the bottom-up approach delivered a higher number of identified proteins a 
complementary peptide identification of both approaches was observed. Thus, the 
protein coverage of some of the identified proteins could be increased by the use of 
both methods. 
The three approaches, MALDI-based, ESI-based and 2D-PAGE-based, were also 
compared at the protein level. Glycolysis, TCA cycle and pentose phosphate pathways 
were analyzed in detail. The three approaches were able to identify many of the 
enzymes participating in the main metabolic pathways, the MALDI-based approach 
was however superior for protein identification. Also the MALDI based approach 
showed the highest sensitivity and highest dynamic range based on the comparison of 
the identified proteins according to their CAI. The results of the proteome analysis by 
2D-RP-HPLC MALDI TOF/TOF were compared with results of the literature like the 
MudPIT approach. In conclusion, we believe the approach proposed here is a robust 
method for the proteome analysis as demonstrated for the bacterium C. glutamicum.  
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7. Outlook 
 
A total of 1208 proteins were identified by more than one peptide by the application of 
2D-RP-HPLC MALDI TOF/TOF to the cytosolic proteome of C. glutamicum but, the 
analysis time necessary was 375 hours. Although this argument can be considered a 
drawback of the method, there are a number of improvements which could shorten the 
analysis time. With the aid of the fast screening method employing MALDI TOF mass 
spectrometry it is possible to determine the low peptide content fractions and pool 
them together thus reducing the total number of fractions to analyze. As an example, 
pooling the first and last five fractions would save up to 30 LC-MALDI runs thus 
reducing the analysis time by 90 hours. Also the use of an exclusion list across 
different runs can improve the measurements [97] because peptides showing intensive 
signals tend to be analyzed repetitively in different runs. In addition the chance of 
identifying low abundant peptides would be enhanced. The overall orthogonality can 
be improved by modifying the gradient of the second dimension for the latest fractions 
which contain the more hydrophobic peptides. The relative tolerance of the MALDI 
MS to the presence of surfactants and phosphate additives permits the application of 
alternative chromatography strategies not considered for the on-line LC-ESI-MS/MS. 
Alternatively, the use of ionic liquid matrices for proteome analysis can be considered 
[113]. 
Assuming that some proteins are not expressed under the cultivation conditions 
employed, we believe that the total number of identified proteins can be expanded 
using alternative cultivation conditions. Furthermore, the use of specific extraction 
protocols for enrichment of membrane proteins and cell wall associated proteins [77] 
could certainly increase the number of identifications of these proteins. Also other 
approaches like MudPIT could deliver more complementary results. 
The data generated about C. glutamicum in this study can be used as reference 
platform for other proteome studies on mutant strains or modified culture conditions 
for C. glutamicum. Furthermore, the proposed method is fully compatible with 
quantification strategies like iTRAQ [114] or metabolic labeling [115] for comparative 
proteomics. 
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8. List of abbreviations, acronyms and symbols 
 
 
µA   microampere 
µL   microliter 
2D   two dimensional 
ACN  acetonitrile 
CAI   codon adaption index 
CHCA  α cyano-4-hydroxicinnamic acid 
CID   collision induced dissociation 
Da   Dalton 
DTT   dithiotreitol  
ESI   electrospray ionization  
FPR   false positive rate 
GRAS  generally regarded as safe 
HFBA  heptafluorobutyric acid 
HPLC  high performance liquid chromatography 
i.d.   internal diameter 
IEF   isoelectric focusing 
IP   ion pair 
iTRAQ  isobaric tag for relative and absolute quantification 
L   liter 
LC   liquid chromatography 
M   molar 
MALDI  matrix assisted laser desorption ionization 
Mbp   megabase pair 
MD   multidimensional 
mg   milligram 
min   minute 
mL   milliliter 
MS   mass spectrometry 
MS/MS  tandem mass spectrometry 
MudPIT  multidimensional protein identification technology 
MW   molecular weight 
m/z   mass to charge ratio 
OD   otical density 
ORF   open reading frame 
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PAGE  polyacrylamide gel electrophoresis 
pI   isoelectric point 
PMF  peptide mass fingerprint 
PS-DVB  polystyrene divinylbenzene 
RPC   reversed phase chromatography 
SCX   strong cation exchange chromatography 
SDS   sodium dodecyl sulfate 
TBS   tris buffered saline 
TEMED  tetramethylethylenediamine 
TFA   trifluoracetic acid 
TMH  trans-membrane helix 
TOF   time of flight 
UV   ultraviolet 
V   volts 
v/v   volume/volume 
w/v   weight/volume 
WCW  wet cell weight 
ZIC-HILIC  zwitterionic  hydrophilic interaction liquid chromatography 
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Appendix I 
 
Analysis of C. glutamicum cytosolic proteins by 2D-PAGE. About 200 µg of cytosolic 
proteins were loaded on a strip for separation between pH 4 and 7. Staining was carried 
out by incubation of the gel in a colloidal Coomassie Blue solution. The excised gel 
plugs which were successfully identified by MALDI TOF/TOF MS are indicated by an 
arrow and labelled with a number. Spot numbers and the corresponding identified 
proteins are listed in table 1. 
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Table 1. List of proteins identified by 2D-PAGE separation followed by MALDI 
TOF/TOF analysis. Left column shows the number of the spot visualised in the gel. 
 
 
Spot Nr. Protein NCgl no. 
1  ribosomal protein L7/L12   NCgl0469 
2  FHA-domain-containing protein   NCgl1385 
5  peptidyl-prolyl cis-trans isomerase (rotamase) [5.2.1.8]   NCgl0033 
7  ketol-acid reductoisomerase [1.1.1.86]   NCgl1224 
8  DNA-directed RNA polymerase alpha subunit/40 kD subunit [2.7.7.6]   NCgl0540 
8  3-phosphoglycerate kinase [2.7.2.3]   NCgl1525 
10  ribosomal protein L10   NCgl0468 
11  superoxide dismutase [1.15.1.1]   NCgl2826 
12 translation elongation factor Ts NCgl1949 
13 fructose-bisphosphate aldolase [4.1.2.13] NCgl2673 
14  acetyl-CoA hydrolase [2.8.3.-]   NCgl2480 
16  elongation factor Tu   NCgl0480 
18  70 kDa heat shock chaperonin protein   NCgl2702 
50  aconitase A [4.2.1.3]   NCgl1482 
53  glutamyl- and glutaminyl-tRNA synthetases [6.1.1.17]   NCgl1244 
54  phosphoserine aminotransferase [2.6.1.52]   NCgl0794 
60  co-chaperonin GroES   NCgl0572 
61  nucleoside diphosphate kinase [2.7.4.6]   NCgl2287 
64  inorganic pyrophosphatase [3.6.1.1]   NCgl2607 
70 FGAM synthase,glutamine amidotransferase domain [6.3.5.3] NCgl2500 
71  nitroreductase [1.6.99.3]   NCgl0328 
73  ribosomal protein L5   NCgl0501 
74  ribosomal protein L1   NCgl0460 
77  hydroxymethylpyrimidine/phosphomethylpyrimidine kinase   NCgl2973 
78  L-2.3-butanediol dehydrogenase   NCgl2582 
81  triosephosphate isomerase [5.3.1.1]   NCgl1524 
82  ABC-type transporter, ATPase component   NCgl1501 
85  sulfate adenylyltransferase subunit 2   NCgl2716 
86  homoserine kinase [2.7.1.39]   NCgl1137 
90  two-component system, response regulator   NCgl2518 
91  thioredoxin reductase [1.6.4.5]   NCgl2984 
92  phosphoribosylaminoimidazolesuccinocarboxamide (SAICAR) synthase [6.3.2.6]   NCgl2508 
92  phosphoribosylaminoimidazolesuccinocarboxamide   NCgl2508 
93  ABC-type transporter, periplasmic component   NCgl0610 
95  3-isopropylmalate dehydratase large subunit [4.2.1.33]   NCgl1262 
95  3-isopropylmalate dehydratase large subunit [4.2.1.33]   NCgl1262 
96  fumarase [4.2.1.2]   NCgl0967 
97  seryl-tRNA synthetase [6.1.1.11]   NCgl2793 
100  phosphoglycerate dehydrogenase [1.1.1.95]   NCgl1235 
101  cell division GTPase   NCgl2075 
102  phosphoenolpyruvate-protein kinase [2.7.3.9]   NCgl1858 
103  isopropylmalate/homocitrate/citramalate synthase  [4.1.3.12]   NCgl0245 
104  methionine synthase II [2.1.1.14]   NCgl1094 
105  ABC-type transporter, periplasmic component   NCgl1915 
106  putative inosine-5-monophosphate dehydrogenase   NCgl0579 
112  phosphomannomutase   NCgl0558 
115  exopolyphosphatase [3.6.1.11]   NCgl0938 
117  NAD synthase [6.3.5.1]   NCgl2446 
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120  hypotheical protein   NCgl1515 
121  6-phosphogluconolactonase [3.1.1.31]   NCgl1516 
124  shikimate 5-dehydrogenase [1.1.1.25]   NCgl1087 
128  uridylate kinase [2.7.4.-]   NCgl1948 
273  putative ferredoxin/ferredoxin-NADP reductase [1.18.1.2]   NCgl2719 
273  putative ferredoxin/ferredoxin-NADP reductase [1.18.1.2]   NCgl2658 
300  ribosomal protein S6   NCgl2881 
306  homoserine dehydrogenase [1.1.1.3]   NCgl1136 
374  S-adenosylmethionine synthetase [2.5.1.6]   NCgl1541 
423  O-acetylhomoserine sulfhydrylase [4.2.99.10]   NCgl0625 
528  cysteine synthase [4.2.99.8]   NCgl2473 
575  electron transfer flavoprotein alpha-subunit   NCgl1183 
700  fatty-acid synthase [2.3.1.85]   NCgl0802 
703  phenylalanyl-tRNA synthetase beta subunit [6.1.1.20]   NCgl1336 
704  pullulanase   NCgl2026 
705  pyruvate carboxylase [6.4.1.1]   NCgl0659 
707  predicted membrane GTPase involved in stress   NCgl1053 
708  detergent sensitivity rescuer dtsR2   NCgl0677 
709  acyl-CoA carboxylase [6.3.4.14]   NCgl0670 
710  catalase [1.11.1.6]   NCgl0251 
711  phosphoribosylformylglycinamidine (FGAM) synthase,synthetase domain [6.3.5.3]   NCgl2499 
712  protease II   NCgl2507 
714  FKBP-type peptidyl-prolyl cis-trans isomerase   NCgl2329 
715  monomeric isocitrate dehydrogenase (NADP+)   NCgl0634 
716  elongation factor G   NCgl0478 
717  elongation factor G   NCgl0478 
721  phosphoribosylaminoimidazolecarboxamide   NCgl0827 
722  predicted dehydrogenase [1.1.99.16]   NCgl1926 
723  adenylosuccinate synthase [6.3.4.4]   NCgl2669 
724  pyruvate kinase [2.7.1.40]   NCgl2008 
728  Asp-tRNAAsn/Glu-tRNAGln amidotransferase B subunit   NCgl1211 
729  chaperonin GroEL   NCgl2621 
730  F0F1-type ATP synthase beta subunit [3.6.1.34]   NCgl1165 
731  F0F1-type ATP synthase alpha subunit [3.6.1.34]   NCgl1163 
732  chaperonin GroEL   NCgl0573 
735  fumarase [4.2.1.2]   NCgl0967 
737  FAD/FMN-containing dehydrogenase   NCgl0187 
738  glutamate dehydrogenase/leucine dehydrogenase   NCgl1999 
738  putative Asp-tRNAAsn/Glu-tRNAGln amidotransferaseA subunit [6.3.5.-]   NCgl1199 
739  glycine hydroxymethyltransferase [2.1.2.1]   NCgl0954 
740  histidyl-tRNA synthetase [6.1.1.21]   NCgl1585 
740  adenylosuccinate lyase [4.3.2.2]   NCgl2509 
741  D-2-hydroxyisocaproate dehydrogenase   NCgl2528 
742  citrate synthase [4.1.3.7]   NCgl0795 
743  predicted iron-regulated ABC-type transporter SufB   NCgl1502 
744  UDP-N-acetylglucosamine enolpyruvyl transferase [2.5.1.7]   NCgl0345 
745  putative fructose-1,6-bisphosphatase/sedoheptulose1,7-bisphosphatase   NCgl0976 
746  predicted iron-regulated ABC-type transporter SufB   NCgl1502 
748 mix  cell division initiation protein   NCgl2070 
748 mix  phosphotransacetylase [2.3.1.8]   NCgl2657 
749  enolase [4.2.1.11]   NCgl0935 
750  aspartokinase [2.7.2.4]   NCgl0247 
751  phosphomannomutase [5.4.2.8]   NCgl0714 
753  6-phosphogluconate dehydrogenase, family 1 [1.1.1.44]   NCgl1396 
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754  gamma-glutamyl phosphate reductase [1.2.1.41]   NCgl2272 
756  diaminopimelate decarboxylase [4.1.1.20]   NCgl1133 
757  Xaa-Pro aminopeptidase [3.4.13.9]   NCgl1430 
758  predicted GTPase   NCgl0988 
759  phosphoserine phosphatase [3.1.3.3]   NCgl2436 
759  elongation factor Tu   NCgl0480 
760  D-alanine-D-alanine ligase [6.3.2.4]   NCgl1267 
761  transaldolase [2.2.1.2]   NCgl1513 
763  predicted sugar phosphatase of the HAD superfamily   NCgl1355 
764  archaeal fructose-1,6-bisphosphatase   NCgl0765 
53  myo-inositol-1-phosphate synthase   NCgl2894 
768 & 
769 
 glyceraldehyde-3-phosphate dehydrogenase [1.2.1.12]   NCgl1526 
772  phosphoribosylaminoimidazol (AIR) synthetase [6.3.3.1]   NCgl2494 
773  PLP-dependent aminotransferase [2.6.1.-]   NCgl2227 
774  class III Zn-dependent alcohol dehydrogenase [1.2.1.-]   NCgl0313 
775  phenylalanyl-tRNA synthetase alpha subunit [6.1.1.20]   NCgl1335 
776  Zn-dependent alcohol dehydrogenase [1.1.1.1]   NCgl2709 
777  carbamoylphosphate synthase small subunit [6.3.5.5]   NCgl1548 
778  cystathionine gamma-synthase [4.2.99.9]   NCgl2360 
781  6-phosphofructokinase [2.7.1.11]   NCgl1202 
782  putative Zn-NADPH:quinone dehydrogenase [1.1.1.1]   NCgl2449 
783  hypothetical protein   NCgl1996 
786  thiosulfate sulfurtransferase [2.8.1.1]   NCgl0671 
788  histidinol-phosphate aminotransferase/tyrosine aminotransferase [2.6.1.9]   NCgl2020 
789  dihydrodipicolinate reductase [1.3.1.26]   NCgl1898 
790  2-keto-4-pentenoate hydratase/2-oxohepta-3-ene-1,7-dioic acid hydratase [5.3.3.-]   NCgl1241 
791  predicted oxidoreductase [1.1.1.91]   NCgl0099 
792  Zn-dependent hydrolase   NCgl0285 
793  phosphoglycerate mutase 1 [5.4.2.1]   NCgl0390 
795  pyridoxine biosynthesis enzyme   NCgl0754 
797  L-lactate dehydrogenase [1.1.1.27]   NCgl2810 
799 mix  UDP-glucose 4-epimerase [5.1.3.2]   NCgl1846 
799 mix  acetylglutamate semialdehyde dehydrogenase [1.2.1.38]   NCgl1340 
800  5,10-methylene-tetrahydrofolate dehydrogenase [1.5.1.5]   NCgl0620 
801  phage shock protein A (IM30)   NCgl1886 
802 mix  nucleoside-diphosphate-sugar epimerase   NCgl0317 
802 mix  ATP phosphoribosyltransferase [2.4.2.17]   NCgl1447 
803  trehalose-6-phosphatase [3.1.3.12]   NCgl2537 
804  2-hydroxyhepta-2,4-diene-1,7-dioatesomerase   NCgl2919 
805  oligoribonuclease (3->5 exoribonuclease) [3.1.-.-]   NCgl2386 
807  hypothetical protein   NCgl2339 
808  hypothetical protein   NCgl2246 
811  predicted hydrolase of the HAD superfamily   NCgl2530 
813  transcriptional regulator [2.7.1.63]   NCgl1835 
814  uracil phosphoribosyltransferase [2.4.2.9]   NCgl0654 
815   ProFAR isomerase   NCgl2015 
816  pentose-5-phosphate-3-epimerase [5.1.3.1]   NCgl1536 
817  Mn-dependent transcriptional regulator   NCgl1845 
818  ATP-dependent Clp protease proteolytic subunit 2 [3.4.21.92]   NCgl2327 
819  transcriptional regulator   NCgl2571 
821  peroxiredoxin [1.11.1.-]   NCgl1041 
822  predicted acyltransferase   NCgl2659 
823  hypothetical protein   NCgl1123 
824  adenylate kinase [2.7.4.3]   NCgl0533 
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825  predicted thioesterase   NCgl2365 
826  ATP-dependent Clp protease proteolytic subunit 1 [3.4.21.92]   NCgl2328 
827  3-isopropylmalate dehydratase small subunit [4.2.1.33]   NCgl1263 
828  ribosome recycling factor   NCgl1947 
830  universal stress protein UspA   NCgl1316 
831  hypothetical protein   NCgl0385 
832  hypothetical protein   NCgl1676 
834  phosphoribosylformylglycinamidine (FGAM) synthase,PurS component   NCgl2501 
835  thioredoxin     NCgl2985 
836  transcriptional regulator   NCgl2886 
837  ribose 5-phosphate isomerase RpiB [5.3.1.26]   NCgl2337 
838  ribosomal protein S6   NCgl2881 
840  thiamine pyrophosphate-requiring enzyme [4.1.3.18]   NCgl1222 
850  Zn-dependent oligopeptidase [3.4.15.5]   NCgl2219 
915  4-alpha-glucanotransferase [2.4.1.25]   NCgl2217 
916  putative acyl-CoA synthetase   NCgl2774 
928  ferritin-like protein   NCgl2439 
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Appendix II 
 
Table 2. List of proteins identified by LC-MALDI TOF/TOF mass spectrometry and 
database search, after separation by two-dimensional reversed phase chromatography at 
high and low pH. Accesion numbers were obtained from the Comprehensive Microbial 
Resources, Institute for Genomic Research (www.tigr.org). Matched peptides include 
redundant hits. 
 
No. Accesión number 
Matched 
peptides 
Seq. 
Cov. 
(%) 
        Protein description 
1 NCgl0001 11 21.9 ATPase involved in DNA replication initiation 
2 NCgl0002 32 50.5 DNA polymerase III beta subunit [2.7.7.7] 
3 NCgl0005 36 37.7 DNA gyrase (topoisomerase II) B subunit [5.99.1.3] 
4 NCgl0006 1 3.7 predicted hydrolase or acyltransferase 
5 NCgl0008 5 10.2 hypothetical protein 
6 NCgl0012 48 30.8 DNA gyrase (topoisomerase II) A subunit [5.99.1.3] 
7 NCgl0014 2 2.9 uncharacterized membrane protein 
8 NCgl0024 3 3.6 predicted transcriptional regulator [3.6.1.-] 
9 NCgl0029 2 11 ABC-type transporter: periplasmic component 
10 NCgl0030 1 3.2 ABC-type transporter: permease component 
11 NCgl0031 5 14.6 ABC-type transporter: ATPase component 
12 NCgl0032 20 19.3 hypothetical protein 
13 NCgl0033 33 64.2 peptidyl-prolyl cis-trans isomerase (rotamase) [5.2.1.8] 
14 NCgl0040 7 12.1 serine/threonine protein kinase [2.7.1.-] 
15 NCgl0042 4 6.5 cell division protein FtsI 
16 NCgl0044 1 2.7 protein serine/threonine phosphatase [3.1.3.16] 
17 NCgl0045 4 20.1 FHA-domain-containing protein 
18 NCgl0046 4 11.8 hypothetical FHA-domain-containing protein 
19 NCgl0049 12 17.1 NAD-dependent aldehyde dehydrogenase [1.2.1.16] 
20 NCgl0055 1 12.9 hypothetical protein 
21 NCgl0056 1 4.2 hypothetical protein 
22 NCgl0058 1 3.8 hypothetical membrane protein 
23 NCgl0060 1 3.8 Mg2+ and Co2+ transporter protein 
24 NCgl0061 2 6.7 4-oxalocrotonate tautomerase-like protein 
25 NCgl0064 1 3.1 ATPase related to phosphate starvation-inducible protein PhoH 
26 NCgl0069 3 17.1 phosphoglycerate dehydrogenase or related dehydrogenase 
27 NCgl0070 6 30.8 hypothetical protein 
28 NCgl0077 7 17.2 hypothetical protein 
29 NCgl0081 1 5.1 hypothetical protein 
30 NCgl0083 3 9 urea amidohydrolase (urease) gamma subunit [3.5.1.5] 
31 NCgl0084 3 19.1 urea amidohydrolase (urease) beta subunit [3.5.1.5] 
32 NCgl0085 9 7.5 urea amidohydrolase (urease) alpha subunit [3.5.1.5] 
33 NCgl0086 6 24.8 urease accessory protein UreE [3.5.1.5] 
34 NCgl0092 13 13.1 hypothetical protein 
35 NCgl0093 6 13 molecular chaperone: HSP90 family 
36 NCgl0094 11 22 nucleoside phosphorylase [3.2.2.4] 
37 NCgl0098 21 14.3 proline dehydrogenase [1.5.1.12] 
38 NCgl0099 9 14 predicted oxidoreductase [1.1.1.91] 
39 NCgl0101 13 19 metal-dependent enzyme 
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40 NCgl0104 4 8 acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II 
41 NCgl0105 7 28.1 deoR family transcriptional regulator of sugar metabolism 
42 NCgl0106 4 16.9 lactoylglutathione lyase or related lyase 
43 NCgl0110 4 16 deoR family transcriptional regulator of sugar metabolism 
44 NCgl0111 1 3.5 sugar (pentulose and hexulose) kinase [2.7.1.17] 
45 NCgl0112 9 19.4 panthothenate synthetase [6.3.2.1] 
46 NCgl0113 6 18.6 hydroxymethyltransferase [2.1.2.11] 
47 NCgl0118 10 29.4 predicted hydrolase of the HAD superfamily 
48 NCgl0119 4 32.8 carbonic anhydrase/acetyltransferase [4.2.1.1] 
49 NCgl0120 13 22.7 transcriptional regulator 
50 NCgl0124 9 20.9 hypothetical membrane protein 
51 NCgl0127 2 3.2 hypothetical membrane protein 
52 NCgl0128 7 11.8 ankyrin repeat protein 
53 NCgl0133 1 15.4 aspartate 1-decarboxylase [4.1.1.11] 
54 NCgl0134 39 34.2 hypothetical protein 
55 NCgl0144 1 14.4 hypothetical protein 
56 NCgl0145 8 18.3 lactoylglutathione lyase-like protein 
57 NCgl0147 1 3.4 hypothetical protein 
58 NCgl0148 2 2.6 hypothetical protein 
59 NCgl0151 30 29.1 predicted metalloendopeptidase 
60 NCgl0154 5 20.6 transcriptional regulator 
61 NCgl0155 5 24.2 sugar kinases: ribokinase family [2.7.1.4] 
62 NCgl0156 4 10.3 hypothetical protein 
63 NCgl0157 10 17.1 NAD-dependent aldehyde dehydrogenase [1.2.1.27] 
64 NCgl0158 11 29.4 hypothetical protein 
65 NCgl0159 6 4.1 thiamine pyrophosphate-requiring enzyme 
66 NCgl0160 17 34.6 hypothetical protein 
67 NCgl0162 4 21.7 sugar phosphate isomerase/epimerase 
68 NCgl0163 1 3.3 permease of the major facilitator superfamily 
69 NCgl0164 2 6.2 predicted dehydrogenase 
70 NCgl0168 4 14.4 predicted dehydrogenase 
71 NCgl0169 4 10.1 sugar phosphate isomerase/epimerase 
72 NCgl0171 8 65.7 cold shock protein 
73 NCgl0179 2 5.2 transposase 
74 NCgl0180 13 39.3 PAS/PAC domain containing protein [2.7.3.-] 
75 NCgl0181 6 4 glutamine 2-oxoglutarate aminotransferase large subunit [1.4.1.13] 
76 NCgl0183 11 18.8 hypothetical protein 
77 NCgl0184 5 5.1 putative arabinosyl transferase 
78 NCgl0185 1 2.2 hypothetical membrane protein 
79 NCgl0186 10 26.9 putative dehydrogenase 
80 NCgl0187 26 50.4 FAD/FMN-containing dehydrogenase 
81 NCgl0188 3 42.7 hypothetical protein 
82 NCgl0189 1 13.5 hypothetical membrane protein 
83 NCgl0190 4 16.6 hypothetical protein 
84 NCgl0191 2 8.4 hypothetical protein 
85 NCgl0194 4 19.4 hypothetical protein 
86 NCgl0195 4 12.9 predicted glycosyltransferases 
87 NCgl0196 2 14.1 hypothetical protein 
88 NCgl0199 11 23.4 selenocysteine lyase 
89 NCgl0200 3 11.3 NADPH:quinone reductase or related Zn-dependent oxidoreductases 
90 NCgl0205 1 6.2 dinucleotide-utilizing enzyme 
91 NCgl0206 1 9.9 molybdopterin converting factor: large subunit 
92 NCgl0207 1 6.5 molybdopterin biosynthesis enzyme 
93 NCgl0209 3 15.5 molybdopterin biosynthesis enzyme 
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94 NCgl0211 5 16 ABC-type transporter: periplasmic component 
95 NCgl0212 1 11.8 hypothetical protein 
96 NCgl0213 5 6.9 ABC-type transporter: ATPase component 
97 NCgl0215 16 33.4 histidinol-phosphate aminotransferase/tyrosine aminotransferase [2.6.1.9] 
98 NCgl0216 1 3.6 hypothetical protein 
99 NCgl0221 2 4.6 Mg/Co/Ni transporter MgtE 
100 NCgl0223 10 20.9 prephenate dehydrogenase 
101 NCgl0224 1 7.9 hypothetical protein 
102 NCgl0226 7 28.4 hypothetical protein 
103 NCgl0229 7 19.9 queuine/archaeosine tRNA-ribosyltransferase [2.4.2.29] 
104 NCgl0232 1 1.9 ABC-type multidrug/protein/lipid transport system: ATPase component 
105 NCgl0233 2 4.8 glutamyl-/ glutaminyl-tRNA synthetase [6.1.1.17] 
106 NCgl0234 2 5.2 hypothetical dioxygenase protein 
107 NCgl0235 1 2.4 putative transposase 
108 NCgl0236 1 7.9 hypothetical protein 
109 NCgl0237 55 41.1 aspartate transaminase [2.6.1.1] 
110 NCgl0238 3 15.8 hypothetical protein 
111 NCgl0239 15 14.2 DNA polymerase III: gamma/tau subunits 
112 NCgl0240 12 30.1 hypothetical protein 
113 NCgl0241 5 24.3 recombinational DNA repair protein RecR 
114 NCgl0242 6 22.8 predicted glutamine amidotransferase 
115 NCgl0243 16 19.6 UDP-N-acetylmuramyl tripeptide synthase 
116 NCgl0244 1 5.3 DNA polymerase III epsilon subunit 
117 NCgl0245 366 63 isopropylmalate/homocitrate/citramalate synthase [4.1.3.12] 
118 NCgl0247 24 27.8 aspartokinase [2.7.2.4] 
119 NCgl0248 27 48.8 aspartate-semialdehyde dehydrogenase [1.2.1.11] 
120 NCgl0249 1 3.1 hypothetical membrane protein 
121 NCgl0251 61 52.9 catalase [1.11.1.6] 
122 NCgl0253 2 6.5 transcriptional regulator 
123 NCgl0259 2 10.1 protein-tyrosine-phosphatase 
124 NCgl0262 1 12.6 hypothetical membrane protein 
125 NCgl0272 6 17.5 predicted phosphohydrolase [3.1.-.-] 
126 NCgl0273 4 16.6 hypothetical protein 
127 NCgl0274 4 8.8 membrane carboxypeptidase 
128 NCgl0276 4 25.9 hypothetical protein 
129 NCgl0277 4 21.6 putative translation initiation inhibitor 
130 NCgl0280 2 6.4 ranscriptional regulator 
131 NCgl0281 1 7.1 dehydrogenase [1.1.1.100] 
132 NCgl0284 1 5.1 predicted acyl dehydratase 
133 NCgl0285 10 28.1 Zn-dependent hydrolase 
134 NCgl0286 35 64.8 cAMP-binding domain containing protein 
135 NCgl0290 2 10.5 NTP pyrophosphohydrolase 
136 NCgl0292 2 8.5 predicted hydrolase or acyltransferase [3.3.2.3] 
137 NCgl0293 3 15.3 hypothetical membrane protein 
138 NCgl0296 1 4.7 hypothetical membrane protein 
139 NCgl0297 1 5.6 predicted ATPase involved in pili and flagella biosynthesis 
140 NCgl0303 7 65.7 cold shock protein 
141 NCgl0304 48 25.8 topoisomerase IA [5.99.1.2] 
142 NCgl0305 2 5.1 hypothetical protein 
143 NCgl0307 2 4.5 ATPase involved in DNA replication [2.7.7.7] 
144 NCgl0309 2 8.6 putative adenylate kinase 
145 NCgl0313 21 41.8 class III Zn-dependent alcohol dehydrogenase [1.2.1.-] 
146 NCgl0314 3 25.6 Zn-dependent hydrolase or glyoxylase 
147 NCgl0315 3 5.4 dehydrogenase [1.1.1.100] 
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148 NCgl0317 21 45.7 nucleoside-diphosphate-sugar epimerase 
149 NCgl0319 4 16.1 glycosyltransferase involved in cell wall biogenesis 
150 NCgl0321 2 7.5 predicted glycosyltransferase 
151 NCgl0324 13 31.7 Zn-dependent alcohol dehydrogenase [1.1.1.2] 
152 NCgl0325 1 5.6 dTDP-glucose pyrophosphorylase [2.7.7.24] 
153 NCgl0326 11 13.7 dTDP-4-dehydrorhamnose 3:5-epimerase or related enzyme 
154 NCgl0327 22 40.7 dTDP-D-glucose 4:6-dehydratase [4.2.1.46] 
155 NCgl0328 13 38.9 nitroreductase [1.6.99.3] 
156 NCgl0329 3 10.5 periplasmic component of ABC-type Fe3+-siderophore transport system 
157 NCgl0332 11 16.3 aminopeptidase N 
158 NCgl0333 17 17.4 serine protease [3.4.21.26] 
159 NCgl0336 6 14 hypothetical esterase 
160 NCgl0337 10 15.5 putative ATPase involved in chromosome partitioning 
161 NCgl0338 10 39.3 protein-tyrosine-phosphatase [3.1.3.48] 
162 NCgl0339 1 3.6 hypothetical protein 
163 NCgl0340 7 14.8 predicted nucleoside-diphosphate sugar epimerase 
164 NCgl0341 29 39 predicted pyridoxal phosphate-dependent enzyme 
165 NCgl0342 3 8.3 sugar transferase involved in lipopolysaccharide synthesis 
166 NCgl0343 5 6.1 predicted glycosyltransferase 
167 NCgl0344 2 3.8 O-antigen and teichoic acid membrane export protein 
168 NCgl0345 31 40 UDP-N-acetylglucosamine enolpyruvyl transferase [2.5.1.7] 
169 NCgl0346 6 11 UDP-N-acetylmuramate dehydrogenase [1.1.1.158] 
170 NCgl0347 13 24.9 cell wall biogenesis glycosyltransferase 
171 NCgl0350 1 4.2 predicted acyltransferase 
172 NCgl0351 22 37 predicted UDP-glucose 6-dehydrogenase [1.1.1.22] 
173 NCgl0353 16 23.7 cell wall biogenesis glycosyltransferase 
174 NCgl0354 9 27.4 acetyltransferase 
175 NCgl0355 105 53.9 dihydrolipoamide dehydrogenase/glutathione oxidoreductase-like protein [1.8.1
176 NCgl0356 11 24.3 UDP-glucose pyrophosphorylase [2.7.7.9] 
177 NCgl0357 7 25.8 hypothetical protein 
178 NCgl0358 22 39.2 predicted transcriptional regulator 
179 NCgl0360 20 27 succinate dehydrogenase/fumarate reductase: flavoprotein subunit [1.3.99.1] 
180 NCgl0361 10 14.1 succinate dehydrogenase/fumarate reductase Fe-S protein 
181 NCgl0364 8 16 hypothetical protein 
182 NCgl0365 1 2.6 uncharacterized membrane protein 
183 NCgl0366 6 35 hypothetical protein 
184 NCgl0368 1 8.9 transcriptional regulator 
185 NCgl0371 24 49.3 formyltetrahydrofolate hydrolase [3.5.1.10] 
186 NCgl0372 7 23.2 deoxyribose-phosphate aldolase [4.1.2.4] 
187 NCgl0374 4 31 hypothetical protein 
188 NCgl0375 4 2.3 cation transport ATPase [3.6.1.-] 
189 NCgl0385 3 10.8 hypothetical protein 
190 NCgl0386 5 10.3 UDP-N-acetylmuramate dehydrogenase [1.1.1.158] 
191 NCgl0387 3 13.2 hypothetical protein 
192 NCgl0388 27 26.6 acyl-CoA synthetase [6.2.1.3] 
193 NCgl0389 7 14.4 predicted glycosyltransferase 
194 NCgl0390 41 44.8 phosphoglycerate mutase 1 [5.4.2.1] 
195 NCgl0392 8 36.2 two-component system: response regulators 
196 NCgl0396 17 37.4 exopolyphosphatase 
197 NCgl0398 7 14.3 pyrroline-5-carboxylate reductase [1.5.1.2] 
198 NCgl0399 2 39.7 hypothetical protein 
199 NCgl0400 3 4.5 phosphoserine phosphatase [3.1.3.3] 
200 NCgl0402 4 8.6 glutamyl-tRNA reductase [1.2.1.-] 
201 NCgl0403 9 12.9 porphobilinogen deaminase [4.3.1.8] 
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202 NCgl0406 1 3.2 permease of the major facilitator superfamily 
203 NCgl0407 6 6.3 sugar phosphate isomerase/epimerase [4.2.1.-] 
204 NCgl0413 2 4.2 ABC-type transporter periplasmic component 
205 NCgl0414 8 10.5 uroporphyrinogen-III synthase/methylase [2.1.1.107] 
206 NCgl0415 2 9.2 hypothetical protein 
207 NCgl0416 14 38.1 delta-aminolevulinic acid dehydratase-like protein [4.2.1.24] 
208 NCgl0420 16 18.2 uroporphyrinogen-III decarboxylase [4.1.1.37] 
209 NCgl0421 8 13.2 protoporphyrinogen oxidase [1.3.3.4] 
210 NCgl0422 11 22.4 glutamate-1-semialdehyde aminotransferase [5.4.3.8] 
211 NCgl0423 3 16.3 phosphoglycerate mutase/fructose-2:6-bisphosphatase [5.4.2.1] 
212 NCgl0428 3 6 hypothetical protein 
213 NCgl0431 6 42 hypothetical protein 
214 NCgl0433 1 3.7 1:4-dihydroxy-2-naphthoate octaprenyltransferase [2.5.1.-] 
215 NCgl0434 3 2.8 hypothetical protein 
216 NCgl0439 4 8.2 transcriptional regulator 
217 NCgl0440 2 18.1 hypothetical protein 
218 NCgl0443 1 8.7 hypothetical protein 
219 NCgl0445 1 2 phosphate/sulphate permease 
220 NCgl0446 8 15.7 dihydroxynaphthoic acid synthase [4.1.3.36] 
221 NCgl0448 4 12.8 peptidase E 
222 NCgl0449 8 16.6 O-succinylbenzoate synthase or related enzyme 
223 NCgl0450 6 9 2-succinyl-6-hydroxy-2: 4-cyclohexadiene-1-carboxylate synthase [4.1.1.71] 
224 NCgl0452 1 3.4 predicted group 1 glycosyltransferase 
225 NCgl0454 6 22.2 methylase [2.1.1.-] 
226 NCgl0455 2 6.4 oxidoreductase 
227 NCgl0456 4 17.4 geranylgeranyl pyrophosphate synthase [2.5.1.30] 
228 NCgl0458 22 23.9 transcription antiterminator 
229 NCgl0459 3 9.7 ribosomal protein L11 
230 NCgl0460 64 49.2 ribosomal protein L1 
231 NCgl0466 3 4 hypothetical protein 
232 NCgl0467 4 12.9 hypothetical protein 
233 NCgl0468 44 62.6 ribosomal protein L10 
234 NCgl0469 35 44.5 ribosomal protein L7/L12 
235 NCgl0471 87 37.4 DNA-directed RNA polymerase beta subunit/140 kD subunit [2.7.7.6] 
236 NCgl0472 137 42.5 DNA-directed RNA polymerase beta subunit/160 kD subunit [2.7.7.6] 
237 NCgl0475 1 5.6 hypothetical protein 
238 NCgl0476 14 28.7 ribosomal protein S12 
239 NCgl0477 50 54.8 ribosomal protein S7 
240 NCgl0478 196 50.8 elongation factor G 
241 NCgl0479 1 2.2 hypothetical protein 
242 NCgl0480 300 63.6 elongation factor Tu 
243 NCgl0481 1 6.9 hypothetical protein 
244 NCgl0482 5 17.4 ABC-type transporter: ATPase component 
245 NCgl0486 22 41.6 ribosomal protein S10 
246 NCgl0487 92 61.5 ribosomal protein L3 
247 NCgl0488 60 61 ribosomal protein L4 
248 NCgl0489 15 49.5 ribosomal protein L23 
249 NCgl0490 130 51.8 ribosomal protein L2 
250 NCgl0491 37 48.9 ribosomal protein S19 
251 NCgl0492 32 67.5 ribosomal protein L22 
252 NCgl0493 32 35.9 ribosomal protein S3 
253 NCgl0494 51 47.1 ribosomal protein L16/L10E 
254 NCgl0495 19 76.3 ribosomal protein L29 
255 NCgl0496 18 44.6 ribosomal protein S17 
  APPENDIX 
 
                                                                  A 13
256 NCgl0498 1 9.5 hypothetical protein 
257 NCgl0499 17 26.2 ribosomal protein L14 
258 NCgl0500 9 20.2 ribosomal protein L24 
259 NCgl0501 39 45.5 ribosomal protein L5 
260 NCgl0503 4 11.2 aldo/keto reductase [1.1.1.-] 
261 NCgl0505 2 12.1 formate dehydrogenase accessory protein [1.2.1.2] 
262 NCgl0507 19 22.8 putative formate dehydrogenase [1.2.1.2] 
263 NCgl0513 6 12.4 hypothetical protein 
264 NCgl0514 2 5 predicted acetyltransferase 
265 NCgl0515 12 29.5 ribosomal protein S8 
266 NCgl0516 31 39.3 ribosomal protein L6 
267 NCgl0517 9 27.6 ribosomal protein L18 
268 NCgl0518 12 32.2 ribosomal protein S5 
269 NCgl0519 6 19.7 ribosomal protein L30/L7E 
270 NCgl0520 25 44.6 ribosomal protein L15 
271 NCgl0523 1 2.4 NAD-dependent aldehyde dehydrogenase 
272 NCgl0525 1 3.8 putative reductase 
273 NCgl0527 1 6.5 dehydrogenase 
274 NCgl0531 4 4.1 transcriptional regulator 
275 NCgl0532 2 7.3 preprotein translocase subunit SecY 
276 NCgl0533 26 41.4 adenylate kinase [2.7.4.3] 
277 NCgl0534 7 23.1 methionine aminopeptidase [3.4.11.18] 
278 NCgl0535 1 7.2 hypothetical protein 
279 NCgl0536 14 44.4 translation initiation factor IF-1 
280 NCgl0537 27 45.1 ribosomal protein S13 
281 NCgl0538 5 11.2 ribosomal protein S11 
282 NCgl0539 55 41.8 ribosomal protein S4 
283 NCgl0540 69 51.2 DNA-directed RNA polymerase alpha subunit/40 kD subunit [2.7.7.6] 
284 NCgl0541 46 66.3 ribosomal protein L17 
285 NCgl0543 3 2 hypothetical membrane protein 
286 NCgl0548 5 14.7 putative cyclopropane-fatty-acyl-phospholipid synthase [2.1.1.79] 
287 NCgl0551 1 2.2 hypothetical membrane protein 
288 NCgl0556 49 58.5 ribosomal protein L13 
289 NCgl0557 27 23.1 ribosomal protein S9 
290 NCgl0558 26 30.2 phosphomannomutase 
291 NCgl0561 2 23.1 hypothetical protein 
292 NCgl0562 24 34.4 hypothetical protein 
293 NCgl0563 3 6.1 alanine racemase [5.1.1.1] 
294 NCgl0564 10 29.1 hypothetical protein 
295 NCgl0565 1 2.1 putative membrane protein 
296 NCgl0567 1 5.3 conserved hypothetical protein 
297 NCgl0568 2 13.6 acetyltransferase [2.3.1.128] 
298 NCgl0569 12 31.7 metal-dependent protease [3.4.24.57] 
299 NCgl0570 6 11.8 hypothetical protein 
300 NCgl0572 33 84.8 co-chaperonin GroES 
301 NCgl0573 40 51.3 chaperonin GroEL 
302 NCgl0575 2 5.9 DNA-directed RNA polymerase specialized sigma subunit 
303 NCgl0576 1 3.8 hypothetical protein 
304 NCgl0578 50 45.7 inosine monophosphate dehydrogenase [1.1.1.205] 
305 NCgl0579 32 44.1 putative inosine-5-monophosphate dehydrogenase 
306 NCgl0582 39 44.7 GMP synthase [6.3.5.2] 
307 NCgl0583 4 21.1 hypothetical protein 
308 NCgl0585 1 3.4 two-component system sensor kinase 
309 NCgl0586 3 13.5 two-component system response regulator 
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310 NCgl0591 2 3.4 hypothetical protein 
311 NCgl0592 4 9.4 hypothetical protein 
312 NCgl0593 1 5.9 hypothetical protein 
313 NCgl0597 1 2.7 putative phytoene dehydrogenase [1.3.-.-] 
314 NCgl0598 1 3.6 phytoene synthetase 
315 NCgl0600 1 2.9 geranylgeranyl pyrophosphate synthase 
316 NCgl0602 1 6 lipocalin 
317 NCgl0603 11 13.6 predicted nucleoside-diphosphate-sugar epimerase 
318 NCgl0604 15 24.1 deoxyribodipyrimidine photolyase 
319 NCgl0605 1 8.4 cell wall biogenesis glycosyltransferase 
320 NCgl0608 2 8 ABC-type transporter: permease component 
321 NCgl0609 15 30.6 ABC-type transporter: ATPase component 
322 NCgl0610 13 31.4 ABC-type transporter: periplasmic component 
323 NCgl0611 2 1.9 DNA polymerase III alpha subunit 
324 NCgl0614 4 14.3 Mn-dependent transcriptional regulator 
325 NCgl0616 8 26.4 SIR2 family NAD-dependent protein deacetylase 
326 NCgl0617 2 12.2 cytosine/adenosine deaminase 
327 NCgl0618 2 7.8 ABC-type Fe3+-siderophores transport system: periplasmic component 
328 NCgl0619 3 7 predicted SpoU class rRNA methylase 
329 NCgl0620 19 40.5 5:10-methylene-tetrahydrofolate dehydrogenase [1.5.1.5] 
330 NCgl0622 20 30 flotillin-like protein 
331 NCgl0623 2 8.4 hypothetical protein 
332 NCgl0624 9 22.5 homoserine O-acetyltransferase [2.3.1.11] 
333 NCgl0625 37 50.3 O-acetylhomoserine sulfhydrylase [4.2.99.10] 
334 NCgl0626 11 10.3 carbon starvation protein: predicted membrane protein 
335 NCgl0627 5 20.6 uncharacterized protein 
336 NCgl0628 4 12.9 uncharacterized protein 
337 NCgl0629 3 18.1 PEP phosphonomutase or related enzyme 
338 NCgl0630 5 9.7 citrate synthase [4.1.3.7] 
339 NCgl0632 4 21.3 transcriptional regulator 
340 NCgl0634 69 39.8 monomeric isocitrate dehydrogenase (NADP+) [1.1.1.42] 
341 NCgl0641 15 28.9 exonuclease III 
342 NCgl0644 1 7.1 ABC-type transporter: periplasmic component 
343 NCgl0647 9 20.9 tryptophanyl-tRNA synthetase [6.1.1.2] 
344 NCgl0648 2 6.4 multiple transmembrane domain containing protein 
345 NCgl0649 1 5.3 hypothetical membrane protein 
346 NCgl0651 10 12.5 hypothetical protein 
347 NCgl0654 21 62.1 uracil phosphoribosyltransferase [2.4.2.9] 
348 NCgl0655 4 24.2 predicted transcriptional regulator 
349 NCgl0656 10 12.5 phosphomannomutase [5.4.2.8] 
350 NCgl0657 5 6.3 metal-dependent amidase/aminoacylase/carboxypeptidase 
351 NCgl0658 24 32.8 dihydrolipoamide dehydrogenase [1.8.1.4] 
352 NCgl0659 102 47.9 pyruvate carboxylase [6.4.1.1] 
353 NCgl0660 3 7.6 hypothetical protein 
354 NCgl0664 4 6.8 hypothetical protein 
355 NCgl0665 1 3.9 PEP phosphonomutase or related enzyme 
356 NCgl0666 1 2.6 citrate synthase [4.1.3.7] 
357 NCgl0668 4 7.5 predicted transcriptional regulator 
358 NCgl0670 97 30.1 acyl-CoA carboxylase [6.3.4.14] 
359 NCgl0671 41 69.4 thiosulfate sulfurtransferase [2.8.1.1] 
360 NCgl0672 12 23.4 hypothetical protein 
361 NCgl0673 7 29.7 hypothetical protein 
362 NCgl0674 2 3.9 predicted acyltransferase 
363 NCgl0677 51 38 detergent sensitivity rescuer dtsR2 
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364 NCgl0678 13 22.5 detergent sensitivity rescuer dtsR1 
365 NCgl0679 9 25.7 biotin-(acetyl-CoA carboxylase) ligase [6.3.4.15] 
366 NCgl0681 2 7.5 phosphoribosylaminoimidazole carboxylase (NCAIR synthetase) [4.1.1.21] 
367 NCgl0682 5 1.4 K+ transporter 
368 NCgl0684 1 17.6 phosphoribosylaminoimidazole carboxylase [4.1.1.21] 
369 NCgl0687 1 3.4 nitrilotriacetate monooxygenase [1.14.13.-] 
370 NCgl0697 7 9.4 ABC-type transporter: periplasmic component 
371 NCgl0698 3 8.1 ABC-type transporter: ATPase component 
372 NCgl0700 5 3.6 helicase family member 
373 NCgl0701 2 0.6 hypothetical protein 
374 NCgl0702 6 18.4 hypothetical protein 
375 NCgl0703 8 6.7 hypothetical protein 
376 NCgl0704 4 6 putative helicase [3.6.1.-] 
377 NCgl0705 9 3.3 putative helicase 
378 NCgl0706 17 10.6 type II restriction enzyme: methylase subunits 
379 NCgl0707 15 14.1 SNF2 family helicase 
380 NCgl0709 12 23.8 predicted glycosyltransferase 
381 NCgl0710 24 36.5 nucleoside-diphosphate-sugar pyrophosphorylase [2.7.7.13] 
382 NCgl0711 2 9.6 hypothetical protein 
383 NCgl0712 2 27.6 hypothetical protein 
384 NCgl0713 2 8.5 hypothetical protein 
385 NCgl0714 15 19.4 phosphomannomutase [5.4.2.8] 
386 NCgl0715 4 16.7 hypothetical protein 
387 NCgl0716 12 22.8 phosphomannose isomerase [5.3.1.8] 
388 NCgl0717 1 6.9 hypothetical protein 
389 NCgl0718 2 9.4 hypothetical protein 
390 NCgl0719 35 38.7 S-adenosylhomocysteine hydrolase [3.3.1.1] 
391 NCgl0720 3 20.7 thymidylate kinase [2.7.4.9] 
392 NCgl0721 10 24.8 two-component system response regulator 
393 NCgl0722 1 3.6 two-component system sensory transduction histidine kinase 
394 NCgl0725 23 43.9 ribosome-associated protein Y 
395 NCgl0726 52 32.8 preprotein translocase subunit SecA 
396 NCgl0727 4 27.9 hypothetical protein 
397 NCgl0728 6 14.3 hypothetical protein 
398 NCgl0729 3 9.2 hypothetical protein 
399 NCgl0730 21 32.8 5-enolpyruvylshikimate-3-phosphate synthase 
400 NCgl0733 3 14.1 DNA-directed RNA polymerase specialized sigma subunits 
401 NCgl0737 10 26.7 putative helicase 
402 NCgl0738 5 40 hypothetical protein 
403 NCgl0740 5 21.3 hypothetical protein 
404 NCgl0741 10 8.1 putative helicase 
405 NCgl0742 16 11.3 putative helicase 
406 NCgl0743 4 14.2 predicted NAD-binding component of Kef-type K+ transport system 
407 NCgl0744 1 5 NTP pyrophosphohydrolase 
408 NCgl0745 11 11.9 putative helicase [3.6.1.-] 
409 NCgl0748 15 14.9 hypothetical protein 
410 NCgl0749 1 5.7 predicted secreted protein 
411 NCgl0750 5 7.2 hypothetical protein 
412 NCgl0751 5 25.9 hypothetical protein 
413 NCgl0752 2 3.1 hypothetical protein 
414 NCgl0754 47 49.2 pyridoxine biosynthesis enzyme 
415 NCgl0755 5 20.5 predicted glutamine amidotransferase 
416 NCgl0764 1 13.6 hypothetical protein 
417 NCgl0765 4 11.2 archaeal fructose-1:6-bisphosphatase 
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418 NCgl0766 6 12.7 archaeal fructose-1:6-bisphosphatase 
419 NCgl0767 8 25 protein chain release factor B 
420 NCgl0769 3 10.3 cell division protein 
421 NCgl0771 2 10.3 hypothetical protein 
422 NCgl0773 1 3.6 siderophore-interacting protein 
423 NCgl0774 6 7.8 ABC-type cobalamin/Fe3+-siderophore transport system: periplasmic compone
424 NCgl0776 20 27.5 ABC-type cobalamin/Fe3+-siderophore transport system: periplasmic compone
425 NCgl0779 9 18.3 ABC-type cobalamin/Fe3+-siderophore transport system: ATPase component
426 NCgl0780 6 18.3 PLP-dependent aminotransferase [2.6.1.7] 
427 NCgl0782 7 11.5 putative helicase 
428 NCgl0783 2 3.5 hypothetical protein 
429 NCgl0784 3 38.1 hypothetical protein 
430 NCgl0786 2 7.1 cold shock protein 
431 NCgl0788 1 9.3 glutamine cyclotransferase 
432 NCgl0789 4 10.2 hypothetical protein 
433 NCgl0791 2 10.1 rRNA methylase [2.1.1.66] 
434 NCgl0792 4 8.3 hypothetical protein 
435 NCgl0793 14 32.2 hypothetical protein 
436 NCgl0794 29 58.5 phosphoserine aminotransferase [2.6.1.52] 
437 NCgl0795 89 45.8 citrate synthase [4.1.3.7] 
438 NCgl0796 6 18.6 FKBP-type peptidyl-prolyl cis-trans isomerase 1 [5.2.1.8] 
439 NCgl0797 13 21.1 acetyl-CoA carboxylase beta subunit [6.4.1.2] 
440 NCgl0799 7 1.8 Na+/proline: Na+/panthothenate symporter or related permease 
441 NCgl0802 296 36 fatty-acid synthase [2.3.1.85] 
442 NCgl0805 9 17.2 homoserine acetyltransferase [2.3.1.31] 
443 NCgl0807 37 69.7 hypothetical protein 
444 NCgl0809 5 6.6 dihydrofolate reductase [1.5.1.3] 
445 NCgl0810 6 12 thymidylate synthase [2.1.1.45] 
446 NCgl0811 11 31.3 inositol monophosphatase family protein 
447 NCgl0812 3 1.8 Lhr-like helicase 
448 NCgl0813 1 3.5 formamidopyrimidine-DNA glycosylase [3.2.2.23] 
449 NCgl0814 3 15.4 alkaline phosphatase like protein 
450 NCgl0815 1 5 hypothetical membrane-associated protein 
451 NCgl0817 29 28.1 glucose-6-phosphate isomerase [5.3.1.9] 
452 NCgl0819 1 8.9 chorismate mutase 
453 NCgl0820 24 19.1 hypothetical helicase [3.6.1.-] 
454 NCgl0821 1 2.2 ABC-type transporter: permease component 
455 NCgl0823 1 7.1 predicted transcriptional regulator 
456 NCgl0826 9 40.1 phosphoribosylglycinamide formyltransferase PurN [2.1.2.2] 
457 NCgl0827 49 42.7 phosphoribosylaminoimidazolecarboxamide formyltransferase/IMP cyclohydrol
458 NCgl0828 7 23.4 citrate lyase beta subunit [4.1.3.6] 
459 NCgl0829 10 27.9 transcriptional regulator 
460 NCgl0830 4 15.1 hypothetical protein 
461 NCgl0831 12 25.3 ribosomal protein S18 
462 NCgl0832 10 24.8 ribosomal protein S14 
463 NCgl0833 5 37 ribosomal protein L33 
464 NCgl0834 32 52.6 ribosomal protein L28 
465 NCgl0837 13 38.6 ribosomal protein L31 
466 NCgl0838 6 38.6 hypothetical protein 
467 NCgl0839 2 6 two-component system: response regulator 
468 NCgl0841 5 8.2 trypsin-like serine protease [3.4.21.-] 
469 NCgl0842 4 27.2 molybdopterin biosynthesis enzyme 
470 NCgl0845 1 13.2 5-formyltetrahydrofolate cyclo-ligase [6.3.3.2] 
471 NCgl0846 8 28.6 UDP-glucose pyrophosphorylase [2.7.7.9] 
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472 NCgl0847 5 10.5 molybdopterin biosynthesis enzyme 
473 NCgl0853 10 15 glycosidase [3.2.1.54] 
474 NCgl0855 10 15.6 predicted methyltransferase 
475 NCgl0857 19 24.8 methionyl-tRNA synthetase [6.1.1.10] 
476 NCgl0858 3 6.3 putative helicase 
477 NCgl0860 1 2.8 hypothetical protein 
478 NCgl0861 1 6.5 hypothetical protein 
479 NCgl0865 19 32.7 FAD/FMN-containing dehydrogenase [1.1.1.28] 
480 NCgl0871 6 18.4 Mg-dependent DNase 
481 NCgl0872 1 5.3 hypothetical protein 
482 NCgl0873 6 17.1 dimethyladenosine transferase [2.1.1.-] 
483 NCgl0874 1 8.4 putative isopentenyl monophosphate kinase [2.7.1.-] 
484 NCgl0875 9 10.8 ABC-type transporter 
485 NCgl0877 4 11.3 hypothetical protein 
486 NCgl0878 7 10.9 hypothetical protein 
487 NCgl0879 4 39.3 hypothetical protein 
488 NCgl0880 35 49.7 hypothetical protein 
489 NCgl0881 11 19.7 hypothetical protein 
490 NCgl0882 5 8.8 enoyl-CoA hydratase/carnithine racemase [4.2.1.17] 
491 NCgl0884 1 3.5 hypothetical protein 
492 NCgl0886 3 13.5 transcriptional regulator 
493 NCgl0892 24 30.2 peptide chain release factor 3 
494 NCgl0895 3 2.8 ABC-type transporter: permease component 
495 NCgl0898 3 13.2 peptidyl-tRNA hydrolase [3.1.1.29] 
496 NCgl0899 5 14.7 dioxygenase [1.13.11.32] 
497 NCgl0900 16 21 glyceraldehyde-3-phosphate dehydrogenase/erythrose-4-phosphate dehydroge
498 NCgl0902 25 48.5 ribosomal protein L25 
499 NCgl0903 8 32.2 predicted lactoylglutathione lyase [4.4.1.5] 
500 NCgl0905 31 33.2 phosphoribosylpyrophosphate synthetase [2.7.6.1] 
501 NCgl0906 35 42.5 N-acetylglucosamine-1-phosphate uridyltransferase 
502 NCgl0908 1 2.9 putative multicopper oxidase 
503 NCgl0909 1 2.6 ABC-type transporter: ATPase component 
504 NCgl0914 1 4.1 putative ABC transporter ATPase component 
505 NCgl0916 23 34.9 gamma-glutamyltranspeptidase [2.3.2.2] 
506 NCgl0919 1 6.4 transposase 
507 NCgl0922 1 4.5 hypothetical protein 
508 NCgl0924 17 11.2 transcription-repair coupling factor - superfamily II helicase 
509 NCgl0925 1 2.3 ABC-type transporter: ATP-binding component 
510 NCgl0927 1 1.2 hypothetical protein 
511 NCgl0930 2 18.6 hypothetical protein 
512 NCgl0932 5 17.9 hypothetical protein 
513 NCgl0933 7 52.4 hypothetical protein 
514 NCgl0935 132 47.8 enolase [4.2.1.11] 
515 NCgl0937 15 49.5 hypothetical protein 
516 NCgl0938 6 13.7 exopolyphosphatase [3.6.1.11] 
517 NCgl0946 2 17.2 transcription elongation factor 
518 NCgl0948 13 42.3 uncharacterized protein 
519 NCgl0950 14 27 3-Deoxy-D-arabino-heptulosonate 7-phosphate (DAHP) synthase [4.1.2.15] 
520 NCgl0951 1 5.3 undecaprenyl pyrophosphate synthase [2.5.1.31] 
521 NCgl0952 5 12.7 hypothetical protein 
522 NCgl0953 6 11.8 panthothenate kinase [2.7.1.33] 
523 NCgl0954 64 47.9 glycine hydroxymethyltransferase [2.1.2.1] 
524 NCgl0957 12 37.4 hypothetical protein 
525 NCgl0959 2 6.1 sortase or related acyltransferase 
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526 NCgl0960 1 3.8 allophanate hydrolase subunit 2 
527 NCgl0962 3 12.3 uncharacterized protein 
528 NCgl0966 8 18.1 hypothetical protein 
529 NCgl0967 49 39.9 fumarase [4.2.1.2] 
530 NCgl0972 3 3.1 putative reductase 
531 NCgl0974 1 2.8 acyl-CoA dehydrogenase 
532 NCgl0976 30 33.4 putative fructose-1:6-bisphosphatase/sedoheptulose 1:7-bisphosphatase 
533 NCgl0977 2 13.6 hypothetical protein 
534 NCgl0981 8 24 exonuclease VII: large subunit [3.1.11.6] 
535 NCgl0982 9 15.1 penicillin tolerance protein 
536 NCgl0986 2 6.6 Na+-dependent transporter of the SNF family 
537 NCgl0987 3 9.5 hypothetical protein 
538 NCgl0988 18 34.3 predicted GTPase 
539 NCgl0989 1 9.1 plasmid maintenance system antidote protein 
540 NCgl0990 2 9.1 ornithine carbamoyltransferase [2.1.3.3] 
541 NCgl0992 1 5.4 dehydrogenase [1.1.1.105] 
542 NCgl0994 16 2.1 GGDEF family protein 
543 NCgl0999 1 11.2 hypothetical protein 
544 NCgl1011 3 4.1 hypothetical protein 
545 NCgl1012 17 35.9 Mg-chelatase subunit ChlI 
546 NCgl1013 4 12.4 phosphoglycerate mutase [5.4.2.1] 
547 NCgl1015 18 23.2 putative PEP phosphonomutase [2.7.8.23] 
548 NCgl1016 2 4 ABC-type transporter: duplicated ATPase component 
549 NCgl1022 4 16.2 cysteine sulfinate desulfinase 
550 NCgl1023 15 25.4 nicotinate-nucleotide pyrophosphorylase [2.4.2.19] 
551 NCgl1024 37 27.3 quinolinate synthase [1.4.3.-] 
552 NCgl1025 4 20.6 ADP-ribose pyrophosphatase 
553 NCgl1027 6 17.7 hypothetical protein 
554 NCgl1029 3 6 lipoate-protein ligase A 
555 NCgl1030 1 12.4 hypothetical protein 
556 NCgl1032 8 11.9 2-polyprenyl-6-methoxyphenol hydroxylase [1.14.13.2] 
557 NCgl1035 1 6.4 ABC-type transporter: permease component 
558 NCgl1040 7 9.9 excinuclease ATPase subunit 
559 NCgl1041 16 23.2 peroxiredoxin [1.11.1.-] 
560 NCgl1042 2 1.4 hypothetical membrane protein 
561 NCgl1043 3 5.3 hypothetical protein 
562 NCgl1045 1 17.7 hypothetical protein 
563 NCgl1048 1 3.2 hypothetical protein 
564 NCgl1049 7 53 arsenate reductase 
565 NCgl1051 10 24 hypothetical protein 
566 NCgl1053 49 43.6 predicted membrane GTPase involved in stress response 
567 NCgl1055 18 40.7 hypothetical protein 
568 NCgl1057 17 45.7 ferredoxin 3 
569 NCgl1058 10 14.4 PLP-dependent aminotransferase [2.6.1.1] 
570 NCgl1061 4 10.1 tetrahydrodipicolinate N-succinyltransferase [2.3.1.117] 
571 NCgl1062 1 2.6 gamma-aminobutyrate permease 
572 NCgl1063 13 29.4 tetrahydrodipicolinate N-succinyltransferase 
573 NCgl1064 5 13.8 succinyl-diaminopimelate desuccinylase [3.5.1.18] 
574 NCgl1065 4 12.1 predicted Rossmann fold nucleotide-binding protein 
575 NCgl1066 6 8.7 putative dihydropteroate synthase [2.5.1.15] 
576 NCgl1068 1 7.8 hypothetical protein 
577 NCgl1069 3 23.6 hypothetical protein 
578 NCgl1070 20 37.8 SAM-dependent methyltransferase 
579 NCgl1071 17 21.5 beta-fructosidase [3.2.1.26] 
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580 NCgl1072 13 23 predicted glycosyltransferase 
581 NCgl1073 12 23.7 ADP-glucose pyrophosphorylase [2.7.7.27] 
582 NCgl1074 15 39.9 hypothetical protein 
583 NCgl1077 7 34.6 hypothetical protein 
584 NCgl1078 9 14.7 ATPase 
585 NCgl1079 4 13.5 hypothetical membrane protein 
586 NCgl1080 5 10 Mg/Co/Ni transporter MgtE 
587 NCgl1081 1 4.8 hypothetical membrane protein 
588 NCgl1083 1 9.6 hypothetical protein 
589 NCgl1084 142 41.1 2-oxoglutarate dehydrogenases: E1 component [1.2.4.2] 
590 NCgl1085 2 2.2 ABC-type transporter: duplicated ATPase component 
591 NCgl1086 3 11.3 hypothetical membrane protein 
592 NCgl1087 8 20.9 shikimate 5-dehydrogenase [1.1.1.25] 
593 NCgl1088 3 7.6 carboxylesterase type B [3.1.1.-] 
594 NCgl1089 2 14.3 hypothetical protein 
595 NCgl1090 9 17.6 hypothetical protein 
596 NCgl1091 1 6.1 hypothetical protein 
597 NCgl1094 249 56.5 methionine synthase II [2.1.1.14] 
598 NCgl1096 2 4.5 predicted flavoprotein involved in K+ transport 
599 NCgl1099 2 3 predicted hydrolase 
600 NCgl1100 1 1.5 non-ribosomal peptide synthetase modules and related proteins 
601 NCgl1102 1 2 ABC-type transporter: ATPase component and permease component 
602 NCgl1106 8 22.1 putative mutT-like protein 
603 NCgl1108 3 4.5 putative gamma-aminobutyrate permease 
604 NCgl1109 29 22.7 putative helicase 
605 NCgl1112 2 8.7 alcohol dehydrogenase IV [1.3.1.32] 
606 NCgl1113 1 5.4 protocatechuate 3:4-dioxygenase beta subunit [1.13.11.1] 
607 NCgl1114 1 10.2 hypothetical membrane protein 
608 NCgl1116 1 3.8 putative Na+/proline: Na+/panthothenate symporter 
609 NCgl1117 8 5.9 putative helicase 
610 NCgl1118 4 9.5 hypothetical protein 
611 NCgl1120 1 1.8 ATPase involved in DNA repair 
612 NCgl1123 19 71.5 hypothetical protein 
613 NCgl1124 3 14.2 transcriptional regulator 
614 NCgl1131 2 5 predicted hydrolase or acyltransferase 
615 NCgl1132 33 30.4 arginyl-tRNA synthetase [6.1.1.19] 
616 NCgl1133 10 15.5 diaminopimelate decarboxylase [4.1.1.20] 
617 NCgl1134 3 8 hypothetical protein 
618 NCgl1136 49 46.7 homoserine dehydrogenase [1.1.1.3] 
619 NCgl1137 11 22.3 homoserine kinase [2.7.1.39] 
620 NCgl1138 3 6.1 hypothetical protein 
621 NCgl1140 6 19.7 nitrate reductase delta subunit [1.7.99.4] 
622 NCgl1141 28 42.7 nitrate reductase beta chain [1.7.99.4] 
623 NCgl1142 34 22.6 anaerobic dehydrogenase [1.7.99.4] 
624 NCgl1144 3 19.1 molybdopterin biosynthesis enzyme 
625 NCgl1149 8 10.2 molybdopterin biosynthesis enzyme 
626 NCgl1150 2 5 molybdenum cofactor biosynthesis enzyme 
627 NCgl1151 2 5.6 acyl-CoA synthetase [6.2.1.-] 
628 NCgl1152 31 17.7 transcription termination factor 
629 NCgl1153 25 41.6 protein chain release factor A 
630 NCgl1155 6 21.8 putative translation factor (SUA5) 
631 NCgl1156 1 2.9 UDP-N-acetylmuramyl pentapeptide phosphotransferase 
632 NCgl1159 3 10.4 F0F1-type ATP synthase a subunit [3.6.1.34] 
633 NCgl1160 13 20 F0F1-type ATP synthase c subunit [3.6.1.34] 
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634 NCgl1161 6 21.3 F0F1-type ATP synthase b subunit [3.6.1.34] 
635 NCgl1162 17 24.7 F0F1-type ATP synthase delta subunit [3.6.1.34] 
636 NCgl1163 45 41.4 F0F1-type ATP synthase alpha subunit [3.6.1.34] 
637 NCgl1164 22 32.6 F0F1-type ATP synthase gamma subunit [3.6.1.34] 
638 NCgl1165 100 58.6 F0F1-type ATP synthase beta subunit [3.6.1.34] 
639 NCgl1166 2 11.3 F0F1-type ATP synthase epsilon subunit [3.6.1.34] 
640 NCgl1167 2 12.1 hypothetical protein 
641 NCgl1168 6 23.9 predicted nuclease of the RecB family 
642 NCgl1170 8 38.4 lactoylglutathione lyase 
643 NCgl1171 2 16.2 hypothetical protein 
644 NCgl1172 8 7.8 thioredoxin domain-containing protein 
645 NCgl1173 1 3.1 coenzyme F420-dependent N5:N10-methylene tetrahydromethanopterin reduc
646 NCgl1175 2 9.5 ABC-type transporter: ATPase component 
647 NCgl1177 39 21.9 1:4-alpha-glucan branching enzyme [2.4.1.18] 
648 NCgl1178 28 24.9 glycosidase [3.2.1.1] 
649 NCgl1179 4 8.5 ABC-type transporter: ATPase component 
650 NCgl1180 2 6.8 hypothetical protein 
651 NCgl1181 5 10.9 hypothetical protein 
652 NCgl1182 12 23.7 electron transfer flavoprotein beta-subunit 
653 NCgl1183 10 20.5 electron transfer flavoprotein alpha-subunit 
654 NCgl1184 5 20.2 cysteine sulfinate desulfinase 
655 NCgl1189 4 12.1 spermidine synthase 
656 NCgl1190 5 12.6 hypothetical protein 
657 NCgl1192 8 26 predicted tRNA (5-methylaminomethyl-2-thiouridylate) methyltransferase [2.1.1
658 NCgl1193 2 12.1 hypothetical protein 
659 NCgl1195 1 8 DNA polymerase III alpha subunit 
660 NCgl1196 16 19.1 NAD-dependent DNA ligase [6.5.1.2] 
661 NCgl1197 8 22.6 hypothetical protein 
662 NCgl1198 3 18.2 Asp-tRNAAsn/Glu-tRNAGln amidotransferase C subunit 
663 NCgl1199 25 32.6 putative Asp-tRNAAsn/Glu-tRNAGln amidotransferase A subunit [6.3.5.-] 
664 NCgl1200 17 39.2 siderophore-interacting protein 
665 NCgl1201 1 19.8 hypothetical membrane protein 
666 NCgl1202 43 55.2 6-phosphofructokinase [2.7.1.11] 
667 NCgl1203 4 2.4 transcriptional regulator 
668 NCgl1204 2 5.2 ABC-type transporter: duplicated ATPase component 
669 NCgl1205 1 4.9 ABC-type transporter: permease component 
670 NCgl1208 1 4.2 acetyltransferase 
671 NCgl1209 4 14.8 ABC-type transport system: periplasmic component 
672 NCgl1211 35 35.7 Asp-tRNAAsn/Glu-tRNAGln amidotransferase B subunit 
673 NCgl1212 1 4.9 predicted dinucleotide-binding enzyme [1.-.-.-] 
674 NCgl1213 13 30.5 predicted oxidoreductases 
675 NCgl1215 4 10 transcriptional regulator 
676 NCgl1216 15 42.6 predicted glutathione S-transferase 
677 NCgl1218 3 9.7 hypothetical membrane protein 
678 NCgl1219 39 33.1 dihydroxyacid dehydratase/phosphogluconate dehydratase 
679 NCgl1220 2 6.2 hypothetical protein 
680 NCgl1222 36 32.9 thiamine pyrophosphate-requiring enzyme [4.1.3.18] 
681 NCgl1223 25 70.3 acetolactate synthase: small subunit [4.1.3.18] 
682 NCgl1224 39 30.2 ketol-acid reductoisomerase [1.1.1.86] 
683 NCgl1230 1 7.5 hypothetical protein 
684 NCgl1231 2 15.4 hypothetical protein 
685 NCgl1233 30 26.6 hypothetical protein 
686 NCgl1235 121 66.8 phosphoglycerate dehydrogenase [1.1.1.95] 
687 NCgl1236 5 23.5 hypothetical protein 
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688 NCgl1237 17 37.1 isocitrate/isopropylmalate dehydrogenase [1.1.1.85] 
689 NCgl1239 16 24.4 predicted signal-transduction protein 
690 NCgl1240 2 11 DNA polymerase III epsilon subunit 
691 NCgl1241 11 31 2-keto-4-pentenoate hydratase/2-oxohepta-3-ene-1:7-dioic acid hydratase [5.3
692 NCgl1243 7 18.6 isochorismate synthase [5.4.99.6] 
693 NCgl1244 42 42.6 glutamyl- and glutaminyl-tRNA synthetases [6.1.1.17] 
694 NCgl1247 2 12.6 hypothetical protein 
695 NCgl1251 3 4.9 hypothetical protein 
696 NCgl1253 1 1.4 thiamine biosynthesis protein ThiC 
697 NCgl1255 157 55.2 glucan phosphorylase [2.4.1.1] 
698 NCgl1257 7 22.4 Zn-dependent hydrolase 
699 NCgl1261 8 29.4 transcriptional regulator 
700 NCgl1262 33 31.6 3-isopropylmalate dehydratase large subunit [4.2.1.33] 
701 NCgl1263 14 47.7 3-isopropylmalate dehydratase small subunit [4.2.1.33] 
702 NCgl1264 3 12.8 NTP pyrophosphohydrolase [3.6.1.-] 
703 NCgl1266 12 24.1 glycerol 3-phosphate dehydrogenase [1.1.1.94] 
704 NCgl1267 11 22.5 D-alanine-D-alanine ligase [6.3.2.4] 
705 NCgl1269 4 20.7 thiamine monophosphate kinase [2.7.4.16] 
706 NCgl1270 3 9.6 uracil DNA glycosylase [3.2.2.-] 
707 NCgl1271 1 2.1 predicted kinase 
708 NCgl1272 1 1.3 RecG-like helicase [3.6.1.-] 
709 NCgl1273 1 29.6 pyruvate carboxylase: C-terminal domain/subunit [2.1.3.1] 
710 NCgl1274 3 9.3 N6-adenine-specific methylase 
711 NCgl1275 2 23.8 phosphopantetheine adenylyltransferase 
712 NCgl1276 4 15.4 ABC-type transporter: ATPase component 
713 NCgl1278 2 5.4 ABC-type transporter: periplasmic component 
714 NCgl1279 1 5.2 hypothetical protein 
715 NCgl1284 1 13.9 hypothetical protein 
716 NCgl1285 1 4.5 hypothetical protein 
717 NCgl1288 2 8.3 hypothetical protein 
718 NCgl1289 1 6.7 hypothetical protein 
719 NCgl1291 1 7.6 hypothetical protein 
720 NCgl1292 1 10.4 hypothetical protein 
721 NCgl1299 33 26.6 DNA polymerase I [2.7.7.7] 
722 NCgl1302 2 5.2 aldo/keto reductase [1.1.1.218] 
723 NCgl1303 3 11.2 SAM-dependent methyltransferase 
724 NCgl1304 145 47.7 ribosomal protein S1 
725 NCgl1305 19 17.1 phosphotransferase system IIC component: glucose/maltose/N-acetylglucosam
726 NCgl1306 5 21 dephospho-CoA kinase 
727 NCgl1307 1 2.2 hypothetical protein 
728 NCgl1309 7 13.8 inosine-uridine nucleoside N-ribohydrolase [3.2.2.1] 
729 NCgl1311 4 5.5 ribokinase family sugar kinase [2.7.1.15] 
730 NCgl1315 12 17.9 helicase subunit of the DNA excision repair complex 
731 NCgl1316 14 38.1 universal stress protein UspA 
732 NCgl1318 12 24.5 predicted nucleoside-diphosphate-sugar epimerase 
733 NCgl1319 1 1.7 hypothetical protein 
734 NCgl1320 25 37.2 hypothetical protein 
735 NCgl1321 6 24.5 hypothetical protein 
736 NCgl1322 21 20.9 excinuclease ATPase subunit 
737 NCgl1324 5 31.2 translation initiation factor IF3 
738 NCgl1326 7 33.1 ribosomal protein L20 
739 NCgl1327 2 3.3 hypothetical protein 
740 NCgl1328 2 14.9 hypothetical protein 
741 NCgl1333 4 12.8 glycerophosphoryl diester phosphodiesterase [3.1.4.46] 
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742 NCgl1334 5 27.8 rRNA methylase [2.1.1.34] 
743 NCgl1335 19 33.3 phenylalanyl-tRNA synthetase alpha subunit [6.1.1.20] 
744 NCgl1336 43 36.3 phenylalanyl-tRNA synthetase beta subunit [6.1.1.20] 
745 NCgl1337 4 9.9 hypothetical protein 
746 NCgl1340 6 13.7 acetylglutamate semialdehyde dehydrogenase [1.2.1.38] 
747 NCgl1341 9 30.2 Ornithine acetyltransferase [2.3.1.35] 
748 NCgl1342 17 36 N-acetylglutamate kinase [2.7.2.8] 
749 NCgl1343 30 44.8 PLP-dependent aminotransferase [2.6.1.11] 
750 NCgl1344 18 33.9 ornithine carbamoyltransferase [2.1.3.3] 
751 NCgl1345 4 17.9 arginine repressor 
752 NCgl1346 46 48.6 argininosuccinate synthase [6.3.4.5] 
753 NCgl1347 17 24.5 argininosuccinate lyase [4.3.2.1] 
754 NCgl1349 1 1.9 hypothetical protein 
755 NCgl1351 2 44.1 hypothetical protein 
756 NCgl1352 16 30 tyrosyl-tRNA synthetase [6.1.1.1] 
757 NCgl1353 10 43.9 universal stress protein UspA 
758 NCgl1354 11 22.4 TPR-repeat-containing protein 
759 NCgl1355 2 11.9 predicted sugar phosphatase of the HAD superfamily 
760 NCgl1356 1 31.5 hypothetical protein 
761 NCgl1357 4 9.5 predicted rRNA methylase 
762 NCgl1358 3 12.8 predicted kinase 
763 NCgl1360 8 15.1 hypothetical protein 
764 NCgl1361 5 13.4 hypothetical protein 
765 NCgl1362 18 23.8 CTP synthase [6.3.4.2] 
766 NCgl1364 5 11.5 integrase 
767 NCgl1366 11 10.7 ATPase involved in chromosome partitioning 
768 NCgl1367 2 11 hypothetical protein 
769 NCgl1368 4 17.6 acetyltransferase 
770 NCgl1369 4 16.6 rhodanese-related sulfurtransferase 
771 NCgl1370 2 8.3 predicted transcriptional regulator 
772 NCgl1371 30 41.6 16S rRNA uridine-516 pseudouridylate synthase [4.2.1.70] 
773 NCgl1372 9 13.6 cytidylate kinase [2.7.4.14] 
774 NCgl1373 27 35.4 predicted GTPase 
775 NCgl1378 1 2.8 ABC-type transport system ATPase component 
776 NCgl1380 6 6.4 NhaP-type Na+/H+ and K+/H+ antiporter 
777 NCgl1382 2 24 hypothetical protein 
778 NCgl1383 2 4.2 hydrolase of the alpha/beta superfamily 
779 NCgl1384 27 24.9 preprotein translocase subunit SecA 
780 NCgl1385 27 72 FHA-domain-containing protein 
781 NCgl1387 8 11.8 hypothetical protein 
782 NCgl1388 1 6.8 predicted transcriptional regulator 
783 NCgl1389 1 4.7 hypothetical membrane protein 
784 NCgl1390 3 4.3 hypothetical protein 
785 NCgl1391 3 3.4 hypothetical protein 
786 NCgl1394 14 28.1 putative helicase 
787 NCgl1396 45 32.2 6-phosphogluconate dehydrogenase: family 1 [1.1.1.44] 
788 NCgl1397 5 30.5 uncharacterized protein 
789 NCgl1398 4 17 SAM-dependent methyltransferase 
790 NCgl1401 1 3.4 transcriptional regulator 
791 NCgl1402 1 3.5 ABC-type transporter: permease component 
792 NCgl1407 4 7.8 hydroxymethylpyrimidine/phosphomethylpyrimidine kinase [2.7.4.7] 
793 NCgl1408 2 11.2 hydroxyethylthiazole kinase [2.7.1.50] 
794 NCgl1409 70 40.7 NADH dehydrogenase: FAD-containing subunit [1.6.99.3] 
795 NCgl1410 3 4.8 cyclopropane fatty acid synthase [2.1.1.79] 
  APPENDIX 
 
                                                                  A 23
796 NCgl1412 6 25.3 predicted phosphoribosyltransferase 
797 NCgl1415 2 10.6 hypothetical protein 
798 NCgl1416 5 14.7 hypothetical protein 
799 NCgl1420 1 4 hypothetical protein 
800 NCgl1422 15 22.7 hypothetical protein 
801 NCgl1423 9 20.4 glycosyltransferase 
802 NCgl1426 2 5.3 hypothetical protein [3.1.1.3] 
803 NCgl1428 6 10.8 precorrin-6B methylase 1 [2.1.1.132] 
804 NCgl1430 10 18.2 Xaa-Pro aminopeptidase [3.4.13.9] 
805 NCgl1431 1 6.1 hypothetical protein 
806 NCgl1432 15 16.9 putative helicase 
807 NCgl1435 3 7.3 predicted transcriptional regulator 
808 NCgl1437 8 14.8 hypothetical protein 
809 NCgl1438 1 15.6 hypothetical protein 
810 NCgl1439 13 17.1 hypothetical protein 
811 NCgl1440 8 12.9 ATPase of the AAA+ class 
812 NCgl1441 16 27.7 predicted SAM-dependent methyltransferase involved in tRNA-Met maturation 
813 NCgl1442 18 36 aspartyl aminopeptidase 
814 NCgl1443 3 8.6 RecB family exonuclease 
815 NCgl1446 9 13.5 aspartate ammonia-lyase [4.3.1.1] 
816 NCgl1447 14 45.2 ATP phosphoribosyltransferase [2.4.2.17] 
817 NCgl1448 3 13.8 phosphoribosyl-ATP pyrophosphohydrolase [3.6.1.31] 
818 NCgl1449 3 15.6 predicted phosphatase/phosphohexomutase 
819 NCgl1450 66 33.8 Methionine synthase I: cobalamin-binding domain [2.1.1.13] 
820 NCgl1452 4 6.4 predicted flavoprotein involved in K+ transport [1.6.4.-] 
821 NCgl1454 1 15.7 protein-tyrosine-phosphatase 
822 NCgl1455 3 4.7 protein-tyrosine-phosphatase 
823 NCgl1456 13 64.3 hypothetical protein 
824 NCgl1457 9 17.9 cysteinyl-tRNA synthetase [6.1.1.16] 
825 NCgl1459 1 3.2 predicted oxidoreductases 
826 NCgl1460 3 8.4 hypothetical protein 
827 NCgl1461 13 36.9 dihydroorotate dehydrogenase [1.3.3.1] 
828 NCgl1466 10 34.5 phospholipid-binding protein 
829 NCgl1470 7 16.3 putative periplasmic protein kinase ArgK [2.7.-.-] 
830 NCgl1471 33 33.6 methylmalonyl-CoA mutase: N-terminal domain/subunit [5.4.99.2] 
831 NCgl1472 29 22.2 methylmalonyl-CoA mutase: N-terminal domain/subunit [5.4.99.2] 
832 NCgl1475 5 4.6 membrane protease subunit 
833 NCgl1477 1 3.2 hypothetical protein 
834 NCgl1478 1 5 hypothetical protein 
835 NCgl1479 22 31.1 protoheme ferro-lyase [4.99.1.1] 
836 NCgl1480 3 4.6 cell wall-associated hydrolase 
837 NCgl1482 124 37.2 aconitase A [4.2.1.3] 
838 NCgl1483 5 12.2 transcriptional regulator 
839 NCgl1484 7 22.6 GMP synthase [6.3.5.2] 
840 NCgl1485 1 5.8 predicted nucleoside-diphosphate-sugar epimerase 
841 NCgl1488 3 0.9 cation transport ATPase [3.6.1.-] 
842 NCgl1489 2 5.7 hypothetical protein 
843 NCgl1493 13 18.8 ABC-type transporter: duplicated ATPase component 
844 NCgl1498 1 6.6 putative aromatic ring hydroxylating enzyme 
845 NCgl1499 4 14.1 NifU-like protein 
846 NCgl1500 11 23.8 selenocysteine lyase 
847 NCgl1501 24 43.3 ABC-type transporter: ATPase component 
848 NCgl1502 26 46.4 predicted iron-regulated ABC-type transporter SufB 
849 NCgl1503 32 52.8 predicted iron-regulated ABC-type transporter SufB 
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850 NCgl1504 1 8.8 predicted transcriptional regulator 
851 NCgl1509 4 2.7 putative helicase 
852 NCgl1510 11 29.6 NADPH:quinone reductase [1.6.5.5] 
853 NCgl1512 59 42 transketolase [2.2.1.1] 
854 NCgl1513 26 44.7 transaldolase [2.2.1.2] 
855 NCgl1514 31 29.8 glucose-6-phosphate 1-dehydrogenase [1.1.1.49] 
856 NCgl1515 21 35.1 hypotheical protein 
857 NCgl1516 18 35.3 6-phosphogluconolactonase [3.1.1.31] 
858 NCgl1520 1 2.9 predicted ornithine cyclodeaminase 
859 NCgl1523 37 22.4 phosphoenolpyruvate carboxylase [4.1.1.31] 
860 NCgl1524 53 55.2 triosephosphate isomerase [5.3.1.1] 
861 NCgl1525 42 54.1 3-phosphoglycerate kinase [2.7.2.3] 
862 NCgl1526 8 24.6 glyceraldehyde-3-phosphate dehydrogenase [1.2.1.12] 
863 NCgl1527 5 14.7 hypotheical protein 
864 NCgl1528 11 24.6 hypothetical protein 
865 NCgl1529 11 30.1 predicted P-loop-containing kinase 
866 NCgl1530 2 3.7 nuclease subunit of the excinuclease complex 
867 NCgl1532 5 34 riboflavin synthase beta-chain [2.5.1.9] 
868 NCgl1533 10 19 GTP cyclohydrolase II [3.5.4.25] 
869 NCgl1534 5 19.9 riboflavin synthase alpha chain [2.5.1.9] 
870 NCgl1536 5 25.6 pentose-5-phosphate-3-epimerase [5.1.3.1] 
871 NCgl1537 6 14.2 tRNA and rRNA cytosine-C5-methylase 
872 NCgl1538 9 32.7 methionyl-tRNA formyltransferase [2.1.2.9] 
873 NCgl1539 8 23.7 N-formylmethionyl-tRNA deformylase [3.5.1.31] 
874 NCgl1540 5 3.6 primosomal protein N 
875 NCgl1541 33 44 S-adenosylmethionine synthetase [2.5.1.6] 
876 NCgl1542 7 18.8 phosphopantothenoylcysteine synthetase/decarboxylase 
877 NCgl1543 6 30.5 DNA-directed RNA polymerase subunit K/omega 
878 NCgl1544 9 26.3 guanylate kinase [2.7.4.8] 
879 NCgl1545 16 38.7 hypothetical protein 
880 NCgl1546 3 8.6 orotidine-5-phosphate decarboxylase [4.1.1.23] 
881 NCgl1547 71 37.6 carbamoylphosphate synthase large subunit [6.3.5.5] 
882 NCgl1548 22 44 carbamoylphosphate synthase small subunit [6.3.5.5] 
883 NCgl1549 19 27.7 dihydroorotase [3.5.2.3] 
884 NCgl1550 19 25.3 aspartate carbamoyltransferase: catalytic chain [2.1.3.2] 
885 NCgl1551 8 33.3 pyrimidine operon attenuation protein [2.4.2.9] 
886 NCgl1552 5 9 predicted SulA family nucleoside-diphosphate sugar epimerase 
887 NCgl1553 4 27 hypothetical protein 
888 NCgl1556 2 4.4 transcription termination factor 
889 NCgl1557 34 48.1 translation elongation factor P 
890 NCgl1558 23 38.8 Xaa-Pro aminopeptidase 
891 NCgl1559 10 24.9 3-dehydroquinate synthetase [4.6.1.3] 
892 NCgl1560 8 30 shikimate kinase [2.7.1.71] 
893 NCgl1561 22 32.9 chorismate synthase [4.6.1.4] 
894 NCgl1568 3 8.5 predicted periplasmic solute-binding protein 
895 NCgl1569 10 38.5 predicted endonuclease involved in recombination 
896 NCgl1570 44 24.9 alanyl-tRNA synthetase [6.1.1.7] 
897 NCgl1571 4 10.5 uncharacterized ATPase related to the helicase subunit of the Holliday junction
898 NCgl1572 13 32.8 hypothetical protein 
899 NCgl1573 54 36.2 aspartyl-tRNA synthetase [6.1.1.12] 
900 NCgl1574 3 6.6 predicted metalloprotease 
901 NCgl1575 3 4.3 hypothetical helicase [3.2.1.3] 
902 NCgl1576 2 6 predicted membrane protein 
903 NCgl1578 1 6.6 transcriptional regulator 
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904 NCgl1579 2 12.6 hypothetical protein 
905 NCgl1580 2 3 coenzyme F420-dependent N5:N10-methylene tetrahydromethanopterin reduc
906 NCgl1584 20 20.2 glycerol-3-phosphate dehydrogenase 
907 NCgl1585 31 47.6 histidyl-tRNA synthetase [6.1.1.21] 
908 NCgl1586 3 5.6 putative Zn-dependent hydrolase 
909 NCgl1587 3 7.1 peptidyl-prolyl cis-trans isomerase (rotamase) [5.2.1.8] 
910 NCgl1588 6 16.2 hypothetical protein 
911 NCgl1590 21 18.6 guanosine polyphosphate pyrophosphohydrolase/synthetase [2.7.6.5] 
912 NCgl1591 11 40.5 adenine/guanine phosphoribosyltransferase [2.4.2.7] 
913 NCgl1592 4 6.6 dipeptide-binding protein DciAE 
914 NCgl1594 2 3 preprotein translocase subunit SecD 
915 NCgl1596 1 6.6 Holliday junction resolvasome helicase subunit 
916 NCgl1597 3 7.3 Holliday junction resolvasome DNA-binding subunit 
917 NCgl1599 13 23.5 hypothetical protein 
918 NCgl1600 4 11.7 acyl-CoA thioesterase [3.1.2.-] 
919 NCgl1603 1 7.5 predicted glycosyltransferase [2.4.1.-] 
920 NCgl1604 2 9 lauroyl/myristoyl acyltransferase 
921 NCgl1606 2 9.4 diadenosine tetraphosphate (Ap4A) hydrolase 
922 NCgl1607 54 38.2 threonyl-tRNA synthetase [6.1.1.3] 
923 NCgl1608 3 5.5 predicted iron-dependent peroxidase 
924 NCgl1609 3 11 hypotheical protein 
925 NCgl1611 2 2.1 hypothetical protein 
926 NCgl1614 5 24.9 histone acetyltransferase HPA2 [2.3.-.-] 
927 NCgl1615 2 11.4 hypothetical protein 
928 NCgl1623 1 5.5 ABC-type transporter: ATPase component 
929 NCgl1626 1 4.1 phosphopantothenoylcysteine synthetase/decarboxylase 
930 NCgl1627 1 3.9 hypothetical protein 
931 NCgl1629 3 14.3 hypothetical protein 
932 NCgl1631 4 4.1 hypothetical protein 
933 NCgl1633 5 6.5 hypothetical protein 
934 NCgl1640 1 4.6 hypothetical protein 
935 NCgl1647 1 12 hypothetical protein 
936 NCgl1650 6 15 transcriptional regulator 
937 NCgl1654 1 3.6 hypothetical protein 
938 NCgl1658 1 1.5 hypothetical protein 
939 NCgl1659 4 1.6 hypothetical protein 
940 NCgl1663 1 6.7 hypothetical protein 
941 NCgl1669 2 3.7 predicted ATPase 
942 NCgl1670 5 1.7 hypothetical protein 
943 NCgl1674 1 9.6 hypothetical protein 
944 NCgl1676 22 56 hypothetical protein 
945 NCgl1685 1 5.2 hypothetical membrane protein 
946 NCgl1699 1 26.7 hypothetical protein 
947 NCgl1700 3 1.3 hypothetical protein 
948 NCgl1702 7 2.8 hypothetical protein 
949 NCgl1703 14 18.5 site-specific DNA methylase or 
950 NCgl1704 4 6.4 stress-sensitive restriction system protein 1 
951 NCgl1705 4 6.2 stress-sensitive restriction system protein 2 
952 NCgl1708 2 3.6 hypothetical protein 
953 NCgl1715 2 4.6 hypothetical protein 
954 NCgl1716 1 1.7 ATPase with chaperone activity: ATP-binding subunit 
955 NCgl1720 2 15 hypothetical protein 
956 NCgl1721 1 1.4 hypothetical protein 
957 NCgl1728 1 4.1 hypothetical protein 
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958 NCgl1731 5 34.3 hypothetical protein 
959 NCgl1732 3 18.9 hypothetical protein 
960 NCgl1734 3 11.2 hypothetical protein 
961 NCgl1738 3 11.9 hypothetical protein 
962 NCgl1739 2 3.5 hypothetical protein 
963 NCgl1744 2 7.1 hypothetical protein 
964 NCgl1745 2 18.9 predicted transcriptional regulator 
965 NCgl1747 1 8.2 hypothetical protein 
966 NCgl1748 4 8 periplasmic serine protease 
967 NCgl1755 1 5.4 hypothetical protein 
968 NCgl1756 4 12 hypothetical protein 
969 NCgl1761 1 6.2 hypothetical protein 
970 NCgl1766 4 5.7 hypothetical protein 
971 NCgl1774 2 1.9 hypothetical protein 
972 NCgl1806 2 7 integrase 
973 NCgl1816 1 4.8 hypothetical protein 
974 NCgl1821 2 8.2 pyrimidine reductase 
975 NCgl1823 10 50 hypothetical protein 
976 NCgl1824 21 44.8 hypothetical protein 
977 NCgl1825 6 26.9 hypothetical protein 
978 NCgl1826 1 2.2 ribonuclease D [3.1.26.3] 
979 NCgl1827 21 26.6 deoxyxylulose-5-phosphate synthase 
980 NCgl1828 7 20.1 SAM-dependent methyltransferase [2.1.1.-] 
981 NCgl1829 7 17.8 hypothetical protein 
982 NCgl1830 9 61.7 dUTPase [3.6.1.23] 
983 NCgl1831 3 16.9 hypothetical membrane protein 
984 NCgl1833 14 46.4 hypothetical protein 
985 NCgl1834 3 16.4 archaeal fructose-1:6-bisphosphatase 
986 NCgl1835 20 43.2 transcriptional regulator [2.7.1.63] 
987 NCgl1836 34 28.3 DNA-directed RNA polymerase sigma subunit SigA 
988 NCgl1839 5 9.1 hypothetical protein 
989 NCgl1842 8 12.8 predicted rRNA or tRNA methylase 
990 NCgl1844 13 20.5 DNA-directed RNA polymerase sigma subunit SigB 
991 NCgl1845 24 53.1 Mn-dependent transcriptional regulator 
992 NCgl1846 8 23.4 UDP-glucose 4-epimerase [5.1.3.2] 
993 NCgl1847 1 2.7 hypothetical protein 
994 NCgl1848 7 14.4 hypothetical protein 
995 NCgl1849 12 14.5 putative helicase 
996 NCgl1850 10 23.5 transcriptional regulator 
997 NCgl1852 18 12.1 HrpA-like helicase 
998 NCgl1853 1 6.7 predicted transcriptional regulator 
999 NCgl1855 6 26.1 SOS-response transcriptional repressor [3.4.21.88] 
1000 NCgl1856 4 13.1 transcriptional regulator of sugar metabolism 
1001 NCgl1857 4 13.8 fructose-1-phosphate kinase [2.7.1.56] 
1002 NCgl1858 52 40.1 phosphoenolpyruvate-protein kinase [2.7.3.9] 
1003 NCgl1859 2 3.8 transcriptional regulator of sugar metabolism 
1004 NCgl1860 6 16.4 putative fructose-1-phosphate kinase [2.7.1.11] 
1005 NCgl1861 3 1.7 phosphotransferase system: fructose-specific IIC component [2.7.1.69] 
1006 NCgl1862 1 13.5 hypothetical protein 
1007 NCgl1863 6 22.3 hypothetical protein 
1008 NCgl1865 4 9.5 GTPase 
1009 NCgl1866 4 12.7 hypothetical protein 
1010 NCgl1867 3 12.3 hypothetical protein 
1011 NCgl1868 9 30.3 diaminopimelate epimerase [5.1.1.7] 
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1012 NCgl1869 5 18.3 tRNA delta(2)-isopentenylpyrophosphate transferase [2.5.1.8] 
1013 NCgl1871 52 51.4 hypothetical protein 
1014 NCgl1872 1 6.2 hypothetical protein 
1015 NCgl1874 16 18.8 2-methylthioadenine synthetase 
1016 NCgl1875 8 20.8 glutamate ABC-type transporter: ATPase component 
1017 NCgl1876 18 34.2 glutamate ABC-type transporter: periplasmic component 
1018 NCgl1877 5 13.6 glutamate ABC-type transporter: permease component 
1019 NCgl1879 1 4.7 hypotheical protein 
1020 NCgl1880 20 26.1 RecA/RadA recombinase 
1021 NCgl1885 3 10.3 ABC-type transporter: permease component 
1022 NCgl1886 37 45.3 phage shock protein A (IM30) 
1023 NCgl1890 4 27.4 hypothetical protein 
1024 NCgl1892 1 7 membrane protein TerC 
1025 NCgl1893 5 4 DNA translocase spoIIIE-like protein 
1026 NCgl1894 7 28.9 hypothetical protein 
1027 NCgl1895 37 28.3 predicted hydrolase of the metallo-beta-lactamase superfamily 
1028 NCgl1896 24 44.2 dihydrodipicolinate synthase/N-acetylneuraminate lyase [4.2.1.52] 
1029 NCgl1897 5 17.6 predicted alternative thymidylate synthase 
1030 NCgl1898 20 40.7 dihydrodipicolinate reductase [1.3.1.26] 
1031 NCgl1899 1 6.4 hypothetical protein 
1032 NCgl1900 52 40.5 polyribonucleotide nucleotidyltransferase [2.7.7.8] 
1033 NCgl1901 25 69.7 ribosomal protein S15P/S13E 
1034 NCgl1902 10 4.7 inosine-uridine nucleoside N-ribohydrolase 
1035 NCgl1903 8 12.9 FAD synthase [2.7.1.26] 
1036 NCgl1904 2 3.4 pseudouridine synthase [4.2.1.70] 
1037 NCgl1905 7 14.3 phosphopantetheinyl transferase component of siderophore synthetase 
1038 NCgl1906 6 19.8 hypothetical protein 
1039 NCgl1908 4 16 exopolyphosphatase-related protein 
1040 NCgl1909 14 52.3 ribosome-binding factor A 
1041 NCgl1910 44 22.1 translation initiation factor 2 
1042 NCgl1911 1 15.2 predicted nucleic-acid-binding protein 
1043 NCgl1912 9 18.1 transcription terminator 
1044 NCgl1913 7 16.9 hypotheical protein 
1045 NCgl1915 12 11 ABC-type transporter: periplasmic component 
1046 NCgl1918 5 5.7 ABC-type transporter: duplicated ATPase component 
1047 NCgl1919 43 48.6 prolyl-tRNA synthetase [6.1.1.15] 
1048 NCgl1920 1 10.6 hypotheical protein 
1049 NCgl1922 1 3 Mg-chelatase subunit ChlI 
1050 NCgl1923 2 13.2 uroporphyrinogen-III methylase 
1051 NCgl1924 9 18.6 hypothetical protein 
1052 NCgl1925 1 5.2 hypothetical protein 
1053 NCgl1926 36 46.8 predicted dehydrogenase [1.1.99.16] 
1054 NCgl1927 1 4.7 hypothetical protein 
1055 NCgl1928 11 24.5 dihydrolipoamide dehydrogenase [1.6.4.2] 
1056 NCgl1930 4 5.9 hypothetical membrane protein 
1057 NCgl1932 16 31.6 methionine aminopeptidase [3.4.11.18] 
1058 NCgl1933 1 1.6 cell division protein FtsI 
1059 NCgl1934 3 16.7 two-component system: response regulator 
1060 NCgl1938 21 41.2 gcpE-like protein 
1061 NCgl1940 9 15.8 1-deoxy-D-xylulose 5-phosphate reductoisomerase [1.1.1.-] 
1062 NCgl1941 4 21.1 hypothetical membrane protein 
1063 NCgl1942 1 1.5 ABC-type transporter: permease component 
1064 NCgl1943 4 15.1 ABC-type transporter: ATPase component 
1065 NCgl1944 13 31.1 predicted Fe-S-cluster redox enzyme 
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1066 NCgl1947 9 24.9 ribosome recycling factor 
1067 NCgl1948 30 46.1 uridylate kinase [2.7.4.-] 
1068 NCgl1949 45 62.5 translation elongation factor Ts 
1069 NCgl1950 80 47.8 ribosomal protein S2 
1070 NCgl1952 1 2.9 integrase 
1071 NCgl1953 2 7.6 predicted Rossmann-fold nucleotide-binding protein 
1072 NCgl1956 6 44.6 hypothetical protein 
1073 NCgl1958 1 6.5 signal peptidase I 
1074 NCgl1959 1 5.1 ABC-type transport systems: periplasmic component 
1075 NCgl1960 17 18.6 ribosomal protein L19 
1076 NCgl1962 3 5.3 glycine/D-amino acid oxidases 
1077 NCgl1966 23 21.1 predicted RNA binding protein 
1078 NCgl1969 1 2.6 adenylosuccinate lyase [5.5.1.2] 
1079 NCgl1972 9 15.4 tRNA-(guanine-N1)-methyltransferase [2.1.1.31] 
1080 NCgl1973 1 8.3 hypothetical protein 
1081 NCgl1974 8 38 RimM protein 
1082 NCgl1975 2 13.8 hypothetical protein 
1083 NCgl1976 19 38.8 ribosomal protein S16 
1084 NCgl1977 1 7 ankyrin repeat containing protein 
1085 NCgl1980 21 24.1 signal recognition particle GTPase 
1086 NCgl1982 7 44.6 nitrogen regulatory protein PII 
1087 NCgl1984 4 10 signal recognition particle GTPase 
1088 NCgl1985 13 7.6 hypothetical protein 
1089 NCgl1986 10 8.1 chromosome segregation ATPase 
1090 NCgl1987 9 59.6 acylphosphatases [3.6.1.7] 
1091 NCgl1988 2 2.2 hypothetical protein 
1092 NCgl1993 1 7 formamidopyrimidine-DNA glycosylase [3.2.2.23] 
1093 NCgl1994 7 22.7 dsRNA-specific ribonuclease [3.1.26.3] 
1094 NCgl1995 5 17.4 hypothetical protein 
1095 NCgl1996 20 30 hypothetical protein 
1096 NCgl1997 2 6.8 ABC-type transporter: ATPase component and permease component 
1097 NCgl1998 2 5.1 ABC-type transporter: ATPase component and permease component 
1098 NCgl1999 117 62.4 glutamate dehydrogenase/leucine dehydrogenase [1.4.1.4] 
1099 NCgl2000 3 2.7 glycerate kinase 
1100 NCgl2001 17 59.8 hypothetical protein 
1101 NCgl2002 1 2.5 hypothetical protein 
1102 NCgl2003 3 6.2 metal-dependent amidase/aminoacylase/carboxypeptidase [3.5.1.32] 
1103 NCgl2008 50 45.7 pyruvate kinase [2.7.1.40] 
1104 NCgl2012 2 13.6 phosphoribosyl-AMP cyclohydrolase [3.5.4.19] 
1105 NCgl2013 7 34.5 imidazoleglycerol-phosphate synthase and cyclase hisF 
1106 NCgl2014 1 6.5 archaeal fructose-1:6-bisphosphatase 
1107 NCgl2015 10 26 phosphoribosylformimino-5-aminoimidazole carboxamide ribonucleotide (ProFA
1108 NCgl2016 7 19.9 glutamine amidotransferase [2.4.2.-] 
1109 NCgl2020 22 40.4 histidinol-phosphate aminotransferase/tyrosine aminotransferase [2.6.1.9] 
1110 NCgl2021 22 23.8 histidinol dehydrogenase [1.1.1.23] 
1111 NCgl2022 3 2.3 hypothetical protein 
1112 NCgl2024 8 4.2 hypothetical protein 
1113 NCgl2025 3 4.7 transcriptional regulator 
1114 NCgl2026 26 22.2 pullulanase 
1115 NCgl2027 4 7.1 SAM-dependent methyltransferase 
1116 NCgl2030 2 6 transcriptional regulator 
1117 NCgl2031 1 3.8 ABC-type transporter: ATPase component 
1118 NCgl2035 6 15.7 DNA polymerase III epsilon subunit [2.7.7.7] 
1119 NCgl2037 27 24.9 maltooligosyl trehalose synthase 
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1120 NCgl2038 8 19.4 hypotheical protein 
1121 NCgl2041 2 11.2 coenzyme F420-dependent N5:N10-methylene tetrahydromethanopterin reduc
1122 NCgl2044 1 3.2 hypothetical protein 
1123 NCgl2045 30 25.2 1:4-alpha-glucan branching enzyme 
1124 NCgl2046 13 19.5 threonine dehydratase [4.2.1.16] 
1125 NCgl2047 3 11.7 hypothetical membrane protein 
1126 NCgl2048 33 29.7 methionine synthase II [2.1.1.14] 
1127 NCgl2049 15 10.9 DNA polymerase III alpha subunit 
1128 NCgl2053 16 41.7 dehydrogenase [1.-.-.-] 
1129 NCgl2054 3 10.7 diaminopimelate decarboxylase [4.1.1.20] 
1130 NCgl2055 1 7.3 cysteine synthase [4.2.99.8] 
1131 NCgl2057 5 19.7 23S RNA-specific pseudouridylate synthase [4.2.1.70] 
1132 NCgl2059 2 12.3 hypothetical protein 
1133 NCgl2061 2 9.5 hypothetical protein 
1134 NCgl2062 1 8.3 L-asparaginase [3.5.1.1] 
1135 NCgl2064 3 1.9 nucleotidyltransferase 
1136 NCgl2066 1 3 predicted transcriptional regulator 
1137 NCgl2067 3 10.8 hypothetical protein 
1138 NCgl2068 56 34.1 isoleucyl-tRNA synthetase [6.1.1.5] 
1139 NCgl2070 25 36.4 cell division initiation protein 
1140 NCgl2071 2 11.6 hypothetical membrane protein 
1141 NCgl2072 15 76.3 hypotheical protein 
1142 NCgl2073 3 16.2 predicted enzyme with a TIM-barrel fold 
1143 NCgl2074 6 25.6 hypothetical protein 
1144 NCgl2075 31 41.2 cell division GTPase 
1145 NCgl2076 1 7.2 cell division septal protein 
1146 NCgl2077 31 38.9 UDP-N-acetylmuramate-alanine ligase [6.3.2.8] 
1147 NCgl2078 7 16.3 UDP-N-acetylglucosamine:LPS N-acetylglucosamine transferase [2.4.1.-] 
1148 NCgl2079 1 1.5 bacterial cell division membrane protein 
1149 NCgl2080 9 14.4 UDP-N-acetylmuramoylalanine-D-glutamate ligase [6.3.2.9] 
1150 NCgl2082 19 24.9 UDP-N-acetylmuramyl pentapeptide synthase [6.3.2.15] 
1151 NCgl2083 14 17.3 UDP-N-acetylmuramyl tripeptide synthase [6.3.2.13] 
1152 NCgl2084 1 1.8 cell division protein FtsI 
1153 NCgl2085 2 8.3 hypothetical protein 
1154 NCgl2086 17 33.5 predicted S-adenosylmethionine-dependent methyltransferase 
1155 NCgl2091 12 32.2 5:10-methylenetetrahydrofolate reductase [1.7.99.5] 
1156 NCgl2092 7 17.3 geranylgeranyl pyrophosphate synthase [2.5.1.1] 
1157 NCgl2094 4 15.4 hypothetical protein 
1158 NCgl2095 6 8.9 serine/threonine protein kinase 
1159 NCgl2098 26 49.4 3-Deoxy-D-arabino-heptulosonate 7-phosphate (DAHP) synthase 
1160 NCgl2099 2 8.3 hypothetical protein 
1161 NCgl2103 1 4.1 hypothetical membrane protein 
1162 NCgl2104 10 23.3 1-acyl-sn-glycerol-3-phosphate acyltransferase [2.3.1.51] 
1163 NCgl2105 7 16.7 glucose kinase [2.7.1.2] 
1164 NCgl2106 1 4.7 predicted glycosyltransferase 
1165 NCgl2107 1 2.6 cell wall-associated hydrolase 
1166 NCgl2109 9 9.8 cytochrome b subunit of the bc complex 
1167 NCgl2110 10 23.8 Rieske Fe-S protein 
1168 NCgl2111 2 5.1 cytochrome C 
1169 NCgl2114 1 11.2 hypothetical membrane protein 
1170 NCgl2115 9 15 cytochrome C oxidase subunit II [1.9.3.1] 
1171 NCgl2116 41 38 asparagine synthase 
1172 NCgl2117 7 36.8 hypothetical protein 
1173 NCgl2120 11 19.6 NaMN:DMB phosphoribosyltransferase [2.4.2.21] 
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1174 NCgl2122 9 36.8 putative short-chain dehydrogenase 
1175 NCgl2123 30 43.1 branched-chain amino acid aminotransferase [2.6.1.42] 
1176 NCgl2124 6 11.4 leucyl aminopeptidase [3.4.11.1] 
1177 NCgl2126 49 31 dihydrolipoamide acyltransferase [2.3.1.61] 
1178 NCgl2127 6 25.1 lipoate-protein ligase B 
1179 NCgl2128 15 33.6 lipoate synthase 
1180 NCgl2129 2 11.5 hypothetical membrane protein 
1181 NCgl2130 1 2.6 predicted permease 
1182 NCgl2132 2 12.3 hypothetical membrane protein 
1183 NCgl2133 63 33.1 glutamine synthase [6.3.1.2] 
1184 NCgl2135 2 25.6 hypothetical protein 
1185 NCgl2136 10 30.3 NTP pyrophosphohydrolase 
1186 NCgl2139 42 43.5 threonine synthase [4.2.99.2] 
1187 NCgl2143 1 7.4 hypothetical protein 
1188 NCgl2145 7 20 hypothetical protein 
1189 NCgl2146 9 27.4 hypothetical protein 
1190 NCgl2147 11 9.5 glutamine synthetase adenylyltransferase [2.7.7.42] 
1191 NCgl2148 12 22 glutamine synthase [6.3.1.2] 
1192 NCgl2150 29 28.1 hypothetical protein 
1193 NCgl2151 2 48.3 hypothetical protein 
1194 NCgl2152 4 11.4 galactokinase [2.7.1.6] 
1195 NCgl2153 10 19.8 exoribonucleases 
1196 NCgl2155 9 18.3 phosphoglycerate mutase 
1197 NCgl2156 10 34.3 Zn-ribbon protein 
1198 NCgl2157 6 14.5 hypothetical protein 
1199 NCgl2158 6 13.8 predicted phosphatase [3.1.3.18] 
1200 NCgl2159 8 31.2 protein-tyrosine-phosphatase [3.1.3.48] 
1201 NCgl2160 1 5 hypothetical protein 
1202 NCgl2165 16 41.3 hypothetical protein 
1203 NCgl2167 149 52.3 pyruvate dehydrogenase: decarboxylase component [1.2.4.1] 
1204 NCgl2168 1 3.8 ABC-type transporter: ATPase component 
1205 NCgl2170 6 6.1 hypotheical protein 
1206 NCgl2172 4 30.6 hypothetical protein 
1207 NCgl2174 3 35.1 acyl carrier protein 
1208 NCgl2175 10 20 predicted sugar phosphatase of the HAD superfamily 
1209 NCgl2176 3 7 hypothetical protein 
1210 NCgl2178 7 18.2 beta-lactamase class C 
1211 NCgl2186 21 26.1 hypothetical protein 
1212 NCgl2188 4 5.4 bacterial type DNA primase [2.7.7.-] 
1213 NCgl2190 2 16 hypothetical protein 
1214 NCgl2191 36 32.9 glucosamine 6-phosphate synthetase [2.6.1.16] 
1215 NCgl2193 3 11.3 dGTP triphosphohydrolase 
1216 NCgl2194 6 16.9 hypothetical protein 
1217 NCgl2195 7 7.3 chromosome segregation ATPase 
1218 NCgl2198 47 46.6 class II glycyl-tRNA synthetase [6.1.1.14] 
1219 NCgl2199 2 8.9 predicted transcriptional regulator 
1220 NCgl2200 6 30.6 Fe2+/Zn2+ uptake regulation protein 
1221 NCgl2203 7 19.8 undecaprenyl pyrophosphate synthase [2.5.1.31] 
1222 NCgl2205 11 23.9 GTPase 
1223 NCgl2208 6 12 phosphate starvation-inducible protein PhoH 
1224 NCgl2209 4 13.7 hypotheical protein 
1225 NCgl2210 17 29.6 molecular chaperone 
1226 NCgl2211 4 14.1 transcriptional regulator of heat shock gene 
1227 NCgl2215 3 12.7 hypothetical protein 
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1228 NCgl2216 19 16.1 long-chain acyl-CoA synthetase (AMP-forming) [6.2.1.3] 
1229 NCgl2217 57 31.9 4-alpha-glucanotransferase [2.4.1.25] 
1230 NCgl2218 1 2.1 ABC-type transporter: ATPase component and permease component 
1231 NCgl2219 23 25.1 Zn-dependent oligopeptidase [3.4.15.5] 
1232 NCgl2221 9 15.7 putative trehalose synthase 
1233 NCgl2222 4 10.2 hypothetical protein 
1234 NCgl2223 2 9.7 isopentenyldiphosphate isomerase [5.3.3.2] 
1235 NCgl2227 13 22.6 PLP-dependent aminotransferase [2.6.1.-] 
1236 NCgl2229 2 12.3 coenzyme F420-dependent N5:N10-methylene tetrahydromethanopterin reduc
1237 NCgl2241 1 3.5 ABC-type transporter: duplicated ATPase component 
1238 NCgl2243 1 4 sugar kinase [2.7.1.15] 
1239 NCgl2246 26 46.8 hypothetical protein 
1240 NCgl2247 16 12.2 malate synthase [4.1.3.2] 
1241 NCgl2248 8 13.4 isocitrate lyase [4.1.3.1] 
1242 NCgl2249 3 5.3 thiamine biosynthesis protein x 
1243 NCgl2250 1 6.8 hypothetical protein 
1244 NCgl2251 6 3.7 choline-glycine betaine transporter 
1245 NCgl2253 2 7.5 hypothetical protein 
1246 NCgl2259 28 38.4 membrane GTPase LepA 
1247 NCgl2260 2 3.9 hypothetical protein 
1248 NCgl2261 41 46 ribosomal protein S20 
1249 NCgl2263 4 28.9 ankyrin repeat containing protein 
1250 NCgl2267 5 12 hypotheical protein 
1251 NCgl2268 7 17.8 phosphoglycerate mutase 
1252 NCgl2269 3 15.9 hypothetical protein 
1253 NCgl2270 3 6 nicotinic acid mononucleotide adenylyltransferase 
1254 NCgl2272 22 24.5 gamma-glutamyl phosphate reductase [1.2.1.41] 
1255 NCgl2273 26 30.9 putative phosphoglycerate dehydrogenase 
1256 NCgl2274 9 11.4 glutamate 5-kinase [2.7.2.11] 
1257 NCgl2275 9 12.6 predicted GTPase 
1258 NCgl2276 1 2 xanthine/uracil permease 
1259 NCgl2277 28 34.9 aldo/keto reductase [1.1.1.-] 
1260 NCgl2278 5 19.8 hypothetical protein 
1261 NCgl2279 18 62.5 ribosomal protein L27 
1262 NCgl2280 8 42.6 ribosomal protein L21 
1263 NCgl2281 38 27.2 ribonuclease E [3.1.4.-] 
1264 NCgl2282 1 4.1 hypothetical membrane protein 
1265 NCgl2287 6 32.4 nucleoside diphosphate kinase [2.7.4.6] 
1266 NCgl2289 9 55.3 predicted acetyltransferase 
1267 NCgl2290 3 10.3 hypothetical protein 
1268 NCgl2292 12 17.9 folylpolyglutamate synthase 
1269 NCgl2293 50 32.1 valyl-tRNA synthetase [6.1.1.9] 
1270 NCgl2294 4 6.9 ABC-type transport systems: periplasmic components 
1271 NCgl2295 15 26 molecular chaperone 
1272 NCgl2296 5 30.3 predicted Rossmann fold nucleotide-binding protein 
1273 NCgl2297 12 24.7 malate/lactate dehydrogenase [1.1.1.37] 
1274 NCgl2298 5 7.7 transcriptional regulator 
1275 NCgl2299 2 6.8 predicted transcriptional regulator 
1276 NCgl2304 19 19.7 ATP-dependent protease Clp: ATPase subunit 
1277 NCgl2305 10 21.3 hypothetical protein 
1278 NCgl2306 3 10 acyl-CoA:acetate CoA transferase beta subunit [2.8.3.6] 
1279 NCgl2307 5 20.4 acyl-CoA:acetate CoA transferase alpha subunit [2.8.3.6] 
1280 NCgl2308 2 5.1 transcriptional regulator 
1281 NCgl2309 8 16.2 acetyl-CoA acetyltransferase 
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1282 NCgl2310 4 9.6 predicted hydrolase/acyltransferase [4.1.1.44] 
1283 NCgl2311 5 5.2 DNA-binding HTH domain-containing protein 
1284 NCgl2312 3 19.7 hypothetical protein 
1285 NCgl2314 3 15.7 protocatechuate 3:4-dioxygenase beta subunit [1.13.11.3] 
1286 NCgl2315 1 9.6 protocatechuate 3:4-dioxygenase beta subunit [1.13.11.3] 
1287 NCgl2318 2 3.2 putative chloromuconate cycloisomerase 
1288 NCgl2319 4 7.7 protocatechuate 3:4-dioxygenase beta subunit [1.13.11.1] 
1289 NCgl2321 1 10.4 benzoate dioxygenase small subunit 
1290 NCgl2324 1 1.3 DNA-binding HTH domain containing protein 
1291 NCgl2325 1 2.7 putative benzoate transporter 
1292 NCgl2327 7 22.6 ATP-dependent Clp protease proteolytic subunit 2 [3.4.21.92] 
1293 NCgl2328 24 52.3 ATP-dependent Clp protease proteolytic subunit 1 [3.4.21.92] 
1294 NCgl2329 26 31.6 FKBP-type peptidyl-prolyl cis-trans isomerase 
1295 NCgl2333 4 30.1 hypothetical protein 
1296 NCgl2336 6 16.6 hypothetical protein 
1297 NCgl2337 10 29.9 ribose 5-phosphate isomerase RpiB [5.3.1.26] 
1298 NCgl2339 9 29.6 hypothetical protein 
1299 NCgl2340 61 37 aminopeptidase N [3.4.11.2] 
1300 NCgl2342 3 7.8 hypothetical protein 
1301 NCgl2343 2 4.5 hypothetical protein 
1302 NCgl2347 1 3.6 phytoene/squalene synthetase [2.5.1.-] 
1303 NCgl2349 22 30.9 hypothetical protein 
1304 NCgl2350 2 6.9 ABC-type transporter: duplicated ATPase component 
1305 NCgl2353 6 6 ABC-type transporter: periplasmic component 
1306 NCgl2354 12 16.2 hypothetical protein 
1307 NCgl2355 13 23.5 PLP-dependent aminotransferase [2.6.1.11] 
1308 NCgl2358 4 14.8 oxidoreductase [1.1.1.36] 
1309 NCgl2359 10 28 transcriptional regulator 
1310 NCgl2360 30 34.5 cystathionine gamma-synthase [4.2.99.9] 
1311 NCgl2361 7 14.4 ABC-type transporter: ATPase component 
1312 NCgl2362 5 32.8 hemoglobin-like protein 
1313 NCgl2364 2 13.4 hypothetical protein 
1314 NCgl2365 13 63.9 predicted thioesterase 
1315 NCgl2368 49 33.6 ABC-type transporter: duplicated ATPase component 
1316 NCgl2373 2 3.9 ABC-type transporter: permease component 
1317 NCgl2374 1 3.2 ABC-type transporter: permease component 
1318 NCgl2375 64 57.6 ABC-type transporter: periplasmic component 
1319 NCgl2376 10 22.7 hypothetical protein 
1320 NCgl2377 43 51.9 ABC-type transporter: ATPase component 
1321 NCgl2383 8 13.2 hypothetical protein 
1322 NCgl2384 4 15.6 hydroxypyruvate isomerase 
1323 NCgl2385 16 27.8 short-chain dehydrogenase 
1324 NCgl2386 5  oligoribonuclease 
1325 NCgl2387 3 3 hypothetical protein 
1326 NCgl2388 5 5 hypothetical protein 
1327 NCgl2395 4 4.6 glutaminase [3.5.1.2] 
1328 NCgl2396 2 17.9 transcriptional regulator 
1329 NCgl2401 5 12.4 amidase 
1330 NCgl2402 2 22 hypothetical protein 
1331 NCgl2403 10 46.2 bacterioferritin comigratory protein 
1332 NCgl2404 4 10.4 transcriptional regulator 
1333 NCgl2409 144 28.8 3-oxoacyl-(acyl-carrier-protein) synthase [2.3.1.85] 
1334 NCgl2414 10 17.5 xanthosine triphosphate pyrophosphatase 
1335 NCgl2415 12 38.4 RNase PH [2.7.7.56] 
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1336 NCgl2422 9 27.1 metal-dependent hydrolase [3.1.6.1] 
1337 NCgl2423 7 8.5 glutamate racemase [5.1.1.3] 
1338 NCgl2424 2 6.3 hypothetical protein 
1339 NCgl2425 3 12.8 transcriptional regulator 
1340 NCgl2428 13 31.8 hypothetical protein 
1341 NCgl2429 3 22.6 hypothetical protein 
1342 NCgl2430 4 25.1 hypothetical protein 
1343 NCgl2431 30 45.3 nicotinic acid phosphoribosyltransferase 
1344 NCgl2434 1 4.4 hypothetical membrane protein 
1345 NCgl2435 1 6 hypothetical protein 
1346 NCgl2436 29 44.1 phosphoserine phosphatase [3.1.3.3] 
1347 NCgl2437 13 13.4 heme/copper-type cytochrome/quinol oxidase: subunit 1 [1.9.3.1] 
1348 NCgl2438 12 18.6 ribonucleotide reductase beta subunit 
1349 NCgl2439 9 34 ferritin-like protein 
1350 NCgl2440 8 28.4 transcriptional regulator 
1351 NCgl2443 39 35.7 ribonucleotide reductase alpha subunit 
1352 NCgl2444 1 14.2 ribonucleotide reduction protein 
1353 NCgl2446 17 26 NAD synthase [6.3.5.1] 
1354 NCgl2448 9 45.3 hypothetical protein 
1355 NCgl2449 12 25 putative Zn-NADPH:quinone dehydrogenase [1.1.1.1] 
1356 NCgl2450 4 8.8 hypothetical protein 
1357 NCgl2452 3 12.5 hypothetical protein 
1358 NCgl2453 29 39.9 phosphoglucomutase [5.4.2.2] 
1359 NCgl2456 2 11.7 hypothetical protein 
1360 NCgl2464 1 1.3 ABC-type transporter: permease component 
1361 NCgl2465 7 27.1 ABC-type transporter: ATPase component 
1362 NCgl2466 2 14.2 hypothetical protein 
1363 NCgl2470 29 27.3 UDP-N-acetylglucosamine enolpyruvyl transferase [2.5.1.7] 
1364 NCgl2471 9 32.6 hypothetical protein 
1365 NCgl2472 28 44.8 regulatory-like protein 
1366 NCgl2473 49 72.3 cysteine synthase [4.2.99.8] 
1367 NCgl2474 12 30.2 serine acetyltransferase [2.3.1.30] 
1368 NCgl2475 14 61.5 predicted acetyltransferase 
1369 NCgl2476 8 17.7 succinyl-CoA synthetase alpha subunit [6.2.1.5] 
1370 NCgl2477 2 2.3 succinyl-CoA synthetase beta subunit [6.2.1.5] 
1371 NCgl2478 6 13.9 predicted dithiol-disulfide isomerase 
1372 NCgl2480 108 46.2 acetyl-CoA hydrolase [2.8.3.-] 
1373 NCgl2481 11 25.5 predicted TIM-barrel containing enzyme 
1374 NCgl2482 18 39.3 phosphate uptake regulator 
1375 NCgl2486 1 5.6 ABC-type transporter: periplasmic component 
1376 NCgl2487 11 40.8 histone acetyltransferase HPA2-like protein 
1377 NCgl2489 3 4.3 hypothetical protein 
1378 NCgl2490 12 24.5 hypothetical protein 
1379 NCgl2491 3 15.9 branched-chain amino acid aminotransferase [2.6.1.42] 
1380 NCgl2492 21 36.2 predicted aminomethyltransferase related to GcvT 
1381 NCgl2493 3 18.3 hypothetical protein 
1382 NCgl2494 28 38 phosphoribosylaminoimidazol (AIR) synthetase [6.3.3.1] 
1383 NCgl2495 14 26.2 glutamine phosphoribosylpyrophosphate amidotransferase 
1384 NCgl2496 3 20.8 hypothetical protein 
1385 NCgl2497 16 24.2 acyl-CoA hydrolase 
1386 NCgl2498 1 3.1 predicted membrane proteins 
1387 NCgl2499 54 42.5 phosphoribosylformylglycinamidine (FGAM) synthase: synthetase domain [6.3.
1388 NCgl2500 38 55.2 phosphoribosylformylglycinamidine (FGAM) synthase: glutamine amidotransfer
1389 NCgl2501 8 48.1 phosphoribosylformylglycinamidine (FGAM) synthase: PurS component 
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1390 NCgl2502 7 20.8 glutathione peroxidase [1.11.1.9] 
1391 NCgl2507 24 24.6 protease II 
1392 NCgl2508 20 33.7 phosphoribosylaminoimidazolesuccinocarboxamide (SAICAR) synthase [6.3.2.
1393 NCgl2509 45 41.6 adenylosuccinate lyase [4.3.2.2] 
1394 NCgl2510 10 28.8 PLP-dependent aminotransferase [2.6.1.1] 
1395 NCgl2511 21 40.9 phosphoribosylamine-glycine ligase [6.3.4.13] 
1396 NCgl2512 5 22.8 diadenosine tetraphosphate (Ap4A) hydrolase 
1397 NCgl2517 1 2.3 two-component system: sensory transduction histidine kinase 
1398 NCgl2518 11 20 two-component system: response regulator 
1399 NCgl2520 4 6.7 hypothetical protein 
1400 NCgl2521 39 26.1 thiamine pyrophosphate-requiring enzyme [1.2.2.2] 
1401 NCgl2522 1 1.4 permease of the major facilitator superfamily 
1402 NCgl2525 4 4.9 hypothetical membrane protein 
1403 NCgl2526 1 5.6 succinate dehydrogenase/fumarate reductase: flavoprotein subunit 
1404 NCgl2528 16 20.6 D-2-hydroxyisocaproate dehydrogenase 
1405 NCgl2529 1 4.1 hypothetical protein 
1406 NCgl2530 24 37.6 predicted hydrolase of the HAD superfamily 
1407 NCgl2531 4 25.5 hypothetical protein 
1408 NCgl2533 1 2 hypothetical protein 
1409 NCgl2534 3 21.1 hypothetical protein 
1410 NCgl2537 7 30.1 trehalose-6-phosphatase [3.1.3.12] 
1411 NCgl2538 4 9.7 transcriptional regulator 
1412 NCgl2540 1 6.1 ABC-type transporter: ATPase component 
1413 NCgl2544 1 2.8 3-ketosteroid 1-dehydrogenase 
1414 NCgl2547 1 7.6 hypothetical protein 
1415 NCgl2550 3 20.6 transcriptional regulator 
1416 NCgl2551 10 19.8 rRNA methylase [2.1.1.-] 
1417 NCgl2552 13 20 cysteinyl-tRNA synthetase [6.1.1.16] 
1418 NCgl2553 4 6.8 phosphotransferase system IIC component [2.7.1.69] 
1419 NCgl2554 23 28.6 beta-fructosidase [3.2.1.26] 
1420 NCgl2555 9 24.9 glucosamine-6-phosphate isomerase [5.3.1.10] 
1421 NCgl2558 3 10.2 transcriptional regulator [2.7.1.2] 
1422 NCgl2559 1 7.3 putative N-acetylmannosamine-6-phosphate epimerase 
1423 NCgl2561 4 17.5 transcriptional regulator 
1424 NCgl2562 6 15.8 ABC-type transporter: periplasmic component 
1425 NCgl2564 2 5.6 ABC-type transporter: ATPase component 
1426 NCgl2569 1 6.3 2C-methyl-D-erythritol 2:4-cyclodiphosphate synthase 
1427 NCgl2570 1 4.7 4-diphosphocytidyl-2-methyl-D-erithritol synthase 
1428 NCgl2571 4 18.2 transcriptional regulator 
1429 NCgl2572 5 17 two-component system: response regulator 
1430 NCgl2574 1 7.7 hypothetical protein 
1431 NCgl2575 4 14 DNA repair protein 
1432 NCgl2576 5 14.2 predicted nucleic-acid-binding protein 
1433 NCgl2578 24 38.8 NAD-dependent aldehyde dehydrogenase [1.2.1.-] 
1434 NCgl2579 16 32.9 carbonic anhydrase [4.2.1.1] 
1435 NCgl2580 1 3.1 A/G-specific DNA glycosylase 
1436 NCgl2582 21 51.2 L-2.3-butanediol dehydrogenase 
1437 NCgl2584 6 33 hypothetical protein 
1438 NCgl2585 49 32 ATPase with chaperone activity: ATP-binding subunit 
1439 NCgl2586 23 36.3 inositol-monophosphate dehydrogenase 
1440 NCgl2587 2 3.3 AraC-type DNA-binding domain-containing protein 
1441 NCgl2588 3 5.4 2-polyprenyl-6-methoxyphenol hydroxylase [1.14.13.7] 
1442 NCgl2589 4 7.3 hypothetical protein 
1443 NCgl2590 3 6.2 hypothetical protein 
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1444 NCgl2591 5 8.5 hypothetical protein 
1445 NCgl2594 27 23.6 lysyl-tRNA synthetase class II [6.1.1.6] 
1446 NCgl2596 2 7.8 hypothetical protein 
1447 NCgl2597 1 3.4 hypothetical membrane protein 
1448 NCgl2599 2 13.8 7:8-dihydro-6-hydroxymethylpterin-pyrophosphokinase [2.7.6.3] 
1449 NCgl2601 2 11.1 dihydropteroate synthase [2.5.1.15] 
1450 NCgl2602 8 26.9 GTP cyclohydrolase I [3.5.4.16] 
1451 NCgl2604 6 33.5 hypoxanthine-guanine phosphoribosyltransferase 
1452 NCgl2606 6 9.1 D-alanyl-D-alanine carboxypeptidase [3.4.16.4] 
1453 NCgl2607 23 46.8 inorganic pyrophosphatase [3.6.1.1] 
1454 NCgl2611 3 21.1 hypothetical protein 
1455 NCgl2615 4 11.9 uncharacterized NAD(FAD)-dependent dehydrogenase 
1456 NCgl2616 14 69.8 rhodanese-related sulfurtransferase 
1457 NCgl2617 1 13.5 transcriptional regulator 
1458 NCgl2620 26 33.3 hypotheical protein 
1459 NCgl2621 57 33.9 chaperonin GroEL 
1460 NCgl2623 5 7.2 hypothetical protein 
1461 NCgl2624 5 9.7 hypothetical protein 
1462 NCgl2625 5 5.7 hypothetical protein 
1463 NCgl2626 14 13.7 hypothetical protein 
1464 NCgl2627 5 2.1 hypothetical protein 
1465 NCgl2628 52 28.5 hypothetical protein 
1466 NCgl2629 3 5.8 hypothetical membrane protein 
1467 NCgl2631 14 16.4 hypothetical protein 
1468 NCgl2638 1 9.5 multisubunit Na+/H+ antiporter 
1469 NCgl2639 1 4 hypothetical protein 
1470 NCgl2640 10 17 hypotheical protein 
1471 NCgl2643 2 7.8 N-formylmethionyl-tRNA deformylase [3.5.1.31] 
1472 NCgl2644 5 13.1 histone acetyltransferase HPA2-like protein 
1473 NCgl2645 10 25.1 exonuclease III [3.1.11.2] 
1474 NCgl2649 9 43.9 predicted epimerase 
1475 NCgl2651 1 6.8 ABC-type transporter: ATPase component 
1476 NCgl2652 1 10.2 NTP pyrophosphohydrolase 
1477 NCgl2656 16 33 acetate kinase [2.7.2.1] 
1478 NCgl2657 16 31.5 phosphotransacetylase [2.3.1.8] 
1479 NCgl2658 38 46.6 putative ferredoxin/ferredoxin-NADP reductase [1.18.1.2] 
1480 NCgl2659 4 22.5 predicted acyltransferase 
1481 NCgl2663 13 30.4 phosphoribosylglycinamide formyltransferase 2 
1482 NCgl2667 1 2.1 two-component system: sensory transduction histidine kinases 
1483 NCgl2668 1 3.9 two-component system: response regulator 
1484 NCgl2669 23 28.4 adenylosuccinate synthase [6.3.4.4] 
1485 NCgl2670 3 16.6 hypothetical protein 
1486 NCgl2673 87 59.6 fructose-bisphosphate aldolase [4.1.2.13] 
1487 NCgl2674 1 5.9 hypothetical protein 
1488 NCgl2675 2 8.7 rRNA methylase 
1489 NCgl2676 12 38 orotate phosphoribosyltransferase [2.4.2.10] 
1490 NCgl2677 6 12.5 hypothetical protein 
1491 NCgl2678 1 3.3 thiosulfate sulfurtransferase 
1492 NCgl2682 39 25.5 ATPase with chaperone activity: ATP-binding subunit 
1493 NCgl2684 2 14.7 predicted transcriptional regulator 
1494 NCgl2687 5 10.1 alkanal monooxygenase 
1495 NCgl2692 4 8 hypothetical protein 
1496 NCgl2694 3 8.8 putative 2-polyprenylphenol hydroxylase 
1497 NCgl2695 9 27.1 putative amidohydrolase 
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1498 NCgl2698 19 34.6 NAD-dependent aldehyde dehydrogenase [1.2.1.3] 
1499 NCgl2699 2 14.4 predicted transcriptional regulator 
1500 NCgl2700 11 15.9 molecular chaperone 
1501 NCgl2701 9 8.3 molecular chaperone GrpE 
1502 NCgl2702 83 48.1 70 kDa heat shock chaperonin protein 
1503 NCgl2703 1 4.4 predicted permease 
1504 NCgl2706 5 6.5 hypothetical protein 
1505 NCgl2709 11 19.7 Zn-dependent alcohol dehydrogenase [1.1.1.1] 
1506 NCgl2715 26 48.5 sulfate adenylate transferase subunit 1 
1507 NCgl2716 27 44.4 sulfate adenylyltransferase subunit 2 
1508 NCgl2717 3 9.5 phosphoadenosine phosphosulfate reductase 
1509 NCgl2718 45 34.4 putative nitrite reductase 
1510 NCgl2719 59 57.3 putative ferredoxin/ferredoxin-NADP reductase 
1511 NCgl2720 11 15.9 hypothetical protein 
1512 NCgl2722 5 29 hypotheical protein 
1513 NCgl2730 15 32.2 putative peptidase 
1514 NCgl2737 25 36.9 putative membrane protease subunit 
1515 NCgl2739 3 11.2 3-methyladenine DNA glycosylase [3.2.2.20] 
1516 NCgl2741 4 14.9 hypothetical membrane protein 
1517 NCgl2747 22 38.2 PLP-dependent aminotransferase [2.6.1.1] 
1518 NCgl2750 7 11.8 predicted UDP-glucose 6-dehydrogenase [1.1.1.22] 
1519 NCgl2751 9 38.6 deoxycytidine deaminase [3.5.4.13] 
1520 NCgl2754 1 5.1 beta-N-acetylglucosaminidase-like protein 
1521 NCgl2755 5 31.8 hypothetical protein 
1522 NCgl2757 1 1.6 hypothetical membrane protein 
1523 NCgl2759 1 3.4 predicted acyltransferase 
1524 NCgl2763 4 22.1 hypothetical protein 
1525 NCgl2765 36 35.2 phosphoenolpyruvate carboxykinase (GTP) [4.1.1.32] 
1526 NCgl2767 10 19.6 predicted S-adenosylmethionine-dependent methyltransferase 
1527 NCgl2768 5 19.3 hypothetical protein 
1528 NCgl2772 17 25 acetyl-CoA carboxylase beta subunit [6.4.1.3] 
1529 NCgl2773 57 24.7 putative polyketide synthase 
1530 NCgl2774 27 21.1 putative acyl-CoA synthetase 
1531 NCgl2775 3 7.8 hypothetical protein 
1532 NCgl2776 3 21.1 hypothetical protein 
1533 NCgl2777 19 19.8 putative esterase 
1534 NCgl2779 6 7.9 putative esterase 
1535 NCgl2780 1 1.6 hypothetical membrane protein 
1536 NCgl2782 4 36.9 membrane-associated phospholipid phosphatase 
1537 NCgl2783 34 30.2 hypothetical protein 
1538 NCgl2784 5 14.2 hypothetical membrane protein 
1539 NCgl2787 21 20.8 predicted flavoprotein involved in K+ transport 
1540 NCgl2788 21 28.4 UDP-galactopyranose mutase [5.4.99.9] 
1541 NCgl2789 8 9.5 hypothetical protein 
1542 NCgl2790 15 27.7 glycerol kinase [2.7.1.30] 
1543 NCgl2792 3 10.3 1-acyl-sn-glycerol-3-phosphate acyltransferase 
1544 NCgl2793 21 43.8 seryl-tRNA synthetase [6.1.1.11] 
1545 NCgl2794 11 38.7 transcriptional regulator 
1546 NCgl2795 7 20.8 hypothetical protein 
1547 NCgl2796 2 15.8 hypothetical protein 
1548 NCgl2798 3 17.5 putative phosphoglycerate mutase 
1549 NCgl2799 9 18.7 prephenate dehydratase [4.2.1.51] 
1550 NCgl2804 8 51.4 hypothetical protein 
1551 NCgl2805 1 3.3 hypothetical protein 
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1552 NCgl2806 12 17.6 hypothetical protein 
1553 NCgl2808 2 3.7 putative gluconate permease 
1554 NCgl2809 11 14.1 pyruvate kinase-like protein 
1555 NCgl2810 26 35 L-lactate dehydrogenase [1.1.1.27] 
1556 NCgl2811 2 2.5 hypothetical protein 
1557 NCgl2812 3 8 predicted hydrolase of the HAD superfamily 
1558 NCgl2813 12 32 predicted flavoprotein 
1559 NCgl2814 4 13.9 transcriptional regulator 
1560 NCgl2816 1 2.8 putative integral membrane transport protein 
1561 NCgl2817 19 25.5 L-lactate dehydrogenase 
1562 NCgl2825 10 31.3 peptide methionine sulfoxide reductase [1.8.4.6] 
1563 NCgl2826 36 40.5 superoxide dismutase [1.15.1.1] 
1564 NCgl2830 3 3.8 hypothetical protein 
1565 NCgl2831 5 14.7 hypothetical protein 
1566 NCgl2833 1 9.2 transcriptional regulator 
1567 NCgl2834 10 19.8 two-component system: response regulator 
1568 NCgl2839 3 5.2 hypothetical membrane protein 
1569 NCgl2840 16 39.4 transcriptional regulator 
1570 NCgl2842 9 25.9 hypothetical protein 
1571 NCgl2843 1 5.2 alkanal monooxygenase-like protein 
1572 NCgl2844 2 6.8 23S RNA-specific pseudouridylate synthase 
1573 NCgl2847 21 25.6 hypothetical protein 
1574 NCgl2848 25 33.7 hypothetical protein 
1575 NCgl2857 3 31.5 hypothetical protein 
1576 NCgl2863 4 10.4 two-component system: response regulator 
1577 NCgl2874 8 37.1 thioredoxin 
1578 NCgl2875 1 33.8 copper chaperone 
1579 NCgl2876 3 8.9 putative transmembrane transport protein 
1580 NCgl2878 7 11.4 replicative DNA helicase [3.6.1.-] 
1581 NCgl2879 14 29.3 ribosomal protein L9 
1582 NCgl2880 3 16.9 single-stranded DNA-binding protein 
1583 NCgl2881 11 50.5 ribosomal protein S6 
1584 NCgl2883 1 2.7 hypothetical membrane protein 
1585 NCgl2884 4 6.3 penicillin-binding protein 
1586 NCgl2885 3 23.8 hypothetical protein 
1587 NCgl2886 13 41.4 transcriptional regulator 
1588 NCgl2887 5 15 hypothetical protein 
1589 NCgl2888 1 10.9 hypothetical membrane protein 
1590 NCgl2889 7 54.2 hypothetical protein 
1591 NCgl2890 16 49.4 hypothetical protein 
1592 NCgl2892 2 10.4 ABC-type transporter: ATPase component 
1593 NCgl2893 3 1.5 efflux system protein 
1594 NCgl2894 72 64.7 myo-inositol-1-phosphate synthase 
1595 NCgl2896 23 30.1 hypothetical protein 
1596 NCgl2897 13 47.3 starvation-inducible DNA-binding protein 
1597 NCgl2898 6 12.2 formamidopyrimidine-DNA glycosylase [3.2.2.23] 
1598 NCgl2899 1 3.9 hypothetical protein 
1599 NCgl2901 3 20.9 methylated DNA-protein cysteine methyltransferase [2.1.1.63] 
1600 NCgl2902 3 8 hypothetical protein 
1601 NCgl2904 20 32.7 malic enzyme [1.1.1.40] 
1602 NCgl2905 11 13.2 sugar kinase [2.7.1.12] 
1603 NCgl2908 1 2.5 putative mercuric reductase [1.16.1.1] 
1604 NCgl2909 10 12.4 D-amino acid dehydrogenase subunit 
1605 NCgl2910 1 2.8 hypothetical protein 
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1606 NCgl2913 2 4.4 nitroreductase 
1607 NCgl2915 56 28.5 leucyl-tRNA synthetase 
1608 NCgl2918 1 3.7 hypothetical protein 
1609 NCgl2919 6 11.8 2-hydroxyhepta-2:4-diene-1:7-dioatesomerase 
1610 NCgl2923 1 2.3 putative hydroxylase/monooxygenase 
1611 NCgl2927 18 26.1 anthranilate synthase component I [4.1.3.27] 
1612 NCgl2929 20 36.8 anthranilate phosphoribosyltransferase [2.4.2.18] 
1613 NCgl2930 25 30.6 indole-3-glycerol phosphate synthase [5.3.1.24] 
1614 NCgl2931 8 18.5 tryptophan synthase beta chain [4.2.1.20] 
1615 NCgl2932 12 31.8 tryptophan synthase alpha chain [4.2.1.20] 
1616 NCgl2934 2 7.8 hypothetical protein 
1617 NCgl2938 6 16.5 NADH:flavin oxidoreductase 
1618 NCgl2940 2 6.2 hypothetical protein 
1619 NCgl2941 1 9.8 predicted transcriptional regulator 
1620 NCgl2942 6 4.8 NADH:flavin oxidoreductase 
1621 NCgl2943 10 41.2 hypothetical protein 
1622 NCgl2950 3 7.6 transcriptional regulator 
1623 NCgl2951 2 10.3 putative hydroxyquinol/catechol 1:2-dioxygenase 
1624 NCgl2952 1 4.4 maleylacetate reductase 
1625 NCgl2954 2 9.1 transcriptional regulator 
1626 NCgl2956 1 5.1 hypothetical protein 
1627 NCgl2958 2 10.2 putative dehydrogenase 
1628 NCgl2961 1 5 putative proline-betaine transporter 
1629 NCgl2964 10 6.7 putative helicase 
1630 NCgl2970 11 22.5 ABC-type transport systems: periplasmic component 
1631 NCgl2971 3 6.2 putative oxidoreductase/dehydrogenase 
1632 NCgl2973 20 47 hydroxymethylpyrimidine/phosphomethylpyrimidine kinase 
1633 NCgl2975 2 25.4 putative copper chaperone 
1634 NCgl2976 2 11.3 hypothetical membrane protein 
1635 NCgl2978 2 7 hypothetical protein 
1636 NCgl2979 24 26.1 putative polynucleotide polymerase 
1637 NCgl2980 9 5 hypothetical protein 
1638 NCgl2982 2 2.7 putative virulence factor 
1639 NCgl2984 26 48.6 thioredoxin reductase [1.6.4.5] 
1640 NCgl2985 7 35.5 thioredoxin 
1641 NCgl2986 11 16.4 N-acetylmuramoyl-L-alanine amidase [3.5.1.28] 
1642 NCgl2988 13 14.8 putative cell division protein ParB 
1643 NCgl2989 11 29.6 putative cell division protein ParA 
1644 NCgl2990 10 25.1 glucose-inhibited division protein B 
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Appendix III 
 
Table 3. List of the DNA-binding transcriptional regulators identified by MALDI 
TOF/TOF MS and database search after separation with two-dimensional reversed 
phase chromatography at high and low pH. The list is based on the work of Brinkrolf et 
al. (2007). 
 
 
Category NCgl no. Description of regulatory function
Carbohydrate metabolism NCgl0110 Repressor of xylulose kinase gene 
 NCgl0154 Repressor of iositol metabolism 
 NCgl0286 Repressor of acetate/gluconate metabolism 
 NCgl0358 Repressor of acetate metabolism 
 NCgl1203* Repressor of ribose uptake 
 NCgl1483 Repressor of aconitate gene 
 NCgl1856 Repressor in fructose PTS gene region 
 NCgl1859* Repressor of fructose PTS system 
 NCgl2299 Repressor of vanillate metabolism 
 NCgl2308* Repressor of protocatechuate degradation 
 NCgl2311 Activator of aromatic compound 
degradation 
 NCgl2324* Activator of aromatic compound 
degradation 
 NCgl2472 Activator of acetate metabolism and cspB 
gene 
 NCgl2587* Activator of phenol degradation 
 NCgl2954 Activator of hydroxyquinol pathway 
Specific biosynthesis 
pathways and transport 
systems 
NCgl0253* Activator of amino acid export system 
BrnEF 
 NCgl0368* Repressor of MFS-type transporters 
 NCgl0886 Repressor of MmpL-type transporter 
 NCgl1215 Activator of amino acid transport system 
LysE 
 NCgl1345 Repressor of arginine biosynthesis 
 NCgl1551 Repressor of pyrH and pyrBC genes 
 NCgl1578* Repressor of genes cg1844-cg1847 
 NCgl1853* Repressor of ribonucleotid 
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Macroelement and metal 
homeostasis 
NCgl0120 Activator of assimilatory sulphate reduction 
 NCgl0829 Repressor exerting global nitrogen control 
 NCgl1845 Dual regulator of iron metabolism 
 NCgl2199* Repressor of furB regulatory gene 
 NCgl2684 Repressor of cg3083–cg3085 genes 
 NCgl2840 Repressor of sulphur metabolism 
SOS and stress response NCgl1504* Repressor of iron-sulfur cluster biogenesis 
 NCgl1855 Repressor of SOS response 
 NCgl2211 Repressor of heat shock response 
 NCgl2699 Repressor of heat shock response 
*Identified by one non-redundant peptide 
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Appendix IV 
 
Table 4. Integral membrane proteins identified in the present by MALDI TOF/TOF 
mass spectrometry and database search after separation with two-dimensional reversed 
phase chromatography at high and low pH. The number of transmembrane helices 
(TMH) of the proteins was obtained from Fischer et al. 
 
Nr. of 
TMH Locus ID Protein 
No. of 
hits 
No. of different 
peptides 
1 NCgl0032 hypothetical protein 20 7 
1 NCgl0044 protein serine/threonine phosphatase [3.1.3.16] 1 1 
1 NCgl0070 hypothetical protein 6 3 
1 NCgl0195 predicted glycosyltransferases 4 3 
1 NCgl0321 predicted glycosyltransferase 2 2 
1 NCgl0400 phosphoserine phosphatase [3.1.3.3] 3 1 
1 NCgl0576 hypothetical protein 1 1 
1 NCgl0603 predicted nucleoside-diphosphate-sugar epimerase 11 5 
1 NCgl0677 detergent sensitivity rescuer dtsR2 51 15 
1 NCgl0678 detergent sensitivity rescuer dtsR1 13 8 
1 NCgl0841 trypsin-like serine protease [3.4.21.-] 5 2 
1 NCgl1360 hypothetical protein 8 5 
1 NCgl1409 NADH dehydrogenase: FAD-containing subunit [1.6.99.3] 70 13 
1 NCgl2095 serine/threonine protein kinase 6 5 
1 NCgl2402 hypothetical protein 2 2 
2 NCgl0060 Mg2+ and Co2+ transporter protein 1 1 
2 NCgl0124 hypothetical membrane protein 9 7 
2 NCgl0293 hypothetical membrane protein 3 2 
2 NCgl0337 putative ATPase involved in chromosome partitioning 10 5 
2 NCgl0365 uncharacterized membrane protein 1 1 
2 NCgl0722 two-component system sensory transduction histidine kinase 1 1 
2 NCgl1079 hypothetical membrane protein 4 2 
2 NCgl1081 hypothetical membrane protein 1 1 
2 NCgl1160 F0F1-type ATP synthase c subunit [3.6.1.34] 13 1 
2 NCgl1201 hypothetical membrane protein 1 1 
2 NCgl1389 hypothetical membrane protein 1 1 
2 NCgl1831 hypothetical membrane protein 3 2 
2 NCgl1930 hypothetical membrane protein 4 1 
2 NCgl1941 hypothetical membrane protein 4 2 
2 NCgl1988 hypothetical protein 2 1 
2 NCgl2071 hypothetical membrane protein 2 1 
2 NCgl2111 cytochrome C 2 1 
2 NCgl2129 hypothetical membrane protein 2 2 
2 NCgl2517 two-component system: sensory transduction histidine kinase 1 1 
2 NCgl2597 hypothetical membrane protein 1 1 
2 NCgl2627 hypothetical protein 5 2 
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2 NCgl2629 hypothetical membrane protein 3 3 
2 NCgl2737 putative membrane protease subunit 25 8 
2 NCgl2741 hypothetical membrane protein 4 2 
3 NCgl0058 hypothetical membrane protein 1 1 
3 NCgl0649 hypothetical membrane protein 1 1 
3 NCgl0743 predicted NAD-binding component of Kef-type K+ transport system 4 3 
3 NCgl1042 hypothetical membrane protein 2 1 
3 NCgl1086 hypothetical membrane protein 3 2 
3 NCgl2110 Rieske Fe-S protein 10 6 
3 NCgl2114 hypothetical membrane protein 1 1 
3 NCgl2132 hypothetical membrane protein 2 1 
3 NCgl2282 hypothetical membrane protein 1 1 
3 NCgl2638 multisubunit Na+/H+ antiporter 1 1 
3 NCgl2888 hypothetical membrane protein 1 1 
4 NCgl0221 Mg/Co/Ni transporter MgtE 2 2 
4 NCgl0249 hypothetical membrane protein 1 1 
4 NCgl0769 cell division protein 3 2 
4 NCgl0815 hypothetical membrane-associated protein 1 1 
4 NCgl0914 putative ABC transporter ATPase component 1 1 
4 NCgl1035 ABC-type transporter: permease component 1 1 
4 NCgl1043 hypothetical protein 3 2 
4 NCgl1114 hypothetical membrane protein 1 1 
4 NCgl2434 hypothetical membrane protein 1 1 
5 NCgl0340 predicted nucleoside-diphosphate sugar epimerase 7 5 
5 NCgl0585 two-component system sensor kinase 1 1 
5 NCgl0608 ABC-type transporter: permease component 2 1 
5 NCgl0925 ABC-type transporter: ATP-binding component 1 1 
5 NCgl1218 hypothetical membrane protein 3 2 
5 NCgl1893 DNA translocase spoIIIE-like protein 5 2 
5 NCgl1997 ABC-type transporter: ATPase component and permease component 2 2 
5 NCgl1998 ABC-type transporter: ATPase component and permease component 2 2 
5 NCgl2564 ABC-type transporter: ATPase component 2 1 
5 NCgl2839 hypothetical membrane protein 3 1 
6 NCgl0648 multiple transmembrane domain containing protein 2 2 
6 NCgl1159 F0F1-type ATP synthase a subunit [3.6.1.34] 3 2 
6 NCgl1576 predicted membrane protein 2 2 
6 NCgl1594 preprotein translocase subunit SecD 2 1 
6 NCgl1877 glutamate ABC-type transporter: permease component 5 3 
6 NCgl2373 ABC-type transporter: permease component 2 1 
6 NCgl2374 ABC-type transporter: permease component 1 1 
7 NCgl0445 phosphate/sulphate permease 1 1 
7 NCgl0752 hypothetical protein 2 2 
7 NCgl2498 predicted membrane proteins 1 1 
8 NCgl0375 cation transport ATPase [3.6.1.-] 4 2 
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8 NCgl1739 hypothetical protein 2 1 
8 NCgl2079 bacterial cell division membrane protein 1 1 
8 NCgl2703 predicted permease 1 1 
9 NCgl0551 hypothetical membrane protein 1 1 
9 NCgl0565 putative membrane protein 1 1 
9 NCgl0927 hypothetical protein 1 1 
9 NCgl0994 GGDEF family protein 16 2 
9 NCgl1488 cation transport ATPase [3.6.1.-] 3 1 
9 NCgl1861 phosphotransferase system: fructose-specific IIC component [2.7.1.69] 3 1 
9 NCgl1892 membrane protein TerC 1 1 
9 NCgl2109 cytochrome b subunit of the bc complex 9 4 
9 NCgl2130 predicted permease 1 1 
9 NCgl2533 hypothetical protein 1 1 
10 NCgl0127 hypothetical membrane protein 2 1 
10 NCgl0532 preprotein translocase subunit SecY 2 2 
10 NCgl0543 hypothetical membrane protein 3 2 
10 NCgl0674 predicted acyltransferase 2 2 
10 NCgl0821 ABC-type transporter: permease component 1 1 
10 NCgl1305 
phosphotransferase system IIC 
component: glucose/maltose/N-
acetylglucosamine-specific 
19 6 
10 NCgl2103 hypothetical membrane protein 1 1 
10 NCgl2464 ABC-type transporter: permease component 1 1 
10 NCgl2553 phosphotransferase system IIC component [2.7.1.69] 4 3 
10 NCgl2780 hypothetical membrane protein 1 1 
10 NCgl2883 hypothetical membrane protein 1 1 
11 NCgl0406 permease of the major facilitator superfamily 1 1 
11 NCgl1380 NhaP-type Na+/H+ and K+/H+ antiporter 6 3 
11 NCgl2961 putative proline-betaine transporter 1 1 
12 NCgl1085 ABC-type transporter: duplicated ATPase component 2 2 
12 NCgl1108 putative gamma-aminobutyrate permease 3 2 
12 NCgl2251 choline-glycine betaine transporter 6 2 
12 NCgl2276 xanthine/uracil permease 1 2 
12 NCgl2437 heme/copper-type cytochrome/quinol oxidase: subunit 1 [1.9.3.1] 13 5 
12 NCgl2757 hypothetical membrane protein 1 1 
12 NCgl2876 putative transmembrane transport protein 3 2 
13 NCgl0185 hypothetical membrane protein 1 1 
13 NCgl0799 Na+/proline: Na+/panthothenate symporter or related permease 7 1 
13 NCgl0986 Na+-dependent transporter of the SNF family 2 2 
13 NCgl1116 putative Na+/proline: Na+/panthothenate symporter 1 1 
14 NCgl0184 putative arabinosyl transferase 5 4 
15 NCgl2982 putative virulence factor 2 2 
16 NCgl0626 carbon starvation protein: predicted membrane protein 11 5 
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Appendix V 
 
Table 5. Two-component signal transduction systems of C. glutamicum identified by 
MALDI TOF/TOF mass spectrometry and database search after separation with two-
dimensional reversed phase chromatography at high and low pH. Out of the two 
components. only the response regulators were identified. The sensor kinases are 
integral membrane proteins which were probably not extracted with the protocol 
employed in this work. 
 
Gene NCgl 
no. 
Component Regulatory role 
mtrB NCgl0722 Sensor kinase 
mtrA NCgl0721 Response 
regulator 
Cell wall metabolism and osmoregulation (Möker et 
al..2004) 
phoS NCgl2517 Sensor kinase 
phoR NCgl2518 Response 
regulator 
Adaptation to phosphate starvation (Koĉan et 
al..2006) 
cgtS4 NCgl0391 Sensor kinase 
cgtR4 NCgl0392 Response 
regulator 
No data 
cgtS5 NCgl2573 Sensor kinase 
cgtR5 NCgl2572 Response 
regulator 
No data 
cgtS7 NCgl0585 Sensor kinase 
cgtR7 NCgl0586 Response 
regulator 
No data 
cgtS9 NCgl2862 Sensor kinase 
cgtR9 NCgl2863 Response 
regulator 
Copper metabolism (Koĉan et al..2006) 
cgtS11 NCgl2835 Sensor kinase 
cgtR11 NCgl2834 Response 
regulator 
No data 
 
 
 
  APPENDIX 
 
                                                                  A 45
Appendix VI 
 
Table 6. List of peptides identified by LC-MALDI that carry net charge +1 at pH 2.1. 
All these peptides corresponded to a C-terminal end of a protein. 
 
Charge  Sequence Protein ID Name  
+1 MGPLSQGMGGLF NCgl0240 hypothetical protein Cterminus 
+1 AVNEYLDSSFYEAG NCgl0399 hypothetical protein Cterminus 
+1 GVGGEVLAYVW NCgl0515 ribosomal protein S8 Cterminus 
+1 APVIPEGLF NCgl0628 uncharacterized protein Cterminus 
+1 AAQLGLVDVEQF NCgl0838 hypothetical protein Cterminus 
+1 WVTAQAMFG NCgl1202 6-phosphofructokinase [2.7.1.11] Cterminus 
+1 LFQWQED NCgl1231 hypothetical protein Cterminus 
+1 FTLPFGIQA NCgl1335 phe-tRNA synthetase alpha subunit Cterminus 
+1 LVFLAGPAE NCgl1385 FHA-domain-containing protein Cterminus 
+1 QTGADDLSAEAFPEFE NCgl1456 hypothetical protein Cterminus 
+1 SIVWGWYEN NCgl1466 phospholipid-binding protein Cterminus 
+1 IAALIAQDLDAE NCgl1862 hypothetical protein Cterminus 
+1 LETANFEGDLQL NCgl2126 dihydrolipoamide acyltransferase  Cterminus 
+1 LDDPTSVSVDPNAPEE NCgl2167 pyruvate dehydrogenase Cterminus 
+1 EYFGEEEVAETESEA NCgl2329 FKBP-type cis-trans isomerase Cterminus 
+1 VIEASTLAEALAAVSL NCgl2575 DNA repair protein Cterminus 
+1 NLLVSYDPNPTGLF NCgl2698 NAD- aldehyde dehydrogenase Cterminus 
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Appendix VII 
 
Calculated isoelectric point for the identified peptides with respect to the fraction were 
they eluted during the first dimension of the 2D-RP-HPLC separation at high and low 
pH. Peptides are grouped according to their net charge at pH 10. 
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Appendix VIII 
 
Hydrophobic character of the identified peptides calculated according to the Eisenberg 
scale. Peptides are plotted according to the fraction were they eluted during the first 
dimension of the 2D-RP-HPLC separation at high and low pH. Peptides are grouped 
according to their net charge at pH 10. 
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Appendix IX 
 
The relative occurrence of aspartic acid and glutamic acid in the peptides identified by 
MALDI MS and ESI MS is higher than the relative occurrence predicted for the 
theoretical digest. 
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Appendix X 
 
Enzymes catalizing the reactions of the lysine biosynthesis pathway identified by the 
different proteomic approaches described in the present work: 2D-PAGE and two-
dimensional RP x IPRP-HPLC followed by either MALDI TOF/TOF MS or ESI-IT 
MS. 
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Appendix XI 
 
Enzymes of the methionine biosynthesis pathway identified. The proteomic approaches 
compared in the present work are: 2D-PAGE and 2D- RP x IPRP-HPLC followed by 
either MALDI TOF/TOF MS or ESI-IT MS. 
 
 
 
 
